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Disclaimer
These Guidelines have been developed to assist health care workers.  The diagnosis and treatment of alcohol problems
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are not a substitute for such advice, and should not be used to diagnose or prescribe treatment for any alcohol problem.
The views expressed in these Guidelines are not necessarily those of the Commonwealth or the National Drug and
Alcohol Research Centre. 
The Commonwealth and the National Drug and Alcohol Research Centre do not accept liability for any injury, illness,
damage or loss incurred by any person arising from the use of or reliance on the information and advice that is provided
in these Guidelines.
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Executive Summary and Recommendations
Introduction
These guidelines are based on a review of the evidence about the effectiveness of treatments, and
on the clinical experience of an expert panel.
The aim of the guidelines is to provide evidence that guides treatment, education and professional
development. It is not our aim to dictate treatments.
These guidelines are intended for all health workers and medical practitioners who come into
contact with dependent or problem drinkers. Summary guidelines are available in 
mid-2003.
Problem drinking affects a broad cross section of Australia’s population, with impacts on health,
social, employment, and economic outcomes. However some groups face barriers to treatment,
namely lower socioeconomic groups, those living in rural and remote communities, Indigenous
Australians, prisoner inmates, those with comorbid mental health problems, and older people. 
SCREENING  STRENGTH OF 
RECOMMENDATION
Screening for risky and high risk alcohol consumption should Strong
be widely implemented in general practice, hospitals, 
community health care, and workplaces. 
The AUDIT, the Quantity Frequency Index or the Retrospective Diary Strong
are recommended for screening in the above settings. 
The T-ACE and the TWEAK are recommended for screening risky Strong
drinking in pregnant women. 
ASSESSMENT
Assessment for more intensive intervention should be conducted Strong
in a semi-structured, narrative style, with strategic use of structured 
questionnaires such as the SADD or the SADC-Q. 
The length of the assessment process needs to be balanced with Strong
retaining the client in treatment. Therefore, clinicians need to make
decisions about which aspects of assessment are essential. Key 
topics are the client’s consumption of alcohol, level of alcohol 
dependence, cognitive functioning, psychological comorbidity, 
family situation, physical well-being, and readiness for change. 
Assessment should lead to a clear, mutually-acceptable treatment plan Strong
that structures a specific intervention to meet the needs of the individual. 
Readiness to change may be best assessed via direct questioning. Moderate
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ASSESSMENT STRENGTH OF 
RECOMMENDATION
Where possible and with the client’s permission, family members Moderate
should be involved in the assessment process. 
Assessment for anxiety and depressive symptoms and disorders Strong
should be routine. 
PATIENT-TREATMENT MATCHING
The intensity of interventions should vary, with clients with more Moderate
severe problems receiving more intensive treatments. 
Co-morbid psychological disorders should be taken into account when Moderate
assigning patients to treatment, particularly when pharmacotherapies 
are being considered as a relapse prevention strategy. 
Where possible, clients should be offered a choice of interventions. Moderate
The pros and cons of abstinence versus moderated drinking should 
be considered in light of the client’s goals, their level of dependence, 
their physical health and their relapse history.
WITHDRAWAL MANAGEMENT
Patient experiencing withdrawal complications such as seizures, Strong 
hallucinations, delirium and delirium tremens should be monitored 
carefully and regularly using a withdrawal rating scale. 
Patients at risk of Wernicke-Korsakoff’s syndrome should be treated Strong
with 100mg of intramuscular or oral thiamine before any glucose intake. 
Patient withdrawing from alcohol should be monitored with  Strong
a withdrawal rating scale. The CIWA-Ar is the recommended scale. 
If the CIWA-Ar scale is unavailable then the AWS should be used. Fair 
Although the AWS is widely used in Australia, it is not validated. 
Home-based withdrawal management is recommended for patients Strong
with mild to moderate withdrawals who have a support network, 
no known co-existing medical or psychiatric illness, and no history 
of withdrawal complications. 
Outpatient withdrawal management is appropriate for patients with  Strong
mild to moderate withdrawals who have no history of severe withdrawal, 
and no known co-existing medical or psychiatric illness.
Inpatient withdrawal management is required for people who have  Strong
severe withdrawal complications, a history of withdrawal complications, 
and/or a known co-existing medical or psychiatric history. 
Supervised non-medicated withdrawal management is appropriate only Strong
for people with mild to moderate alcohol withdrawal, and for those 
who have no known coexisting medical or psychiatric illnesses. 
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WITHDRAWAL MANAGEMENT STRENGTH OF 
RECOMMENDATION
A supervised medicated withdrawal is required for people who are Strong
at risk of or suffer from alcohol withdrawal complications. 
Diazepam is recommended as the “gold-standard” and first-line Strong
treatment for alcohol withdrawal symptoms. 
Anti-convulsant medications are recommended for patients who take Moderate 
them on a regular basis before admission, and with patients who have
epilepsy related to alcohol withdrawal. 
Haloperidol (a major tranquilliser) is recommended for use with Moderate
patients experiencing hallucinations and/or paranoid symptoms where 
diazepam is not effective in reducing or alleviating the hallucinations 
and paranoid symptoms. 
100mg of intramuscular or oral thiamine should be administered Strong
before any glucose intake to any patient at risk of alcohol 
withdrawal complications. 
Multi-vitamins and fluids should be given to any patient withdrawing Moderate
from alcohol. 
POST-WITHDRAWAL TREATMENT SETTING
Decisions about treatment setting should be based on the client’s Strong
treatment goals, preferences, severity of dependence, the presence 
of comorbid disorders, cognitive and social functioning, relapse 
history, and social circumstances. 
Residential programs should aim to increase retention in treatment Moderate
by running structured, interactive induction sessions addressing the 
problems of staying in treatment and other client concerns, by using 
motivational interviewing techniques, and by strengthening the 
client’s involvement in treatment and therapeutic alliances. 
Residential programs should be modified to meet the needs Moderate
of particular groups, for example those with comorbid disorders, 
those with childcare responsibilities, and the homeless. 
BRIEF INTERVENTIONS
Brief interventions should be routine practice in general practice  Strong
settings, general and emergency hospital wards, and community 
counselling centres. 
Brief interventions should consist of the six components of the Moderate
FRAMES acronym: feedback, responsibility, advice, menu, empathy 
and self-efficacy. 
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BRIEF INTERVENTIONS STRENGTH OF 
RECOMMENDATION
Where brief interventions are not successful in reducing alcohol Strong
consumption, a more intensive treatment should be offered to the client. 
Health care professionals who work in general practice settings,  Strong
general and emergency hospital wards, and community counselling  
services should be trained to deliver brief interventions. 
PSYCHOSOCIAL INTERVENTIONS
Since clinician characteristics influence treatment outcomes, it is Strong
recommended that clinicians receive interpersonal skills training, 
focusing particularly on empathy. 
An organised approach to treatment is most effective, supported by Moderate 
careful case and progress notes. 
General counselling skills should form the basis of Strong
a therapeutic relationship. 
General counselling skills should be supported by more specific  Strong
techniques aimed at initiating a change in behaviour. 
Motivational interviewing is recommended as a treatment intervention. Strong
Motivation is recommended particularly for patients who are Moderate
ambivalent about changing their behaviour. 
Personalising information about the adverse health effects of risky  Strong
drinking is recommended as a strategy to increase motivation to change. 
The various interventions that fall under the umbrella of cognitive Strong
behavioural interventions should be implemented in treatment settings. 
Skills training should be offered to clients who lack the relevant skills. Strong
Problem solving skills training, assertiveness skills training, Strong
communication skills training, drink refusal skills training, and 
relaxation and stress management skills trainings are recommended 
for use with risky and dependent drinkers. 
Although appropriate for individual settings, skills should be  Moderate
implemented in group settings to allow for role-play and modelling.
Skills training is recommended for patients who have a high Strong
risk of relapse.
Behavioural self-management should be offered to clients with a goal Strong
of moderation, and to those who are extremely unlikely to stop drinking.
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PSYCHOSOCIAL INTERVENTIONS STRENGTH OF 
RECOMMENDATION
The client should be introduced to the National Health and Medical Strong
Research Council’s Alcohol Guidelines. 
Clients should be taught the concept of a standard drink to assist Strong
in monitoring levels of consumption. 
Cognitive restructuring procedures are recommended as part of more Strong
comprehensive interventions that rely on providing the client with 
specific skills. 
Cognitive restructuring is not recommended for patients with Strong
cognitive deficits. 
Cognitive restructuring should be practised throughout the Strong
treatment process. 
Cue exposure should consist of six to 12 sessions of 50 - 90 minutes. Moderate
Cue exposure should only be offered by treatment specialists who Strong
have appropriate training in the strategy. 
Behavioural couples therapy should emphasise that drinking  Strong
is the problem, and focus on drinking behaviour as the problem 
which needs to be fixed. 
Behavioural couples therapy should not address entrenched Strong
relationship problems or be used to counteract violence. 
Behavioural couples therapy is recommended for couples with Fair
moderate to low problems in their relationship, couples who are 
living together, are at least high school educated and are employed. 
Clinicians who deliver behavioural couples therapy should be  Strong
suitably trained in the delivery of this intervention. 
The interventions delivered should be supported by empirical research. Strong
Self-help manuals should be made readily available to the general Strong
public to assist drinkers who wish to cease or cut-down drinking 
without the aid of professionals. 
Self-help materials are most appropriate for risky drinkers rather than Moderate
those suffering from alcohol dependence. 
Self-help manuals should be modified to suit people from non-English Strong
speaking backgrounds and those with a low reading age. 
Computer and internet based self-help materials should continue Strong
to be developed, as they may provide helping materials to a population 
of problem drinkers who may not ordinarily access treatment. 
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PSYCHOSOCIAL INTERVENTIONS  STRENGTH OF 
RECOMMENDATION
Treatment intervention procedures should be clearly specified Strong
in a written form. 
Clinicians should be adequately trained in the procedures involved. Strong
RELAPSE PREVENTION
Psychosocial relapse prevention strategies are recommended for use Strong
with all moderate to severely alcohol dependent clients. 
Psychosocial relapse prevention is best delivered after acute Moderate
withdrawal symptoms have subsided. 
High risk situations should be assessed for each client, along with Strong
other risk factors such as cravings, disease beliefs, and coping skills.
Acamprosate is recommended as an adjunct to psychosocial relapse Strong
prevention for moderate to severely alcohol dependent clients, 
with the exception of those contraindicated as per table 9.1. 
Naltrexone is recommended as an adjunct to psychosocial relapse Strong
prevention for moderate to severely alcohol dependent clients, with 
the exception of those contraindicated as per table 9.1. 
Patients who are opioid dependent should not be prescribed Strong
naltrexone. All patients should be warned of the potential for 
opioid withdrawal syndrome if any form of opiates is taken, 
i.e. heroin, methadone, and opioid analgesics. 
For some patients, GP management to accompany acamprosate Moderate
and naltrexone will be sufficient. More severely dependent clients and 
chronic relapsers will need more intensive psychosocial interventions. 
Thus, psychosocial treatment should be tailored to the needs of the 
patient and should include relapse prevention strategies. 
Acamprosate and naltrexone should be started within one week Moderate
of detoxification. 
Acamprosate and naltrexone are usually taken for three to six months, Moderate
and in some cases up to 12 months. Optimum treatment duration has 
not been established. 
Many patients find it difficult to comply with a medication program. Strong
This issue should be addressed with compliance therapy which is 
based on motivational interviewing and cognitive-behavioural strategies. 
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EXTENDED CARE STRENGTH OF 
RECOMMENDATION
Attention should be given to the client’s retention in treatment and Strong
social support networks. 
Aftercare should be structured and assertive, with follow-up Strong
of missed appointments. 
Clients who show signs of dependence on alcohol should be made Moderate
aware of the service offered by meetings of Alcoholics Anonymous 
(AA). Mandated AA participation is not recommended. 
Conventional AA meetings should not be viewed as treatment for Moderate
alcohol dependence. 
TREATMENT ISSUES FOR SPECIFIC GROUPS
ADOLESCENTS
Given the limitations of diagnostic criteria for alcohol use disorders Strong
with adolescents, a flexible approach to diagnosis and treatment 
is needed. Whilst some young people may not meet strict diagnostic 
criteria for alcohol dependence or abuse, this should not be a barrier 
to treatment. 
Clinicians should focus on building and maintaining a relationship Strong
with younger clients through outreach, crisis intervention and harm 
reduction activities, and the use of an empathetic, non-judgemental, 
developmental approach to counselling. 
Brief and motivational interventions help to reduce alcohol Strong
consumption among adolescent heavy or binge drinkers, across 
a range of settings. 
Younger drinkers who require more intensive intervention may Strong
have different treatment needs to older drinkers. These needs should 
start to be identified during the assessment phase, and may include 
crisis intervention, assertive outreach, and building social 
support networks. 
The recommended psychological treatment for young people Moderate 
is cognitive behavioural therapy. Other potentially useful treatments 
include social skills training, family therapy, therapeutic support 
groups, and interpersonal therapy. 
COGNITIVELY IMPAIRED CLIENTS
A brief assessment of cognitive functioning should be a routine Strong
part of assessment upon treatment entry. 
More detailed assessment should be carried out where brief assessment Strong
suggests that a patient suffers from significant cognitive deficits. 
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TREATMENT ISSUES FOR SPECIFIC GROUPS STRENGTH OF 
RECOMMENDATION
COGNITIVELY IMPAIRED CLIENTS
Where cognitive impairment is confirmed, information presented Strong
to patients should be concrete and patients should be given 
opportunities to practise behaviours taught during treatment sessions. 
Cognitively impaired patients should be engaged in treatment Moderate
by the clinician by:
· providing information about treatment
· discussing different treatment options
· establishing a positive relationship
· maintaining contact with the client
The clinician should frequently check that the client understands what Strong 
is being said, and that the clinician understands what the client is saying.
The possibility of improvement in cognitive functioning should Strong
be taken into account by allowing a sufficient period of abstinence 
from alcohol to elapse before finalising treatment planning. 
Cognitively impaired patients should be taught relapse Moderate
prevention strategies. 
COMORBID DISORDERS
The AUDIT is recommended for screening psychiatric populations. Strong
Assessment for comorbid disorders should take place once the Strong
client’s withdrawal syndrome has diminished, since some anxiety 
and depressive symptoms may abate once alcohol consumption 
is reduced or ceased. 
Comorbid mood and anxiety disorders which do not abate Strong
after alcohol withdrawal is complete should be treated with
integrated/concurrent CBT for the cormorbid disorder. 
Alcohol dependent patients with comorbid anxiety should Moderate 
be considered for treatment with buspirone, depending on the 
severity and nature of their symptoms. 
Alcohol dependent patients with major depression should Fair 
be considered for treatment with desipramine, depending on the 
severity and nature of their symptoms. 
Schizophrenic patients who are risky drinkers should be Fair
considered for treatment with clozapine or risperidone, depending 
on the severity and nature of their symptoms. 
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TREATMENT ISSUES FOR SPECIFIC GROUPS STRENGTH OF 
RECOMMENDATION
COMORBID DISORDERS
Alcohol dependent patients with antisocial personality disorder Fair
should be considered for treatment with nortriptyline, depending 
on the severity and nature of their symptoms. 
GENDER
Treatment providers need to be aware of and sensitive to issues Strong
particular to women with alcohol problems. 
Service providers should try to improve the recruitment of women Moderate
to their services by improving outreach, setting up referral networks, 
advertising facilities specifically targeting women, and providing 
more detailed information about services. This would increase 
women’s awareness of treatment services available, and may 
decrease any reservations or fears about entering treatment. 
All clients should be provided with a safe therapeutic environment, Strong
as the prevalence of physical and sexual abuse is high, particularly 
among women with alcohol problems. 
Treatment agencies should offer all clients the opportunity to receive Strong
information about, and address health and other issues such as 
depression, anxiety and sexual and physical assault. 
Women should be referred to other specialist services where Strong
necessary and appropriate. 
Where possible, patients should be given the option of having Moderate
a clinician of the same or opposite gender, as preferred. 
INDIGENOUS CLIENTS
Relapse among Indigenous clients who have completed treatment Moderate 
is likely to be high when clients return to a poor socio-economic 
situation. Treatment services therefore need to be supported by 
effective, culturally appropriate interventions at the population level. 
Clients may present to health care clinics with minor complaints Strong 
without volunteering information about alcohol consumption. 
Carefully worded questions about the frequency of heavy drinking 
and average daily consumption can help to identify risky drinking. 
Cultural sensitivity should not be confused with treatment efficacy. Moderate 
For example, brief interventions may still be effective with Indigenous
drinkers, but ways of communicating and knowledge of issues such 
as gender roles are important issues in their implementation. 
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TREATMENT ISSUES FOR SPECIFIC GROUPS STRENGTH OF 
RECOMMENDATION
INDIGENOUS CLIENTS
Increasing compliance with medications such as acamprosate Moderate 
and naltrexone for Indigenous clients may entail addressing 
a slightly different set of issues, which will in turn depend on the 
client’s cultural environment. 
There is great potential for opportunistic intervention by medical Strong
staff in hospitals, as well as in other settings, such as in sobering 
up centres, workplaces, correctional facilities, and community 
health services. 
The services available for Indigenous clients need to provide Strong
a greater quality and diversity of treatment options. 
Health care practitioners should seek to keep clients engaged Strong
in treatment, whether or not the drinking behaviour changes. 
In the meantime, support can be offered to the drinker’s family 
and community. 
Primary care practitioners are advised to develop close working Moderate
relationships with the relevant area mental health service in order 
to help them deal with psychiatric comorbidity. 
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Chapter 1: Introductory comments
In 1993, the National Drug and Alcohol Research Centre (NDARC) completed a monograph on
behalf of the National Campaign Against Drug Abuse (NCADA), entitled “An outline for the
management of alcohol problems: Quality assurance project for the management of alcohol
dependence” (QAP). [1] The primary aim of the project was to advise drug and alcohol treatment
personnel in Australia on the current knowledge about the effectiveness of various techniques for
assisting people who are risky drinkers or who exhibit a dependence on alcohol. 
The Commonwealth, as part of the National Drug Strategy, has commissioned NDARC to develop
updated guidelines for the treatment of alcohol problems. Since 1993 research has been undertaken
for a range of treatments that at the time were relatively new or unavailable in Australia.
These guidelines are based on a review of the evidence for treatment efficacy, and upon the clinical
experience of the expert panel. In developing the guidelines, we have relied where possible on
evidence from well-designed research studies. Where this evidence was not available, recommen-
dations are based upon appropriate clinical experience. There is a “summary of evidence” box at
the end of each section. From this, readers can determine the strength of the evidence upon which
the recommendations that follow are based.
As with the 1993 guidelines, our intention is to provide evidence that guides rather than dictates
treatment interventions, education and professional development. Current research techniques do
not allow us to rule in or out various treatment methods: they do, however, provide a sound level
of evidence about what is effective in a research setting. In practice, many other factors impact
upon the effectiveness of treatment (e.g. resource availability, patients’ comorbid disorders, clinical
skills). However, it is reasonable to expect that treatments possess some evidence of efficacy before
they are supported in anything other than an experimental way. 
There are a number of treatment guidelines for treating people with alcohol problems. This
document is not intended to replace existing guidelines, rather, it provides a broad reference to a
range of treatment options. Where it is appropriate and relevant, we refer practitioners to existing
guidelines for more detail about the use of particular interventions. In other instances, we have
integrated - with acknowledgement - existing recommendations into our own.
Purpose of the guidelines
The primary aim of the current guidelines is to provide up-to-date, evidence-based information to
clinicians on the available treatments for people with alcohol problems. Up-to-date information is
required because of the size and importance of the health burden created by alcohol problems,
and the variations in practice for the treatment of alcohol dependence. Variation per se is not
problematic. Different treatments are appropriate for different clients. However, variation in the
quality of care remains an issue. In some instances, this is a resource and equity issue rather than
an issue of knowledge. These guidelines are aimed at the latter. 
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Audience for the guidelines
This comprehensive version of the guidelines is intended for clinicians who want a full review of
the treatment options for alcohol problems. Specific, summarised guidelines are also available (in
mid-2003) for general practitioners, drug and alcohol workers, general hospital workers, and
consumers. Throughout this document we use the terms “clinician” or “health care worker” to refer
to any of the above professionals.
Development of the guidelines
The guidelines are based on a review of the available evidence of efficacy (the Treatment of Alcohol
Problems: A Review of the Evidence) and the knowledge of an expert panel convened to develop
the guidelines. Members of the expert panel are listed in the preliminary pages. The procedure
used to identify research has involved searching relevant databases for published clinical trials,
hand searching journals, searching website bibliographies, canvassing for unpublished research,
and contact with major research centres for unpublished research and other relevant guidelines.
Databases searched include Medline, Psychinfo, Cochrane Database of Systematic Reviews, the
National Clearinghouse for Alcohol and Drug Information, Evidence Based Medicine Reviews, and
the Alcohol and Other Drug Council of Australia’s (ADCA) Drug Database. 
Levels of evidence and strength of recommendations
The National Health and Medical Research Council levels of evidence hierarchy (Table 1.1) was
used to classify the quality of the evidence available in each treatment area. [2] The preferred level
of evidence was a systematic review of all relevant randomised controlled trials. Overall, the quality
of evidence available was high: meta-analyses1 have been completed for most of the major treatment
modalities. We have therefore opted to use these existing analyses. 
For each treatment modality we have included the findings from meta-analytic reviews with a
narrative review of other relevant evidence, typically randomised controlled trials. Quality evidence
is scant for the effectiveness of treatment of specific sub-groups: indigenous clients, adolescents
and those with comorbid mental disorders. For these areas, we have reviewed clinical trials where
available, or otherwise relied on expert opinion. Similarly, while the residential/non-residential
rehabilitation debate has been discussed and researched at length, little has been done to clarify
which components of residential rehabilitation treatment work best, or for which clients residential
treatment is recommended. 
A randomised controlled trial refers to a study that has at least one treatment group and a control
group, usually placebo or no treatment. The study uses outcome measures before and after
treatment, and randomly assigns participants to the groups. Some trials, normally those testing
medications, also use a double blind where neither the participants nor the researcher know who
is receiving which treatment, or a single blind design where either the participants or the researcher
does not know who is receiving which treatment. Controlled trials allow the researcher to conclude
with a degree of certainty whether or not the treatment being tested is more effective than no
treatment. In field research with patients, this ideal design is not always possible because of ethical
concerns. However it is still possible to draw conclusions from some of these quasi-experimental
14 Guidelines for the Treatment of Alcohol Problems
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1 Meta analysis is a statistical technique which combines a number of single trials to increase the overall power and
certainty of outcomes.
designs, provided the correct statistical analysis is used to control for confounding variables. The
conclusions drawn though might be more tentative.
TABLE 1.1: DESIGNATION OF LEVELS OF EVIDENCE
LEVEL OF EVIDENCE STUDY DESIGN
I Evidence obtained from a systematic review of all relevant randomised
controlled trials.
II Evidence obtained from at least one properly designed randomised
controlled trial.
III-1 Evidence obtained from well-designed pseudo-randomised controlled
trials (alternate allocation or some other method).
III-2 Evidence obtained from comparative studies (including systematic
reviews of such studies) with concurrent controls and allocation not
randomised, cohort studies, case-control studies, or interrupted time
series with a control group.
III-3 Evidence obtained from comparative studies with historical control, two
or more single arm studies, or interrupted time series without a parallel
control group.
IV Evidence obtained from case series, either post-test or pre-test/post-test.
Source: “How to use the evidence: assessment and application of scientific evidence”, National
Health and Medical Research Council, 2000. Reproduced with permission. [2]
The strength of recommendation is based primarily on the evidence presented for the technique
in question, combined with clinical expertise. Three levels are used:
STRENGTH DESCRIPTOR
OF RECOMMENDATION
Strong The recommendation is supported by at least level II research and
expert clinical opinion.
Moderate The recommendation is supported by at least level III research and
expert clinical opinion.
Fair The recommendation is based on expert clinical opinion.
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Although experimental research evidence is the most appropriate way to determine the relative
efficacy of one treatment against another, the effects seen in such trials might be diluted when the
interventions are applied in normal clinical settings. Most trials examine the effects of interventions
under highly controlled and ideal conditions. Attention should also be given to more pragmatic
trials where interventions found to be efficacious in highly controlled trials are tested for their
effectiveness in real-life settings. Loss of effect can result from factors associated with the realities
of health care delivery, such as the training and experience of clinicians, the faithfulness with
which the intervention is delivered, and the time and resources that are available to implement
the intervention. These problems are present in all areas of health care, although they are likely
to be more marked in the case of non-pharmacological and non-proprietary methods of
intervention. [3] This commentary represents a clear caution about the adequacy of the implemen-
tation of interventions. The guidelines provide a summary of treatment procedures that are
advocated for use in interventions, from relatively brief interventions through to more intensive
approaches to the management of risky drinkers and alcohol dependent individuals, respectively. 
Despite the coverage of brief interventions, the interventions that are designed to assist people
with serious drinking problems remain the major focus of this document. Brief interventions are
an important part of the overall approach to alcohol problems in Australia, but they should not
be expected to replace specialist interventions that deal with chronic and severe cases. Programs
for alcohol dependent patients need to vary in intensity and length according to the degrees of
dependency and other problems in those drinkers. 
A distinction is drawn between two types of intervention: proactive and reactive. Proactive
interventions are those that should routinely occur when a person is recognised as a risky drinker
by a health care worker, even where drinking is not a focus of the examination. Thus, these
proactive interventions occur when the risky drinker has not specifically sought help for alcohol
problems. For a proactive intervention to occur, the health care worker needs to screen clients
routinely for alcohol problems to detect risky drinkers, and offer them an intervention aimed to
reduce alcohol consumption. The methods for proactive interventions are covered in Chapter 3:
Screening and assessment and Chapter 7: Brief interventions. In contrast, reactive interventions are
those that are conducted when the drinker directly seeks help for an alcohol problem. The
assessment and treatment plan involved in this intervention is likely to be longer than in the
proactive case. Most of this document is devoted to this type of intervention. Where appropriate,
clients can be referred from a brief, proactive intervention to an intensive intervention. 
What the guidelines cover
These guidelines are complementary to existing practical guidelines for the treatment of alcohol
problems and are to help clinicians make decisions about the type of interventions that should be
made available in their practice. A range of appropriate treatment procedures is described in this
monograph so that clinicians can select those approaches that match the setting and client type
with which they deal. 
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The treatment guidelines here provide a summary of what is supported by current research and
specialist opinion. Clinical practice must change with advances in the field. It is up to informed
individual clinicians to use the guidelines to guide but not to limit treatment needed for the circum-
stances of individual patients. The recommendations are outlines for treatment approaches, not
mandatory and inflexible rules for intervention. However, it is inappropriate for clinicians in Australia
to continue using treatment approaches of uncertain efficacy when there are procedures for which
there is reasonable evidence of effectiveness available. It is the responsibility of individual drug
and alcohol workers and counsellors as well as the government systems which support treatment
provision to ensure that the treatments made available are those believed to be the most effective. 
Interventions not in these guidelines either had no research supporting their effectiveness, based
on the review of the literature, or were deemed irrelevant because of undeveloped research, or
because the intervention concerned was not easily implemented. The information presented in
these guidelines should allow interested groups to design an overall intervention by selecting from
the procedures advocated. These guidelines do not attempt to provide information about systems
of treatment delivery, which is a policy decision that relates to the needs, resources and structure
of health care within jurisdictions. 
Finally, it is recognised that some people with alcohol problems change without formal help or
intervention. A complete account of alcohol use involves general societal factors, such as the
availability of alcohol, societal pressure to drink or not drink, prohibitions on permissibility of use
and restrictions on the age of use. At a more personal level, factors such as peer pressure, familial
and parental drinking patterns, as well as early learning experiences, life events, initial drinking
experiences and genetic predisposition are involved. It is not surprising then that there are many
influences outside the formal treatment system that affect drinking behaviour. Many of these
influences can also be directly manipulated within a formal treatment setting to take advantage of
this effect on drinking behaviour, but it remains true that formal treatment will affect the drinking
of only a proportion of the risky and problem drinkers in our society. Even so, there is a need for
a formal treatment approach based on reasonable evidence. 
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Chapter 2: Access to treatment: overcoming barriers
CHAPTER AIM
The aim of this chapter is to identify barriers that drinkers may encounter in seeking treatment.
Many barriers to treatment are equity-based and systemic. For example, lower socioeconomic
groups are less likely to be offered brief interventions. [4] Remote Indigenous communities often
have very limited access to treatment resources. [5] Types of barriers include: 
• Lower socioeconomic status.
• Lack of resources in rural areas, particularly within Indigenous communities
• Homelessness
• Comorbid psychological disorders, especially psychosis and schizophrenia
• Systemic barriers within the health care system (for example, Medicare rebate structure) which
influence health professionals’ behaviour
• Lack of awareness on the part of health professionals, and/or unwillingness to “interfere”
Some dependent drinkers face a number of these barriers. Those thought to be most at risk of
harm include young adults, older males, pregnant women, Indigenous people, prisoners, and
people with a comorbid psychological disorder.
Lower socioeconomic groups, rural and remote communities
Homeless people are included in this group, many of whom also have a comorbid psychiatric
disorder. Often current health-care structures do not reach many of these people, let alone cater
for their complex needs. Assertive outreach and follow-up is required to locate, treat and retain
these clients in treatment.
In remote communities, health care workers may be faced with great demands upon their skills
and resources to deal with alcohol related problems because of a lack of specialist services in the
local area. Many dependent drinkers have family responsibilities which prevent them from travelling
to seek specialist treatment. Thus, general practitioners and nursing staff must attempt to meet the
varied needs of these patients.
Indigenous Australians
Although Indigenous Australians are less likely to consume alcohol than non-Indigenous Australians,
many of those who consume alcohol drink at risky levels. [6] In some Indigenous communities the
key barriers include:
• Lack of a strong relationship with health care workers and a real or perceived lack of cultural
sensitivity
• Restricted health services and opportunities for health education
• Lack of time and resources to deal with anything other than the presenting problem
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• Unwillingness by health care workers to raise the topic of risky drinking
• Awareness that the environment to which the patient is returning does not support non-
drinking and a subsequent sense of hopelessness on the part of health care workers
• Some patients may become annoyed when alcohol is raised as an issue in addition to their
presenting problem
• The severity and complexity of the illness and problems with which patients present
Annual use of hospital outpatients and emergency rooms is much higher in the indigenous than
the non-indigenous population (8 percent vs 2.5 percent). Indigenous people are three times more
likely to use outpatients than to go to a doctor’s practice. This points to the potential for
interventions by medical staff working in hospital settings. Other opportunities for intervention
include workplaces, sobering-up centres, and correction facilities. [5]
Interventions based around the principles described in Chapter 7: Brief interventions can be used
in many of these settings as a first step towards changing risky drinking behaviour. For more
information, see Chapter 11: Interventions for specific client groups.
Prison inmates
The main barriers to treatment for inmates include under-diagnosis, limited access to health services,
and non-screening of risk behaviours.
Comorbidity 
Mental health problems commonly co-occur with alcohol use disorders. Some mental disorders,
such as schizophrenia, are correlated with homelessness, thus making this population even more
difficult to reach and to keep in treatment. Other mental health problems such as personality
disorders complicate treatment so much that some providers are reluctant to accept these clients
into treatment. Still other problems such as mood and anxiety disorders are more prevalent among
women who may have difficulties attending treatment because of family responsibilities.
Older people
Under-diagnosis appears to be the key barrier to treatment for older patients. For instance, hospital
workers are significantly less likely to identify alcohol-related problems in an older patient than
in a younger patient. [7]. 
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Chapter 3: Screening and assessment
Chapter Aim
The aim of this chapter is to guide screening which might take place prior to a brief and/or early
intervention for those patients who may be drinking at risky levels, or have risky patterns of
consumption.
The need for screening 
There is strong evidence for the cost-effectiveness of screening and early intervention in primary
care settings. [8, 9] Given the pervasiveness of risky alcohol consumption in Australia and the
seriousness of the health consequences of risky drinking, detection of risky alcohol consumption
through routine screening should be conducted in all health care settings. This activity must be
followed by a time-limited intervention aimed at reducing consumption for those with risky levels
or patterns of drinking. 
Screening should be conducted in settings where the prevalence of risky drinkers is likely to be
highest and where detection will have the greatest salience for both the health care worker and
the drinker. The following settings are appropriate for screening. Their order reflects their probable
effect, with medical settings most likely to show a high rate of identification, followed by workplace
and other health care settings. The settings include the following sites:
Medical practices.
Detection and brief intervention activities should be encouraged in general and specialist medical
practices. Barriers to implementing brief interventions in general practice settings are described in
Chapter 7: Brief interventions. [10] Because of their role in primary health care and their high rate
of contact with the general public, general practitioners are ideally placed to detect and offer
patients help with drug and alcohol problems. [11]
General hospitals. 
In all general hospitals routine screening procedures for risky alcohol consumption among inpatients
and outpatients, and procedures for appropriate intervention should be in place. These procedures
should be followed by brief intervention and referral as necessary. This may include a letter to the
referring GP giving feedback about the level of risky consumption and advising the need for follow-
up of the patient. Hospital accreditation should assess whether these screening procedures are in
place and are followed. 
The workplace. 
Young male drinkers, who are less likely to attend primary care settings, may be screened in the
workplace. Detection of risky consumption should be a part of any routine health evaluation in
the workplace. Such screening and brief intervention increase the health and safety of workers,
and limit hazards and accidents in the workplace. There is evidence of high rates of problem
drinking in some of these settings suggesting that the workplace is a suitable venue for detection
of risky drinking and intervention. [12]
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Welfare and general counselling services. 
Although not an obvious setting for detection activities, screening in welfare and counselling services
offers the opportunity of referral for intervention, and potentially a better outcome for the clients
of these services. It is likely in a significant proportion of cases that risky alcohol intake has
contributed to the presenting problem. 
In all of these settings, there is a need to develop a structure where screening can occur in a routine
way, thereby increasing the likelihood that it will become and will remain a part of the normal
activities. There are significant barriers to the widespread adoption of screening and intervention
procedures. For instance, there are few incentives and some disincentives to primary health care
workers and others becoming involved in screening activities [13]. 
See Chapter 7, Brief Interventions.
A number of initiatives to deal with these barriers are being or will be undertaken as part of the
Smoking, Nutrition, Alcohol and Physical Activity (SNAP) Framework for General Practice. [4] 
QUESTIONNAIRE APPROACHES TO SCREENING 
The approaches used to detect people with risky drinking patterns vary considerably across settings.
For specialist drug and alcohol agencies, detecting risky drinkers is less of an issue because their
clients are likely to declare their drinking problem when they present for assistance. For general
practitioners and other general health care workers, however, screening is a major consideration.
There are a number of methods for detecting risky drinkers, including asking the person about
their alcohol consumption, using screening questionnaires, or clinical examinations to assess for
the presence of signs and symptoms of risky use of alcohol, and biological markers of excessive
consumption. One established method for detecting people with risky drinking habits is the use
of a standard questionnaire. Many questionnaires have been designed to screen for alcohol
dependence, but only a few have been devised specifically to detect risky drinkers who may be
non-dependent. 
The questionnaires described below do not represent an exhaustive list of the available instruments.
See the National Drug Strategy publication, “Review of diagnostic screening instruments for alcohol
and other drug use and other psychiatric disorders”, for a description of instruments available for
screening for risky alcohol and other drug consumption. [14]
DETECTING RISKY ALCOHOL CONSUMPTION
The Alcohol Use Disorders Identification Test (AUDIT) was designed to detect people with risky
alcohol consumption (Table 3.1). [15] The AUDIT is comprised of ten questions that represent the
three major conceptual domains of intake (questions one to three), dependence (questions four to
six), and problems (questions seven to ten). Each question will receive a score from zero to four.
For the last two questions: “No” scores zero, “Yes, but not in the last year” scores two, and “Yes,
during the last year” scores four. The scores for each question are then totalled, with a score over
eight indicating risky drinking patterns. For more detailed administration and scoring information,
refer to the World Health Organization Guidelines [16]. The AUDIT has demonstrated validity among
adolescents, drug-dependent clients, cross-cultural groups, drink drivers, emergency ward patients,
and psychiatric patients. The AUDIT performed as well as the Michigan Alcoholism Screening Test
(MAST) and the CAGE for identifying dependent drinking, and had higher sensitivity and specificity
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for detecting risky, non-dependent drinking. [17] The AUDIT is also considered desirable because it
is relatively short, easy to administer, and needs no formal training for administration.
A shortened version of the AUDIT, the AUDIT-C which consists of the alcohol consumption
questions one to three, has been used successfully with male Veterans’ Affairs patients to screen
for heavy drinking. The AUDIT-C performed similarly to the full AUDIT for detecting heavy
drinking. Patients were considered to be heavy drinkers if they drank more than 14 drinks a week
or five or more drinks on one occasion in the past or a typical month. [18]
The prototype alcohol dependence questionnaire is the MAST. [19] Instruments such as the MAST
and the CAGE questionnaire were derived on the basis of their ability to distinguish chronic alcohol
dependent individuals from non-alcohol dependent individuals. [20] Their performance is good in
that 95 percent or more of chronic alcoholic dependent people are detected. These questionnaires
are, however, much less satisfactory in detecting people with less severe drinking problems. Because
of this limitation they are not advocated for screening in primary care settings. 
q
For screening in primary care settings, the AUDIT is more appropriate than the MAST
or the CAGE for detecting less severe drinking problems.
SCREENING FOR ALCOHOL-RELATED PROBLEMS
There are a number of other screening instruments that measure alcohol-related problems. These
instruments were developed to overcome the limitations of existing inventories, including the
heavy emphasis on dependence questions, and the use of quantity and frequency measures that
do not always detect the experience of alcohol-related problems. 
The Alcohol Problems Questionnaire is a reliable 44-item instrument covering eight problem
domains: friends, money, police, physical, affective, marital, children, and work. All questions
relate to the past six months. Each of these domains yields a subscale score, and their combination
provides a total or common score. Every positive response is scored as one. [21, 22]. Validated cut-off
scores are not available.
The Alcohol-Related Problems Screening Questionnaire was developed in Australia. [23] It is brief
and has been used in both general practice and hospital settings. Another instrument that has been
developed in Australia and subjected to validation studies is the Newcastle Alcohol-related Problems
Scale (NAPS.) [24] Both of these scales are designed to assist in the efficient identification of individuals
with alcohol-related problems associated with risky consumption, and thus their focus is broader
than simply consumption or signs and symptoms of dependence. This gives them an advantage
for use in screening activities. Moreover, the NAPS has the advantage of detecting problems arising
from either the respondent’s or from someone else’s drinking, potentially allowing a greater rate
of detection than is the case with other scales. 
These scales will not detect all cases where risky consumption is present. For example, in the case
of episodic intoxication it is less likely that the alcohol consumption will be detected as problematic.
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Screening instruments for pregnant women: the T-ACE and the TWEAK
Because of concerns that standard screening instruments may be less sensitive with women, or
when used in prenatal clinics [25], two screening instruments were developed for use with pregnant
women. The T-ACE consists of three CAGE questions and a tolerance question. The TWEAK is a
modified, five-item version of the MAST:
Both the T-ACE and the TWEAK are more specific and sensitive in screening for risky drinking
during pregnancy than either the MAST or the CAGE. [26] The T-ACE is quick and easy to administer.
A score of two or more indicates that the client may be drinking at risky levels, and that further
investigation is required. The TWEAK has five items, with a score of two or more suggesting that
the client is drinking at risky levels.
TWEAK
T Tolerance: how many drinks can you
hold?
W Have close friends or relatives Worried
or complained about your drinking in the
past year?
E Eye Opener: do you sometimes take a
drink in the morning when you get up?
A Amnesia: Has a friend or family member
ever told you about things you said or did
while you were drinking that you could
not remember?
K(C)Do you sometimes feel the need to Cut
down on your drinking?
T-ACE
T Tolerance: how many drinks does it take
to make you feel high?
A Have people Annoyed you by criticizing
your drinking?
C Have you ever felt you ought to Cut
down on your drinking?
E Eye opener: Have you ever had a drink
first thing in the morning to steady your
nerves or get rid of a hangover?
Source: Russell et al. 1994 [26]
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Table 3.1: Alcohol use disorders identification test screening instrument 
AUDIT: PLEASE CIRCLE THE ANSWER THAT IS CORRECT FOR YOU.
1. HOW OFTEN DO YOU HAVE A DRINK CONTAINING ALCOHOL?
Never Monthly or less 2–4 times a month 2–3 times a week 4 or more times a week
(0) (1) (2) (3) (4)
2. HOW MANY DRINKS CONTAINING ALCOHOL DO YOU HAVE ON A TYPICAL DAY WHEN YOU
ARE DRINKING?
1 or 2 3 or 4 5 or 6 7 to 9 10 or more
(0) (1) (2) (3) (4)
3. HOW OFTEN DO YOU HAVE SIX OR MORE DRINKS ON ONE OCCASION?
Never Less than monthly Monthly Weekly Daily or almost daily
(0) (1) (2) (3) (4)
4. HOW OFTEN DURING THE LAST YEAR HAVE YOU FOUND THAT YOU WERE NOT ABLE TO STOP
DRINKING ONCE YOU HAD STARTED?
Never Less than monthly Monthly Weekly Daily or almost daily
(0) (1) (2) (3) (4)
5. HOW OFTEN DURING THE LAST YEAR HAVE YOU FAILED TO DO WHAT WAS NORMALLY EXPECTED
FROM YOU BECAUSE OF DRINKING?
Never Less than monthly Monthly Weekly Daily or almost daily
(0) (1) (2) (3) (4)
6. HOW OFTEN DURING THE LAST YEAR HAVE YOU NEEDED A FIRST DRINK IN THE MORNING TO 
GET YOURSELF GOING AFTER A HEAVY DRINKING SESSION? 
Never Less than monthly Monthly Weekly Daily or almost daily
(0) (1) (2) (3) (4)
7. HOW OFTEN DURING THE LAST YEAR HAVE YOU HAD A FEELING OF GUILT OR REMORSE AFTER
DRINKING?
Never Less than monthly Monthly Weekly Daily or almost daily
(0) (1) (2) (3) (4)
8. HOW OFTEN DURING THE LAST YEAR HAVE YOU BEEN UNABLE TO REMEMBER WHAT 
HAPPENED THE NIGHT BEFORE BECAUSE YOU HAD BEEN DRINKING? 
Never Less than monthly Monthly Weekly Daily or almost daily
(0) (1) (2) (3) (4)
9. HAVE YOU OR SOMEONE ELSE BEEN INJURED AS A RESULT OF YOUR DRINKING?
No Yes, but not in the last year Yes, during the last year
(0) (1) (2)
10. HAS A RELATIVE OR FRIEND OR A DOCTOR OR OTHER HEALTH WORKER, BEEN CONCERNED 
ABOUT YOUR DRINKING OR SUGGESTED YOU CUT DOWN?
No Yes, but not in the last year Yes, during the last year
(0) (1) (2)
Source: World Health Organization, 1992 [27]
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DETECTION USING MEDICAL HISTORY AND CLINICAL INDICATORS
Certain physical disorders or signs are indicative of risky alcohol use. Common physical indicators
include hypertension, a pattern of accidents, dilated facial capillaries, blood shot eyes, hand or
tongue tremor, history of gastrointestinal disorders, duodenal ulcers and cognitive deficits. [28, 29]
Conditions such as liver cirrhosis and pancreatitis are commonly alcohol-induced. Subtler signs
include work, financial, marital and relationship problems, domestic violence, insomnia, depression
and anxiety. [30]
While the above problems are indicative of alcohol misuse, they are not conclusive. Nor does their
absence rule out the existence of risky alcohol consumption. 
DETECTION USING BIOLOGICAL MARKERS 
A number of biological markers are used to detect alcohol consumption: serum GGT, aspartate
(AST), alanine aminotransferase (ALT), HDL-cholesterol, uric acid, mean cell volume, and
carbohydrate-deficient transferrin (CDT). Serum GGT, a liver enzyme, is elevated in 60 to 80 percent
of alcoholics. Newer markers, including CDT and antibodies to acetaldehyde-protein abducts, offer
fair prospects for early detection. A CDT test kit is now available and is in use at some clinics in
Australia. GGT is also used in some clinical settings.
The other generally available laboratory tests are less sensitive: for example, an elevated mean cell
volume is found in only 5 to 20 percent of alcoholic patients. The value of these tests in detecting
non-alcohol dependent people with risky alcohol consumption is correspondingly lower. 
The combination of a number of biological markers can provide a rate of detection above the rate
achievable by any biochemical marker alone, with a sensitivity of 78 percent. [31] However,
combinations of tests are not recommended for clinical use because of reduced specificity. [32] 
q
Because of the greater sensitivity and specificity of questionnaire approaches (for
example, the AUDIT) these are preferred to biological markers. Biological markers
should only be used as an adjunct to other screening measures.
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OTHER SCREENING METHODS FOR BINGE DRINKING: QUANTITY-FREQUENCY INDEX
AND RETROSPECTIVE DIARY
The retrospective diary (RD) requires drinkers to identify the type and quantity of alcoholic beverage
consumed beginning with the previous day and working back through each day of the week. [33]
The Quantity-Frequency Index (QFI) question asks the drinker to indicate the number of occasions
during the previous 30 days on which they had consumed four different levels of standard drinks
as defined by NHMRC guidelines [34]:
TABLE 3.2: LEVELS OF STANDARD DRINKS
Levels of standard drinks Males Females
Level 1 7 to 10 5 to 8
Level 2 11 to 15 9 to 13
Level 3 16 to 20 14 to 18
Level 4 > 20 > 18
The lowest categories (7 to 10 drinks for males and 5 to 8 drinks for females) were used as the
cut-off score, that is any respondents who identified an occasion of drinking above those levels
were classified as binge drinkers (Table 3.2).
Although the RD takes longer to administer than the QFI (mean completion times of three minute,
38 seconds and one minute, 41 seconds respectively), it provides two important pieces of
information: weekly and binge consumption. Further, while the RD was inferior in detecting binge
drinking, the QFI underestimated overall drinking relative to the RD. [35]
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SUMMARY OF EVIDENCE: SCREENING LEVEL OF EVIDENCE
In routine general practice, without specific screening II
techniques, 75 percent of risky/high risk drinkers 
are not detected.
There is strong evidence that health care providers in II
general practice and hospital settings can effectively 
screen for and intervene with risky/high risk drinkers. 
Screening can also be usefully conducted in community 
health care settings and workplaces.
The AUDIT is a reliable, valid way of screening for risky II
drinking in primary care settings: it has demonstrated 
validity among adolescents, drug-dependent clients, a 
range of cross-cultural groups, drink drivers, emergency 
ward patients, and psychiatric patients.
The T-ACE and the TWEAK are more specific and II
sensitive in screening for risky drinking in pregnant 
women than the MAST  or the CAGE.
The Alcohol Problems Questionnaire (APQ) is a valid II
and reliable measure of alcohol-related problems, and 
is relatively independent of levels of consumption.
The Quantity-Frequency Index and the retrospective II
diary are both reliable ways of identifying risky/high 
risk levels and patterns of consumption.
STRENGTH
RECOMMENDATIONS SCREENING:  OF RECOMMENDATION
Screening for risky and high risk alcohol consumption Strong 
should be widely implemented in general 
practice, hospitals, community health care, 
and workplaces. 
The AUDIT, the Quantity-Frequency Index or the Strong  
retrospective  diary are recommended for 
screening in the above settings.
The T-ACE and the TWEAK are recommended Strong 
for screening risky drinking in pregnant women.
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In-depth assessment before more intensive treatment
SECTION AIM
The aim of this section is to guide assessment which might take place before a relatively intensive
and extensive intervention for those drinkers who: 
• Have not responded to brief advice to cut down their drinking 
• Have severe alcohol related problems
• Have asked for specialised assistance
• Are clearly in need of specialist help in dealing with their drinking 
This level of assessment is not appropriate for brief intervention. 
In the preceding section, guidelines are provided for brief, routine screening for proactive
interventions. Assessment intensity and detail varies across settings, the amount of assessment
being related to the level of specialisation in alcohol problems. 
This section covers several areas for assessment: 
• motivation to change
• alcohol dependence and consumption pattern
• concurrent psychological and psychiatric problems
• family factors
• physical well-being and cognitive functioning 
From the first contact with the client there is a need to instil in the client a sense of hope and a
belief that change is possible. This is especially important in clients who have tried to alter their
drinking and failed. Self-efficacy, that is the client’s belief that there is something they can do about
their problem, is an important factor in treatment success. [36] Self-efficacy may in turn be influenced
by the therapeutic relationship. [37] (see Chapter 8: Psychosocial interventions)
q
The need for comprehensive assessment must be balanced with engaging and
retaining the client.
If the client perceives that little or no progress is being made in the first sessions, their motivation
to stay in treatment may reduce, and they will leave. The assessment process might be spread over
several sessions, allowing some time in each session for setting preliminary treatment goals and
working towards those goals. As more in-depth assessment occurs, these treatment goals and
strategies may need to be adjusted.
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THE PURPOSE OF ASSESSMENT
Before intensive and extensive interventions, assessment needs to be carefully conducted.
Assessment has two important functions:
1. It assists the client and clinician to develop shared treatment goals and a treatment plan. Different
patients will require different approaches, as risky drinkers and alcohol dependent people do
not have a homogeneous group of problems. Any underlying and accompanying problems must
be identified and treated, even if the causal relationship is not clear. 
2. It provides an opportunity for clinician and client to develop a rapport. If the clinician shows
the client empathy and courtesy and provides a sense of hope and optimism, the client is less
likely to take a defensive stance in the interview, and is more likely to look at the opportunity
as one that facilitates change. In this shared process, feedback from the clinician can encourage
the client to appraise their situation from a new perspective. Assessment could be defined as
the beginning of therapy, and sympathetic understanding of the implications of this for the
drinker and their family is important. In particular, it is important to highlight the client’s
perception of the opportunity for change, and this requires the clinician to have a positive and
realistic approach. 
KEY ISSUES IN ASSESSMENT:
• Assessment is one of the earliest opportunities the clinician has for engaging and retaining the
client in treatment.
• Intensive treatment for alcohol problems should begin with a comprehensive assessment so
that the most appropriate intervention(s) can be selected. 
• Assessment should be balanced with achieving treatment progress so that the client remains
motivated.
• Assessment should lead to agreed treatment goals and a treatment plan. The treatment plan
should be based on the most effective intervention for the client, not just on the kind of
treatment typically provided by the agency. It is preferable that the client be informed about
the range of options for intervention available locally and assisted to make a reasoned decision
as to which intervention is most suited to his or her needs. In this way, assessment should
help to guide client-treatment matching. 
• Assessment should continue throughout treatment as the client’s progress is measured against
the treatment goals. 
• Assessment should combine a variety of techniques for gathering information about the client,
including diagnostic interviews, standardised questionnaires, medical examinations, and/or
biological markers. 
• Much information can be best collected in a semi-structured, open-ended interview, using a
guided exploration of the client’s subjective experience of drinking. This has the advantage
of clinician involvement which is personal and responsive to the drinker, rather than mechanical
and impersonal. Yet, it should maintain a purposeful structure so as to avoid a vague,
directionless discussion of the drinker’s history. 
• The assessment should emphasise the client’s present situation. Information about past
experiences is useful in clarifying how the client came to be in the present situation and what
is maintaining maladaptive thoughts and behaviours. However, the assessment should be
geared to collecting information that will help to tailor treatment so that it is appropriate for
the client.
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ENGAGING THE CLIENT IN TREATMENT
Client engagement may be viewed in terms of intensity and duration of treatment participation.
Higher levels of engagement are predictive of positive treatment outcomes and are, in turn, contingent
upon both client characteristics - for example pre-treatment motivation, higher pre-treatment alcohol
consumption, more pre-treatment arrests, higher levels of concentration - and treatment experiences:
strength of the therapeutic relationship, perceived helpfulness of the treatment services, empathy of
the clinician, removal of practical barriers such as transportation, and the inclusion of relapse
prevention training. [38, 39] Clinician characteristics and the therapeutic relationship are also crucial to
engaging the client in treatment 
(see Chapter 8: Psychological interventions for more information on this issue). [37]
Goal-setting and treatment planning
The client’s perception of a gap between their goals and their present state may improve motivation
for change. [36] Acknowledging the client’s goals rather than insisting on a particular set of goals is more
effective motivationally. [40] Sanchez-Craig claims that offering clients choices about treatment goals
and strategies produces better outcomes. [41] There is also evidence that providing the client with a
choice of treatment options improves treatment retention. [42]
THE INITIAL INTERVIEW
The assessment procedure ideally takes the form of a semi-structured interview where the client
and the clinician compile a narrative history, using questionnaires as appropriate and necessary.
The clinician should cover the important areas for assessment presented in Table 3.3. Specific areas
for assessment are covered in detail in the following sections. It is recommended that these areas
be covered in two or more sessions. Assessment is an ongoing part of the treatment process, and
it should not be viewed as something that occurs in isolation, to be ignored later.
In some settings, for example psychiatric or medico-legal settings, a more structured interview may
be appropriate. The Composite International Diagnostic Interview (CIDI) is a standardised and
comprehensive interview designed to assess psychological disorders against the International
Classification of Diseases (ICD) and Diagnostic Statistics Manual-IV (DSM-IV) diagnoses. It must be
administered or supervised by a fully trained mental health professional who has undertaken
recognised CIDI training. As well as substance use disorders, it covers eating disorders, organic
mental disorders, schizophrenic disorders, paranoid disorders, affective disorders, anxiety disorders,
somatisation disorders, dissociative disorders, and psychosexual disorders. 
The CIDI, the Schedules for Clinical Assessment in Neuropsychiatry (SCAN) and the Alcohol Use
Disorder and Associated Disabilities Interview Schedule-Alcohol/Drug-Revised (AUDADIS-ADR)
all have reasonable test-retest reliability and diagnostic concordance for alcohol dependence, but
not for risky alcohol use or abuse.
The sections that follow cover specific areas that may require assessment. Each of these areas needs
to be covered to ensure a comprehensive assessment. It is not necessary for every client to be
assessed extensively on each of the areas. In some cases, such a detailed assessment is unnecessary
as the status of the client will be obvious. In other cases the information provided below allows
the clinician to carry out a careful assessment of the important aspects. 
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TABLE 3.3: ISSUES TO BE COVERED IN THE INITIAL CLINICAL INTERVIEW
INITIAL ASSESSMENT
• Presenting problems
• Role of drinking/drug use in presenting problems
• Motivation for change
• Other concerns, for example relationship issues, work problems, legal problems
DRINKING/DRUG USE ASSESSMENT
• Quantity, frequency, pattern of drinking
• Last drink/drug use
• Length of drinking/drug problem
• Consequences of drinking/drug use
• DSM-IV symptoms of abuse or dependence
• Assessment of need for detoxification
ASSESSMENT OF OTHER PROBLEMS
• Psychotic symptoms
• Depression
• Anxiety
• Cognitive impairment
• Physical wellbeing
• Family issues
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ASSESSING MOTIVATION
Motivation to change is an important mediating variable in treatment outcome, so enhancing the
drinker’s level of motivation may be an important aspect of treatment. [43] Perhaps the simplest
method for assessing a drinker’s readiness to change is through direct questioning during the
assessment interview. This should only be done after risky alcohol consumption has been discussed,
and the patient has received feedback on their level of drinking. Two questions that might prove
useful are: 
1. “How interested are you in changing your drinking now?” and 
2. “Do you feel that you ought to stop drinking, or do you really want to?”. 
The client may also be asked: 
1. “What would you be prepared to do to solve this drinking problem?”
2. “How confident are you that you can achieve this?” 
3. “Are you prepared to attend the next appointment?” 
The client may be encouraged to explore the various treatment options from the perspective of motivation
to participate. Alternatively, as developed elsewhere [44] the client may simply be asked:
“How do you feel about your drinking at the moment?” 
Responses may vary from:
1. “I’m happy with my drinking”, “I enjoy drinking”, “I’m not interested in stopping drinking”;
through to 
2. contemplative responses such as “I’m thinking about stopping”, “I’m not sure if I’m ready at
the moment”, “I’m interested in weighing up stopping”; to 
3. action-oriented responses such as “I want to stop now”, “I may need some help”, or “The
disadvantages of drinking outweigh the benefits for me”. 
q
These questions should be asked with curiosity and a willingness to explore the
client’s answers, not in a confronting or adversarial way.
The client’s responses may indicate a need for a motivational intervention, particularly for the
ambivalent drinker, methods for which are outlined in Chapter 8: Motivational interviewing.
The stages of change model, also known as the transtheoretical model (TTM), includes change
processes and levels of change. [45] However, assessment tools are primarily available to measure
stages of change; thus our discussion is limited to this aspect of the model. Although the model is
widely used there is equivocal evidence of its ability to predict treatment outcome with alcohol
dependent patients. [46, 47] The model though, appears to identify some differences between drinkers
at various stages. [48] A number of reviewers have concluded that the stages are not mutually
exclusive; there is little evidence of sequential movement through discrete stages; and better quanti-
tative outcome studies are needed. [49, 50, 51] One problem may be that the link between stages and
particular treatments has been oversimplified. [52] For example, people in the preparation and action
stages may still be confused over the costs and benefits of changing their drinking behaviour, and
continue to have doubts about making such changes. 
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Because of the mixed evidence supporting the model, we recommend that the stages of change
model be used with caution and that motivational interviewing strategies be used whenever clients
appear to be struggling with decisions, not just at the beginning of treatment. 
Two questionnaires have been designed to assess the drinker’s readiness to change: the University
of Rhode Island Change Assessment (URICA) scale, and the Readiness to Change Questionnaire
(RTCQ). URICA is a 32-item questionnaire with subscales corresponding to the stages of change.
URICA seems to produce consistent profiles corresponding to the stages of change, which in turn
predicts alcohol and drug use severity. [53]
The RTCQ is a 12-item questionnaire with three subscales that correspond to the pre-contemplation,
contemplation and action stages of the model. Although the RTCQ demonstrated reasonable
predictive validity with a sample of male risky drinkers in a general hospital setting [54], its usefulness
in clinical settings is yet to be determined, given the low internal reliability of the pre-contem-
plation and contemplation subscales. [55]
ASSESSING THE CONSEQUENCES OF DRINKING 
It is important for the clinician to assess the range of problems encountered by the client as a result
of their drinking. In addition to health and family problems, the client’s drinking may have
detrimentally affected work performance, social relations or financial stability. Alcohol-related offences
such as drink-driving might also be relevant. A specific crisis about one of these factors may have
been the impetus for seeking help, and this should be explored. Discussion of the “less good things”
about drinking can also help to enhance the client’s readiness for change (see the motivational
interviewing material in Chapter 8: Psychosocial interventions). 
The Alcohol Problems Questionnaire (APQ) is a reliable instrument that covers eight domains: 
• friends
• money
• police
• physical
• affective
• marital
• children
• work 
For more information on the APQ, see the Screening section earlier in this chapter.
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ASSESSING LEVEL AND HISTORY OF ALCOHOL CONSUMPTION
This part of the assessment process should gather information about the drinking history, including
how the risky drinking pattern evolved, fluctuated and/or progressed. The assessment should
include the client’s reconstruction of a typical drinking day and week, from the time of waking
through all the day’s activities. This information can be used when planning relapse prevention
procedures with the client. 
Edwards (1982) has recommended that clients be asked to timetable their drinking on a typical
day. [56] For example, the clinician might ask at what time the first drink is taken, where and with
whom. The time spent drinking or the money spent on alcohol can be compared with the client’s
estimate of the amount of alcohol consumed to test the accuracy of that estimation. Consumption
can be linked to particular events, behaviours and times. An assessment of a typical day also gives
information about the antecedents and consequences of drinking.
Careful probing in the interview assists the client to make accurate estimations of the amount of
alcohol usually consumed. It is useful for the clinician to suggest a level of drinking that is higher
than expected so that the client is most likely to feel comfortable in admitting the real level of
drinking by bringing the estimation down to the correct level. 
q
Quantity of alcohol consumed is not the only way to look at alcohol consumption.
The clinician also needs to assess frequency of drinking. It is strongly recommended
that the assessment also look at the client’s pattern of drinking.
The clinician needs to distinguish between daily drinking and binge drinking where the weekly
or monthly consumption is concentrated over several days and the client is abstinent or drinks
lightly at other times. There are many methods available for this assessment, ranging from diary
methods, using a calendar to assess drinking over the previous month or months, as well as
gathering information from a spouse or other person close to the drinker to validate the drinker’s
report. 
The Timeline Followback Method (TLFB) helps to obtain an accurate, retrospective account of
alcohol consumption over a particular period, typically three months. [57] This method requires the
client and clinician to fill in a blank calendar with a detailed description of alcohol consumption.
The client is first asked to note all events that may assist with recall, for example public holidays
or significant personal events. Any personal diaries may help with recall. The client then fills in
the drinking days, noting the amount consumed, and perhaps also the number of hours of
consumption.
The Brief Drinker Profile and the Comprehensive Drinker Profile allow for a standardised
assessment of both “steady pattern” drinking and binge drinking. [58, 59] Other drug use, including
use of sedative medications and illicit drugs, should also be assessed. 
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ASSESSING ALCOHOL DEPENDENCE
The measurement of the degree to which a drinker is dependent upon alcohol allows the clinician
to plan the treatment goals. A person who is less alcohol dependent may be able to achieve
controlled drinking. The dependence level indicates whether the client can expect to experience
withdrawal and might also provide some initial indication of how intense the treatment program
needs to be. 
The DSM-IV-R criteria for the alcohol dependence and abuse syndromes are presented in Appendix
three. [60] There are several questionnaires that measure alcohol dependence and two of these are
included in these guidelines.
The SADQ-C has three sections and is shown in Table 3.4 [61]. The Short Alcohol Dependence Data
questionnaire (SADD) [62] is shown in Table 3.5. 
The SADQ-C
Answers to each question are rated on a four-point scale as follows: 
0 = almost never
1 = sometimes
2 = often
3 = nearly always
q
Section B and Section C SADQ-C scores lower than or equal to 30 indicate low 
(zero to 20) to moderate dependence, while scores higher than 30 indicate a high
level of dependence.
This dichotomy has been used in the past as a point at which drinkers who exceed the cut-off
should be advised that abstinence is the appropriate goal, as well as being used to determine kind
and intensity of intervention. The SADQ-C emphasises tolerance and withdrawal symptoms, and
physical dependence generally. [63] The impaired control items are a new inclusion, but they do not
feature in the current scoring of dependence, and should not be used in reaching an overall score
on the SADQ-C. The impaired control items form a separate scale. [61]
The SADD
By way of contrast, the SADD questionnaire measures physiological and behavioural features of
dependence, such as the salience of the drink-seeking behaviour. [62] Its authors have recommended
that scores of one to nine be considered low dependence, 10 to 19 medium dependence, and 20
or more high dependence, on the basis of a four-point rating scale similar to that used in the SADQ-
C. Other questionnaires are available to the interested reader, including the Alcohol Dependence
Scale (ADS). [64]
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q
The client can complete these questionnaires during assessment or, alternatively,
they can provide a checklist to help organise the clinician’s questions. Explore the
client’s experiences of dependence and tolerance by asking the client to describe
the last two or three occasions on which they reached intoxication and the last two
or three occasions when they did not become intoxicated.
No test or measure should be used in an absolute or rigid way to determine the kind of intervention
that might be appropriate. Moreover, it should be recognised that dependence is used, to an extent,
as a proxy for the severity of the alcohol problems and although it is a useful concept, there is a
need to assess the severity of the person’s alcohol related problems more widely. The implication
that more severely dependent and affected drinkers require a more intense intervention is relevant
for three aspects of treatment delivery: 
• These people may require more attention and more time during treatment.
• Treatment might be spread over a longer period and/or come from multiple sources.
• Treatment might be more strategically focussed on the particular problem and deficits that are
apparently responsible for the risky drinking.
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TABLE 3.4: SEVERITY OF ALCOHOL DEPENDENCE QUESTIONNAIRE FORM-C (SADQ-C)
SADQ-C
Name: . . . . . . . . . . . . . . . . . . . . . . . . Sex: M / F   Date of birth:  . . . . . . . . . .Age:  . . . . . . .
Have you drunk any alcohol in the past six months? YES / NO.
If YES, please answer all the following questions by circling the most appropriate response.
(Section A - ICQ) During the past SIX MONTHS:
1. AFTER HAVING JUST ONE TO TWO DRINKS, I FELT LIKE HAVING A FEW MORE.
Never or almost never Sometimes Often Nearly always
2. After having two or three drinks, I could stop drinking if I had other things to do.
Never or almost never Sometimes Often Nearly always
3. When I started drinking alcohol, I found it hard to stop until I was fairly drunk.
Never or almost never Sometimes Often Nearly always
4. When I went drinking, I planned to have at least six drinks.
Never or almost never Sometimes Often Nearly always
5. When I went drinking, I planned to have no more than two or three drinks.
Never or almost never Sometimes Often Nearly always
(Section B - SADQ, Form-C) During the past SIX MONTHS:
1. The day after drinking alcohol, I woke up feeling sweaty.
Never or almost never Sometimes Often Nearly always
2. The day after drinking alcohol, my hands shook first thing in the morning.
Never or almost never Sometimes Often Nearly always
3. The day after drinking alcohol, I woke up absolutely drenched in sweat.
Never or almost never Sometimes Often Nearly always
4. The day after drinking alcohol, my whole body shook violently first thing in the morning if I
didn’t have a drink.
Never or almost never Sometimes Often Nearly always
5. The day after drinking alcohol, I dread waking up in the morning.
Never or almost never Sometimes Often Nearly always
6. The day after drinking alcohol, I was frightened of meeting people first thing in the morning.
Never or almost never Sometimes Often Nearly always
7. The day after drinking alcohol, I felt at the edge of despair when I awoke.
Never or almost never Sometimes Often Nearly always
(Section B - SADQ, Form-C) During the past SIX MONTHS: cont.
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8. The day after drinking alcohol, I felt very frightened when I awoke.
Never or almost never Sometimes Often Nearly always
9. The day after drinking alcohol, I liked to have a morning drink.
Never or almost never Sometimes Often Nearly always
10. The day after drinking alcohol, in the morning I always gulped my first few alcoholic drinks
down as quickly as possible.
Never or almost never Sometimes Often Nearly always
11. The day after drinking alcohol, I drank more alcohol in the morning to get rid of the shakes.
Never or almost never Sometimes Often Nearly always
12. The day after drinking alcohol, I had a very strong craving for an alcoholic drink when I woke.
Never or almost never Sometimes Often Nearly always
13. I drank more than a quarter of a bottle of spirits in a day ( or 1 bottle of wine or 
7 middies of beer).
Never or almost never Sometimes Often Nearly always
14. I drank more than half a bottle of spirits in a day ( or 2 bottles of wine or 15 middies of beer).
Never or almost never Sometimes Often Nearly always
15. I drank more than one bottle of spirits per day ( or 4 bottles of wine or 30 middies of beer).
Never or almost never Sometimes Often Nearly always
16. I drank more than two bottles of spirits per day ( or 8 bottles of wine or 60 middies of beer).
Never or almost never Sometimes Often Nearly always
(Section C - SADQ, Form-C) Imagine the following situation:
(1) You have HARDLY DRUNK ANY ALCOHOL FOR A FEW DAYS.
(2) You then drink VERY HEAVILY for TWO DAYS.
How would you feel the MORNING AFTER those two days of heavy drinking?
17. I would start to sweat
Not at all Slightly Moderately Quite a lot
18. My hands would shake
Not at all Slightly Moderately Quite a lot
19. My body would shake
Not at all Slightly Moderately Quite a lot
20. I would be craving for a drink
Not at all Slightly Moderately Quite a lot
Source: Stockwell et al. (1994) [61]
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TABLE 3.5: THE SEVERITY OF ALCOHOL DEPENDENCE DATA (SADD) QUESTIONNAIRE 
SADD: The following questions cover a wide range of topics to do with drinking. Please read each
question carefully but do not think too much about its exact meaning. Think about your MOST
RECENT drinking habits and answer each question by placing a tick (¸) under the MOST
APPROPRIATE heading. If you have any difficulties ASK FOR HELP.
Never Some- Often Nearly 
times always
1. Do you find difficulty in getting the thought 
of drink out of your mind? q q q q
2. Is getting drunk more important than your 
next meal? q q q q
3. Do you plan your day around when and 
where you can drink? q q q q
4. Do you drink in the morning, afternoon 
and evening? q q q q
5. Do you drink for the effect of alcohol 
without caring what the drink is? q q q q
6. Do you drink as much as you want irrespective 
of what you are doing the next day? q q q q
7. Given that many problems might 
be caused by alcohol do you 
still drink too much? q q q q
8. Do you know that you won’t be able 
to stop drinking once you start? q q q q
9. Do you try to control your drinking 
by giving it up completely for days 
or weeks at a time? q q q q
10. The morning after a heavy drinking session do 
you need your first drink to get yourself going? q q q q
11. The morning after a heavy drinking 
session do you wake up with a definite 
shakiness of your hands? q q q q
12. After a heavy drinking session do you 
wake up and retch or vomit? q q q q
13. The morning after a heavy drinking session 
do you go out of your way to avoid people? q q q q
14. After a heavy drinking session do you see 
frightening things that later you realise 
were imaginary? q q q q
15. Do you go drinking and the next day find you 
have forgotten what happened the night before? q q q q
Source: Raistrick, et al. 1983 [62]
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The level of dependence can assist in determining the appropriate goal for the drinker: moderation
or abstinence. Heather (1989) has used clinical judgement and research experience to develop a
set of suggested ranges on these instruments for determining both the goal and the intensity of
the intervention that might be used. [65] His scheme is partly produced in Table 3.6. Heather notes
that the range of scores is not based on empirical data, and that there is no evidence to suggest
that the ranges are equivalent. They should be treated as “rule of thumb”. He also indicates that
it “cannot be stated too strongly that allocation to moderate drinking or abstinence goals and to
brief and intensive interventions are essentially clinical decisions, depending critically on the unique
circumstances of the individual client”. [65]
A SADQ score should not be the sole criterion for determining the intensity of treatment because
the cut-off point might exclude some people who are clearly dependent upon alcohol in a psycho-
logical sense, or who require a more intense intervention than their dependence level might suggest
was necessary. Therefore all aspects of the drinker’s presentation should be considered when
assisting him or her to choose an appropriate treatment goal and strategy.
TABLE 3.6: SUGGESTED SCORES ON THREE MEASURES OF ALCOHOL DEPENDENCE TO
DETERMINE TREATMENT GOAL AND INTENSITY 
Scale Low dependence; Moderate dependence; High dependence;
Moderation goal; Moderation/abstinence; Abstinence goal;
Brief intervention Brief or intensive intervention Intensive intervention
SADQ 0-20 21-40 41-60
SADD 0-9 10-19 20-45
ADS 0-13 14-30 31-51
Source: Heather (1989) [65]
ASSESSING PSYCHOLOGICAL PROBLEMS AND PSYCHIATRIC DISORDERS
Assessment of the presence of psychiatric comorbidity and psychological problems among alcohol
dependent patients is essential, and when problems are detected, ensuring that the patient receives
an appropriate intervention must be a high priority. Psychological problems and psychiatric
comorbidity are more prevalent among people who are alcohol dependent than in the general
population. [66]
q
Depressive and anxiety disorders are the most prevalent psychiatric disorders among
alcohol dependent persons.
The specialist interventions required to resolve serious psychiatric disorders may not be within the
range of qualification or experience of most drug and alcohol workers, be they nurses, doctors,
or social workers/psychologists. It is important that:
• All drug and alcohol counsellors and professional personnel in this area develop links with
other services that can deal with these disorders. 
• The presence of behavioural or affective problems be assessed in the narrative interview with
questions about mood, fears and anxieties. Alternatively, there are a number of symptom
46 Guidelines for the Treatment of Alcohol Problems
C
H
A
P
T
E
R
 3
S
creen
in
g
 an
d
 A
ssessm
en
t
checklists that can be used to assess for the more common disorders. These include the Beck
Depression Inventory [67], the Beck Anxiety Inventory [68], the Hopkins Symptom Checklist 90-
Revised [69], and the Depression, Anxiety and Stress Scale (DASS, [70]). The responses to these
questionnaires can form the basis for a discussion with the client about psychological problems.
Where it is suspected that there is some psychological problem present, a full diagnostic
assessment should be undertaken by a suitably qualified professional, that is, a psychiatrist
or a clinical psychologist. 
• Clients are reassessed after three or four weeks of treatment, and a final psychiatric diagnosis
is delayed until this time: it is likely that many of these disorders are reactions to the chaos
and disarray in the client’s life that are associated with the risky drinking, or to the neurological
effects of alcohol. Therefore some of these apparent disorders resolve without formal therapy
when the drinking ceases or decreases. Depressive disorders can be expected to lessen in
severity with ongoing abstinence in a substantial number of cases. Anxiety may also be caused
by the drinking problem, rather than the reverse. However, serious anxiety disorders may be
present and can lead to relapse. 
• Questions about sexual abuse should be framed in a non-threatening way so that the client
can discuss the experience without fear of rejection. There is evidence that a high percentage
of alcohol-dependent women in treatment have had some experience of physical and sexual
abuse. [71] Women with a history of child sexual abuse who are pressured to discuss the issue
with non-specialist counsellors in the context of treatment for drug and alcohol problems may
have worse outcomes at six months compared to women who have not received this form
of treatment. Based on these trends, and drawing on clinical expertise, it has been argued
that if child sexual abuse is an issue, the client should be referred for a specialist intervention.
Although caution should be exercised in addressing the issue, clinicians need to discuss the
issue without seeming too tentative or fearful. In some jurisdictions, training in dealing with
child sexual abuse is now available for alcohol and drug counsellors. A number of jurisdictions
have set up services for treating victims of child sexual assault but resources are limited.
• Assessment covers subclinical symptoms of depression and anxiety. Some symptoms may not
be obvious to the clinician inexperienced in the area. Because of the risk of missing such
symptoms at the initial assessment it is important to ask the client directly whether he or she
has had problems with relaxing or in dealing with stress. A positive response may indicate
the need to offer an intervention to deal with these issues. Similarly, the presence of difficulties
in interpersonal situations, again often subclinical and within “normal” limits, can result in
some emotional turmoil which causes the person to drink. Again the clinician is advised to
discuss these problems with the drinker. The presence of such problems may suggest the
need to deal with interpersonal skills, such as assertiveness and other social skills. These and
other such interventions are covered later in this chapter. 
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• Suitable scales for the assessment of comorbid mental health disorders include: 
3 The General Health Questionnaire (GHQ) is designed as a screening instrument to identify
likely non-psychotic psychiatric “cases” in general health settings. [72]
3 The Short Form 12 (SF-12) assesses possible limitations in both physical and mental health.
[73]
3 The Beck Depression Inventory measures depression and its symptoms. [67]
3 The Beck Hopelessness Scale measures hopelessness and negative views about the future,
and an indicator of suicide attempts. [74]
3 The Spielberger State-Trait Anxiety Scale measures current anxiety - state anxiety - and
a more enduring personality characteristic - trait anxiety. [75]
3 The Social Anxiety Interaction Scale and the Social Phobia Scale are useful for assessing
social phobia. [76]
3 The Modified PTSD Symptom Scale is a brief (17-item) measure of post-traumatic stress
disorder symptoms. [77]
3 The Acute Stress Disorder Scale is a measure of acute stress disorder symptoms. [78]
3 The Eating Attitudes Test is used to detect disturbed eating patterns. [79]
3 The Kessler 10 Symptom Scale is a scale of psychological distress, suitable for use as an
outcome measure in people with anxiety and depressive disorders. It is likely to become
the standard scale for use by general practitioners and mental health workers. [80]
ASSESSING COGNITIVE FUNCTIONING
Formal assessment of alcohol related brain damage is a specialist activity that is outside the scope
of most drug and alcohol workers, and referral may be necessary to a psychologist or a neuropsy-
chologist. Nevertheless, since there is a high prevalence of cognitive dysfunction among people
with alcohol problems [81], drug and alcohol workers should screen for deficits, even if such an
assessment is limited. Only some clients presenting for treatment for alcohol problems will need
to be formally assessed for cognitive dysfunction, that is, those whose deficits interfere with day-
to-day functioning and participating in treatment.
It is estimated that more than 50 percent of patients over the age of 45 who have lengthy histories
of drinking at risky levels will show some degree of cognitive dysfunction, although this may not
be permanent. [82] In fact, between 75 percent and 100 percent of patients admitted to alcohol
treatment facilities perform below normal for their age groups on tests of cognitive function. [83] If
the client has pronounced organic brain damage, the problems are usually obvious. 
q
For other clients who have alcohol-related cognitive dysfunction there might not be
obvious behavioural signs of impairment, and specific tests are required to detect
and to measure the extent of the deficits.
The drug and alcohol professional must be aware of the possibility of alcohol-related brain damage
and be watchful for signs of it in the clinical interview. This section provides some information
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about the kinds of deficits that can occur and the range of methods available to detect them. See
Chapter 11: Interventions for specific client groups for more information about treatment.
Cognitive impairment associated with alcohol abuse and dependence
Amnesia associated with Wernicke Korsakoff’s syndrome (WKS) leaves short term memory and
memory for some long term events intact, but particularly interferes with learning new information.
A person suffering from the amnesic syndrome might, for example, not recognise their doctor even
though she or he visited only yesterday. The client might also show deficits in planning, organi-
sation, and problem-solving. The prevalence of Wernicke Korsakoff’s syndrome has reduced in
Australia since the introduction of thiamine enriched bread flour. However, there is evidence that
some single symptoms of Wernicke Korsakoff’s syndrome are present in about one-third of alcohol-
dependent people, and that lower estimates are because of the difficulty in diagnosing Wernicke
Korsakoff’s syndrome. [81]
Cognitive deficits such as impairment in verbal abilities, visual-spatial abilities, problem-solving
skills and memory often improve with a period of abstinence from alcohol. [83] However, they can
still hamper the effectiveness of treatment programs. These deficits may impair motivation, attention
span, the capacity to evaluate situations critically or the ability to acquire new skills. Therefore
interventions during this early stage may need to be kept relatively simple until or unless it is
apparent that the client can cope with more complex information. The possibility of improving
cognitive functioning should be taken account of in the assessment process by allowing a sufficient
period of abstinence from alcohol to elapse before finalising assessment of cognitive dysfunction. 
Assessment Instruments for Cognitive Impairment
For the non-psychologist who is seeking a quick screening for cognitive dysfunction, the Mini-Mental
State Examination is helpful. [84] The use of age-and education-specific cut-off scores may improve
sensitivity without affecting specificity. Because the test may have limited sensitivity to subtle deficits,
care should be taken not to interpret an apparent lack of cognitive deficit as a real lack of deficit. [85]
To ensure optimal performance, testing should not be conducted during detoxification and the client
must be sober during testing. The clinician also needs to be aware of the effects of anxiety in the
testing situation as extreme anxiety reduces performance. It is recommended that drug and alcohol
workers be trained in basic screening for marked cognitive dysfunction, such as that represented in
the Mini-Mental State Examination. [84]
For a more extensive assessment, a variety of tests have been shown to be sensitive to alcohol-
related brain damage. These tests include the Rey Complex Figure Test, designed to test perceptual
organisation and visual memory, the Rey Auditory-Verbal Learning Test which measures verbal
memory recall and recognition, and the Trail Making Test which tests visual concepts and
visuomotor tracking. However, some of these tests have very limited normative data available and
they are not specific to alcohol-related brain damage, so that their confident interpretation is made
difficult. Also some of the tests relevant to the detection of cognitive dysfunction should only be
administered by psychologists who have been trained in their interpretation. This is the case for
the Wechsler Adult Intelligence Scale-III (WAIS-III). Two subtests are especially useful in this context,
although the entire WAIS-III should be administered to determine if there is significant scatter
among the various subtests, rather than relying upon a single subtest result. The most relevant
subtests of the WAIS-III are the Digit Symbol subtest and the Block Design subtest. [86] The Wechsler
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Memory Scale (Revised) provides a comprehensive assessment of memory function. These psycho-
logical testing materials are available, depending upon professional qualifications, from the
Australian Council for Educational Research and the Psychological Corporation. 
Issues in assessing for cognitive impairment
• Weighing the client’s risk factors for cognitive dysfunction. For example, if the client is 45 years
old and has been drinking to excess for 15 years or more, and also reports social or vocational
disruption, there is a risk that this person has some alcohol-related brain damage or cognitive
dysfunction. Many clients can report that there has been a decline in memory function as shown
by a number of changes in memory ability, although some commentators caution against relying
upon the self-report of clients, especially in the case of damage to the frontal lobes, as they may
not be aware that the changes have occurred. [87] 
• If the clinician suspects that the client has marked cognitive impairment, referral to a clinical
psychologist or neuropsychologist for further testing might be appropriate. 
ASSESSING PHYSICAL WELL-BEING
The following areas should be assessed:
• medical history 
• current physical symptoms 
• use of medication 
• any current withdrawal symptoms
• liver disease
• previous or current health problems related to drinking 
Medical examination should at least assess signs of liver disease, blood pressure, withdrawal
symptoms, and organic brain damage. [88] The medical results provide tangible evidence of the
effects of risky drinking. There is potential value in the simple act of feeding back to the client the
results of the medical examination. For instance, a discussion with the client about the implications
of abnormal liver function tests is not only informative, but might also increase the client’s
motivation to change. 
The Drinker’s Check-up relies heavily on this motivating function of feeding back objective
information. [88]
The advantages of feedback are less clear when the medical tests show normal results. However,
the whole assessment process should allow clients to assess accurately the degree of their alcohol-
related problems and normal medical results should not detract from this process. The issue of
normal range results can be looked at within the context of a clinical interaction and is further
discussed in the motivational interviewing material in Chapter 8: Psychosocial interventions. 
ASSESSING FAMILY FACTORS
Clients should be encouraged to explore relevant family issues during assessment. These might
include: 
• How their drinking might have affected relationships with their spouse or partner, their parents,
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their children, and other significant people in their lives. The Alcohol Problems Questionnaire
has a subscale assessing family problems and one assessing marital/relationship problems. [21]
• The quality of various family relationships independent of any attributions about the effects
of the client’s drinking. 
• Experience of domestic violence and sexual abuse from the perspective of the client as
perpetrator and/or victim. Because of the sensitivity of these issues, it is not usually appropriate
to raise them in the first contact session. As mentioned above, these issues may require
specialist assessment and intervention.
• The family’s role in convincing the client to seek help. A client who is “self-referred” may be
responding to family pressure and this is important information for the assessment of the
client’s motivations and ambivalence.
When it is possible the clinician should interview the spouse or the family members. The interview
should provide family members with the opportunity to explore: 
• Their observations about the drinker’s behaviour.
• The problems they have had in coping with the drinking behaviour. The clinician will need
to evaluate the levels of distress within the family, feelings of isolation and confusion, specific
crises preceding help-seeking, and who feels responsible for solving the family problems. 
• Expectations that family members have about treatment. If the spouse or significant other is
going to be involved in the alcohol treatment (see Chapter 8: Psychosocial interventions), the
clinician needs to assess whether the couple have adequate communication to enable mutual
problem solving. 
• What happens before and after drinking episodes, so that particular dynamics relevant to the
drinking can be identified. If the spouse’s role in therapy is aimed at selectively reinforcing
certain behaviours in their partner, then the clinician should be sure that does not threaten
the spouse’s well-being by reinforcing the notion that she or he is somehow responsible for
the partner’s drinking. 
The family interview is an opportunity for family members to ask questions and to voice their
concerns. It is also a good time to help the family see the drinking problem in perspective. For
instance, family members should be advised that achieving abstinence or moderation does not
necessarily resolve family problems, and that their personal health and wellbeing does not
necessarily depend upon the resolution of the drinker’s problem. Most importantly, the attitude of
the clinician should permit the significant other to help themselves rather than feeling obligated
to help the drinker.
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SUMMARY OF EVIDENCE: IN-DEPTH ASSESSMENT LEVEL OF EVIDENCE
Client involvement in goal setting and treatment planning III-1
helps increase motivation and retention in treatment.
The stages of change model and its associated questionnaire IV
(the RTCQ) have not demonstrated consistent reliability and 
validity. Although the client’s readiness to change is important, 
its assessment may best be carried out through direct questioning.
A number of validated scales are available to assess the client’s II
severity of dependence. Three useful scales are the SADQ-C, 
the SADD and the ADS.
The Timeline Followback Method helps to obtain an accurate, II
retrospective account of alcohol consumption over a particular 
period, typically three months.
Psychological comorbidity, particularly anxiety and depression, II
is common in alcohol dependent clients. 
Including family members in the assessment can provide important IV
information about the triggers for drinking, drinking patterns, 
and alcohol-related problems. It also provides an opportunity 
to clarify family members’ expectations about treatment.
RECOMMENDATIONS: IN-DEPTH ASSESSMENT STRENGTH OF 
RECOMMENDATIONS
Assessment for more intensive intervention should be conducted Strong
in a semi-structured, narrative style, with strategic use of structured 
techniques and questionnaires such as the Timeline Followback 
Method for assessing alcohol intake, and the SADD or the SAD-Q 
for assessing severity of dependence.
The length of the assessment process needs to be balanced with Strong
retaining the client in treatment. Therefore, clinicians need to make 
decisions about which aspects of assessment are essential. Key 
topics are the client’s consumption of alcohol, level of alcohol 
dependence, cognitive functioning, psychological comorbidity, 
family situation, physical wellbeing, and readiness for change. 
Assessment should lead to a clear, mutually acceptable treatment Strong
plan that structures a specific intervention to meet the client’s needs.
Readiness to change may be best assessed through direct questioning Moderate
Where possible, and with the client’s permission, family members Moderate 
should be involved in the assessment process
Assessment for anxiety and depressive symptoms and disorders Strong
should be routine.
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Chapter 4: Patient-treatment matching
Chapter aim
The aim of this chapter is to describe how clinicians can decide which treatment intervention is
likely to be most effective for a patient, based on the individual characteristics and needs of that
patient. 
Patient-treatment matching refers to the prescription of treatment according to individual patient
characteristics, as opposed to providing the same therapy to all patients with a common diagnosis.
[89] The ultimate goal of matching research is to develop valid, practical rules for clinicians to use
in assigning patients to treatment regimes. In the accompanying literature review, a range of
treatment options were evaluated in terms of the evidence relating to their effectiveness. A major
conclusion of this review was that there are a range of treatment interventions, all of which appear
to have a role in treatment, but that no single intervention is effective for all persons with alcohol
problems. A second major conclusion is that there is no reason to believe that persons with alcohol
problems are a homogeneous group with identical reasons for risky drinking, or that they all should
receive a single intervention of the same type, content and duration. 
Despite the intuitive appeal of these conclusions, the largest investigation of patient-treatment
matching, Project MATCH, found no evidence to support the patient-treatment matching hypothesis.
[90] The ten attributes considered were: 
• severity of alcohol involvement
• cognitive impairment
• client conceptual level
• gender
• meaning seeking
• motivational readiness to change
• psychiatric severity
• social support
• sociopathy 
• typology
Psychiatric severity was the only attribute that showed a significant attribute by treatment interaction:
in the outpatient study, clients low in psychiatric severity had more abstinent days after 12-step
facilitation than after cognitive behavioural therapy. Neither treatment was clearly superior for
clients with higher levels of psychiatric severity.
Although evidence does not indicate that certain patients respond best to certain treatment
interventions, in practice clinicians do match clients to treatments. Clinicians often use criteria such
as severity of dependence, the presence of co-occurring pathology or other problems such as
marital problems or a lack of social support to assign patients to treatment. By doing this, clinicians
ensure that the treatments offered consider the factors associated with the alcohol problem. [89] This
form of matching depends upon the careful and comprehensive assessment described in Chapter
3: Screening and assessment. 
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Further, the clinician can make the decision with the client about treatment modality. It is thought
that if the client contributes in deciding which treatment to receive, they are more likely to
participate more fully in treatment. In this situation the clinician describes the available treatment
options that might best assist with the various deficits or problems identified as being associated
with the client’s drinking, and the client and clinician agree upon which treatment is likely to be
most appropriate. 
SUMMARY
The role of matching in alcohol treatment is an important area of research, but at this stage research
evidence provides few clear guidelines. In the absence of clear research evidence, clients and
clinicians should make joint decisions about the treatment likely to be most appropriate, given the
severity of dependence of the client, and their treatment goals. 
SUMMARY OF EVIDENCE: PATIENT-TREATMENT MATCHING LEVEL OF EVIDENCE
Evidence from well-controlled trials does not support II
the patient-treatment matching hypothesis
RECOMMENDATIONS: PATIENT-TREATMENT MATCHING STRENGTH OF RECOMMENDATION
The intensity of interventions should vary, with Strong
clients with more severe problems receiving 
more intensive treatments
Comorbid psychological disorders should be taken Strong
into account when assigning patients to treatment, 
particularly when pharmacotherapies are being 
considered as a relapse prevention strategy.
The clinician and the client should discuss and Moderate
agree upon treatment goals and interventions.
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Chapter 5: Alcohol withdrawal management2
The clinical management of alcohol dependent drinkers during withdrawal is a critical phase of
an alcohol treatment program, since it serves to minimise the severity of withdrawal symptoms
that occur when alcohol consumption is ceased.
CHAPTER AIM
To provide knowledge and guidance on the appropriate management of patients in alcohol
withdrawal. 
Alcohol withdrawal syndrome
People who are physically dependent upon alcohol are likely to experience withdrawal symptoms
6 to 24 hours after the last drink is consumed. The alcohol withdrawal syndrome usually begins
as the blood alcohol level (BAL) reduces and may become clinically apparent usually before the
BAL reaches zero. [91, 92] The alcohol withdrawal is usually self-limiting and usually uncomplicated
resolving within 5 days with minimal or no intervention. However, this depends largely on the
individual’s drinking pattern, frequency, duration and quantity. While for most individuals the
alcohol withdrawal syndrome is short-lived and inconsequential in others it increases in severity
through the first 48 to 72 hours of abstinence. The patient becomes highly vulnerable to psycho-
logical and physiological stress during this time. Alcohol withdrawal seizures may occur 12 to 48
hours post-drinking and alcohol withdrawal delirium tremens 48 to 96 hours post-drinking. [93]
Figure 5.1 outlines the alcohol withdrawal syndrome progression. 
FIGURE 5.1: THE PROGRESSION OF THE ALCOHOL WITHDRAWAL SYNDROME 
Source: Frank
and Pead (1995). Reproduced with permission. [94]
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2 Since the 1993 monograph `An outline for the management of alcohol problems: quality assurance project’,there
has been little research on alcohol withdrawal. Therefore with permission from the authors the withdrawal section
is based upon that of the previous monograph. 
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Alcohol withdrawal symptoms may be present when the person has a significant BAL. The BAL
does not have to be zero for the onset of alcohol withdrawal to occur, with a significant proportion
of dependent drinkers experiencing the onset of withdrawal symptoms before the BAL reaches
zero. Patient care should not be decided based on the BAL alone, the alcohol withdrawal rating
scales should also be used to assess the patient’s level of alcohol withdrawal symptoms. 
The severity of alcohol withdrawal also depends on the number of drinks per day, the total number
and severity of past withdrawal episodes, greater use of non-therapeutic sedative-hypnotic drugs,
and the number of medical problems. However, caution is necessary as clinical experience suggests
that some patients may undergo severe withdrawal at lower levels of consumption than others
who are heavier drinkers. Therefore it is important to monitor patients carefully during the alcohol
withdrawal period to identity patients at risk. Patients withdrawing from alcohol may also be
withdrawing from multiple substances. As a result these patients may require closer monitoring
for abstinence on a range of substances in addition to alcohol. 
ALCOHOL WITHDRAWAL SYMPTOMS AND SIGNS
THE SIGNS AND SYMPTOMS OF THE ALCOHOL WITHDRAWAL SYNDROME INCLUDE:
• increased body temperature (hyperthermia)
• increased pulse rate (tachycardia)
• increased respiration rate
• increased blood pressure (hypertension)
• nausea and vomiting
• tremor
• sweating
• agitation and anxiety
• disturbed sleep
• tactile disturbances such as pins and needles, itching, burning, numbness, crawling sensations
and “electric fleas”, including tactile hallucinations
• auditory and/or visual disturbances including hallucinations
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Medical care for alcohol withdrawal complications
q
All health professionals planning on prescribing or using any of the medications listed
below are advised to first refer to MIMS Australia. [95]
SEIZURES
Withdrawal-induced seizures may occur 12 to 48 hours after the last drink is consumed. A patient with
a previous history of alcohol withdrawal seizures should be monitored regularly and carefully with an
alcohol withdrawal rating scale and withdrawal medication given, preferably as a loading dose regime
with diazepam orally and in some cases intravenously. However, one study has examined the use of
2mg lorazepam in 2ml of normal saline compared to 4ml of normal saline for preventing recurrent seizures
in patients withdrawing from alcohol and found that the lorazepam group had a significant effect on
preventing recurrent seizures. [96] If the patient experiences two or more seizures, focal seizures [97] or
develops status epilepticus the patient should be investigated separately since these are not necessarily
because of alcohol withdrawal. [98]
HALLUCINATIONS
Some patients may experience hallucinations, which may occur during any stage of the alcohol
withdrawal phase. 
The symptoms and signs of hallucinations include:
• hallucinations usually auditory
• perceptual distortions
• paranoid delusions
• psychomotor disturbances
• abnormal affect
Patients experiencing hallucinations should be monitored regularly and carefully. Alcohol withdrawal
medication such as diazepam should be given. However, if the patient continues to experience halluci-
nations an anti-psychotic medication, such as haloperidol, may be given as well. An initial dose of
2.5mg to 10mg of haloperidol orally or intramuscularly can be given if diazepam is not effective in
reducing or alleviating the hallucinations. Additional doses of haloperidol may be given if the patient
continues to experience hallucinations. [1, 97] The patient should also be monitored carefully for
hypotension.
DELIRIUM
A small percentage of patients withdrawing from alcohol experience delirium during the first 24
to 48 hours of withdrawal. 
The symptoms and signs of delirium include:
• agitation
• hyperactivity
• tremor
• confusion
• disorientation
Patients experiencing delirium should be monitored regularly and carefully. Alcohol withdrawal
medication such as diazepam and fluids should be given to prevent progression to delirium tremens. 
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DELIRIUM TREMENS (DTs)
Delirium tremens is by far the most serious life-threatening complication of the alcohol withdrawal
syndrome, which usually occurs 48 to 96 hours after the last drink is consumed, and should be
monitored. 
The symptoms and signs of delirium tremens include:
• exaggerated alcohol withdrawal syndrome
• extreme restlessness or agitation
• autonomic instability
• gross tremor
• confusion and disorientation
• paranoid ideation
• hallucinations (any senses)
Delirium tremens complications may include dehydration, arrhythmias, hypotension, renal failure
and pneumonia. Patients with DTs should be monitored and given intravenous fluids, effective
sedation (either benzodiazepines or major tranquillisers) and should be treated for conditions occurring
at the same time. Management needs to be tailored to the patients’ needs, however an intravenous
injection of 10 to 20mg diazepam may be given over two to five minutes. [1, 97] The patient should be
observed continuously and if necessary a further two doses (given over the next hour). [1, 97] A
maintenance dose of one to five mg per hour (gradually reducing) intravenously may be necessary
over the first 24 hours or 10 to 20mg diazepam every two hours for six hours as required followed
by 10 to 20mg every six hours until 24 hours since initial dose. [1, 97] The patient should be kept under
close supervision at all times. 
WERNICKE-KORSAKOFF’S SYNDROME
Wernicke-Korsakoff’s syndrome is a form of brain injury resulting from a lack of thiamine (vitamin
B1) deficiency in chronically alcohol dependent patients. The condition could lead to permanent
brain damage and memory loss if not treated early. 
The symptoms and signs of Wernicke-Korsakoff’s syndrome:
• nystagmus (reduced eye movement) 
• neuropathy
• ataxia
• confusion 
Patients at risk of Wernicke-Korsakoff’s syndrome should be treated with 100mg of intramuscular
or oral thiamine before any glucose intake.[1]
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SUMMARY OF EVIDENCE: ALCOHOL WITHDRAWAL LEVEL OF EVIDENCE
It is important to monitor patients for alcohol I
withdrawal symptoms. The severity of the symptoms 
depends upon the number of drinks per day, 
duration of drinking, number of previous alcohol 
withdrawal episodes, a known coexisting illness and 
use of other psychotropic drugs.
Alcohol withdrawal complications may occur, such I
as seizures, hallucinations, delirium and delirium 
tremens. Patients should be monitored with an 
alcohol withdrawal rating scale and managed with 
withdrawal medication.
Alcohol dependent patients risk developing I
Wernicke-Korsakoff’s syndrome (permanent 
brain damage), which can be prevented by giving 
the patient parenteral thiamine before any glucose 
intake during withdrawal.
RECOMMENDATIONS:ALCOHOL WITHDRAWAL STRENGTH OF RECOMMENDATIONS
Patient experiencing withdrawal complications such Strong
as seizures, hallucinations, delirium and delirium 
tremens should be monitored carefully and regularly 
with a withdrawal rating scale and withdrawal 
medication should be given.
Patients at risk of Wernicke-Korsakoff’s syndrome should                               Strong
be treated with 100mg of intramuscular or oral thiamine 
before any glucose intake.
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Monitoring the withdrawal state
All patients in alcohol withdrawal, or who are considered at risk of alcohol withdrawal, should be
monitored regularly. It is beneficial to use an alcohol withdrawal rating scale to assess the severity
of the withdrawal state. 
q
The alcohol withdrawal rating scales are intended for monitoring the severity of the
alcohol withdrawal syndrome and should not be used as diagnostic tools.
The Clinical Institute Withdrawal Assessment for Alcohol revised CIWA-Ar is a 10-item scale and
is helpful in assessing the severity of the alcohol withdrawal (Table 5.1). It helps to guide treatment
and allows clinicians to communicate more objectively about the severity and management of
alcohol withdrawal. The CIWA-Ar is important in helping to indicate when the alcohol withdrawal
is continuing to develop in spite of conservative measures. Patients scoring more than 10 have an
increased risk of complications if they remain without sedatives. [99] As the CIWA-Ar score increases
the risk increases and the patient should be monitored closely and sedatives given. The scale is
usually used one to three times a day and more frequently when patients are symptomatic. [98]
An alternative scale is the Alcohol Withdrawal Symptoms - Rating Scale (AWS) (Table 5.2). The
AWS has not been validated. However, the AWS is widely used and is considered acceptable for
use in hospitals and non-medicated environments despite no strong evidence or validation. If the
CIWA-Ar scale is not available then an AWS score of up to four indicates a mild withdrawal
syndrome, five to seven a moderate withdrawal, eight to 14 a severe withdrawal and 15 or more
is indicative of a very severe withdrawal. Close monitoring is advised at least every four hours and
if the AWS score reaches 10 or more, every two hours. The point at which sedatives should be
prescribed depends upon the severity of the alcohol withdrawal and the setting in which the
alcohol withdrawal is taking place.
The Short Alcohol Withdrawal Scale (SAWS) was developed as a self-completion scale (Table 5.3).
The SAWS should be explained to the patient on first administration. The scale is designed for
administration once every 24 hours. The severity of each symptom is rated on a four point scale
from none (zero) to severe (four). An item score total of 12 or above indicates the possible need
for medication to reduce alcohol withdrawal symptoms. The SAWS requires further research and
is recommended for use with the standard clinical assessment and nursing observations.
Not all patients will be withdrawing from just alcohol. Patients may also be withdrawing from other
substance(s) such as heroin and diazepam. In these cases, the patient should be monitored very
closely for withdrawal from alcohol and other substance(s). Clinicians are advised to refer to the
withdrawal guidelines for these substance(s) and use these guidelines with these alcohol withdrawal
management guidelines.
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TABLE 5.1: CLINICAL INSTITUTE WITHDRAWAL ASSESSMENT FOR ALCOHOL REVISED
(CIWA-AR)
NAUSEA AND VOMITING
Ask “Do you feel sick to your stomach? Have
you vomited?” and observe.
q 0 No nausea and no vomiting
q 1 Mild nausea with no vomiting
q 2
q 3
q 4 Intermittent nausea with dry heaves
q 5 
q 6
q 7 Constant nausea, frequent dry
heaves and vomiting
TREMOR
Observe patient’s arms extended and fingers
spread apart
q 0 No tremor
q 1 Not visible, but can be felt fingertip
to fingertip
q 2
q 3
q 4 Moderate, with patient’s arms
extended
q 5
q 6
q 7 Severe, even with arms not
extended
PAROXYSMAL SWEATS
q 0 No sweat visible
q 1 Barely perceptible sweating, palms
moist
q 2
q 3
q 4 Beads of sweat obvious on forehead
q 5
q 6
q 7 Drenching sweats
ANXIETY
Observe, and ask “Do you feel nervous?”
q 0 No anxiety, at ease
q 1 Mildly anxious
q 2
q 3
q 4 Moderately anxious, or guarded, so
anxiety is inferred
q 5
q 6
q 7 Equivalent to acute panic states as
seen in severe delirium or acute
schizophrenic reactions
AGITATION
q 0 Normal activity
q 1 Somewhat more than normal activity
q 2
q 3
q 4 Moderately fidgety and restless
q 5
q 6
q 7 Paces back and forth during most of
the interview, or constantly thrashes
about
TACTILE DISTURBANCES
Ask “Have you any itching, pins and needles
sensations, any burning, any numbness or do
you feel bugs crawling on or under your skin?”
q 0 None
q 1 Very mild itching, pins and needles,
burning or numbness
q 2 Mild itching, pins and needles,
burning or numbness
q 3 Moderate itching, pins and needles,
burning or numbness
q 4 Moderately severe hallucinations
q 5 Severe hallucinations
q 6 Extremely severe hallucinations
q 7 Continuous hallucinations
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AUDITORY DISTURBANCES
q 0 Not present
q 1 Very mild harshness or ability to
frighten
q 2 Mild harshness or ability to frighten
q 3 Moderate harshness or ability to
frighten
q 4 Moderately severe hallucinations
q 5 Severe hallucinations
q 6 Extremely severe hallucinations
q 7 Continuous hallucinations
VISUAL DISTURBANCES
Ask “Does the light appear to be too bright?
Is its colour different? Does it hurt your eyes?
Are you seeing anything that is disturbing to
you? Are you seeing things you know are not
there?” and observe.
q 0 Not present
q 1 Very mild sensitivity
q 2 Mild sensitivity
q 3 Moderate sensitivity
q 4 Moderately severe hallucinations
q 5 Severe hallucinations
q 6 Extremely severe hallucinations
q 7 Continuous hallucinations 
HEADACHES, FULLNESS IN HEAD
Ask “Does your head feel different? Does it
feel like there is a band around your head?”
Do not rate for dizziness or light-headedness.
Otherwise, rate severity.
q 0 Not present
q 1 Very mild
q 2 Mild
q 3 Moderate
q 4 Moderately severe
q 5 Severe
q 6 Very severe
q 7 Extremely severe
ORIENTATION AND CLOUDING OF
SENSORIUM
Ask “What day is this? Where are you? Who
am I?”
q 0 Orientated and can do serial
additions
q 1 Cannot do serial additions or is
uncertain about date
q 2 Disorientated for date by no more
than 2 calendar days
q 3 Disorientated for date by more than
2 calendar days
q 4 Disorientated for place and/or
person
Source: Sullivan et al. (1989). [99]
TABLE 5.1: CLINICAL INSTITUTE WITHDRAWAL ASSESSMENT FOR ALCOHOL REVISED
(CIWA-AR) CONT.
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TABLE 5.2: ALCOHOL WITHDRAWAL SCALE (AWS)
ITEM 1   PERSPIRATION
q 0 No abnormal sweating.
q 1 Moist skin.
q 2 Localised beads of sweat (such as on
face, chest etc).
q 3 Whole body wet from perspiration.
q 4 Profuse sweating (such as Clothes,
linen etc are wet).
ITEM 2 TREMOR
q 0 No tremor.
q 1 Slight intentional tremor.
q 2 Constant slight tremor of upper
extremities.
q 3 Constant marked tremor of
extremities.
ITEM 3 ANXIETY
q 0 No apprehension of anxiety.
q 1 Slight apprehension.
q 2 Apprehension or understandable
fear (such as of withdrawal
symptoms).
q 3 Anxiety occasionally accentuated to
a state of panic.
q 4 Constant panic-like anxiety.
ITEM 4 AGITATION
q 0 Rests normally during day, no signs
of agitation.
q 1 Slight restlessness, cannot sit or lie
still, awake when others sleep.
q 2 Moves constantly, looks tense, wants
to get out of bed but obeys requests
to stay in bed.
q 3 Constantly restless, gets out of bed
for no obvious reason, returns to
bed if taken.
q 4 Maximally restless, aggressive,
ignores request to stay in bed.
ITEM 5 AXILLA (ARMPIT) TEMPERATURE
q 0 Temperature of 37ºC or less
q 1 Temperature of 37.1ºC to 37.5ºC
q 2 Temperature of 37.6ºC to 38.0ºC
q 3 Temperature of 38.1ºC to 38.5ºC
q 4 Temperature above 38.5ºC
ITEM 6 HALLUCINATIONS (A FALSE
PERCEPTION OF SIGHT, SOUND,
TASTE OR TOUCH)
q 0 No evidence of hallucinations.
q 1 Distortions of real objects. Aware
that these are not real if this is
pointed out. 
q 2 Appearance of totally new objects or
perceptions, aware that these are not
real if this is pointed out. 
q 3 Believes the hallucinations real but
still oriented in place and person.
q 4 Believes self to be in a totally non-
existent environment, preoccupied
and cannot be diverted or reassured.
ITEM 7 ORIENTATION
q 0 The patient is fully oriented in time,
place and person.
q 1 The patient is oriented in person but
is not sure where he is or what time
it is. 
q 2 Oriented in person but disoriented in
time and place.
q 3 Doubtful personal orientation,
disoriented in time and place, there
might be short periods of lucidity.
q 4 Disoriented in time, place and
person, no meaningful contact can
be obtained.
Source: Novak et al (1989). [100]
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TABLE 5.3: THE SHORT ALCOHOL WITHDRAWAL SCALE (SAWS)
Please put a tick in the boxes to show how you have been feeling for all of the following conditions
in the last 24 hours.
None (0) Mild (1) Moderate (2) Severe (3)
Anxious q q q q
Sleep disturbance q q q q
Problems with memory q q q q
Nausea q q q q
Restless q q q q
Tremor (shakes) q q q q
Feeling confused q q q q
Sweating q q q q
Miserable q q q q
Heart pounding q q q q
Source: Gossop et al (2002). Reproduced with permission. [101]
SUMMARY OF EVIDENCE:WITHDRAWAL SCALES LEVEL OF EVIDENCE
The Clinical Institute Withdrawal Assessment for I
Alcohol Revised (CIWA-Ar) is the most widely used and 
validated alcohol withdrawal scale.
However, the expert panel agreed that the Alcohol IV
Withdrawal Scale - Rating Scale (AWS) is widely used 
and is acceptable for use in hospitals and non-medicated 
environments despite no strong evidence or validation.
The Short Alcohol Withdrawal Scale (SAWS) is a more IV
recent scale to be used with the standard clinical 
assessment and observation.
RECOMMENDATIONS:WITHDRAWAL SCALES STRENGTH OF RECOMMENDATIONS
Patient withdrawing from alcohol should be monitored Strong
with a withdrawal rating scale. The CIWA-Ar is the most 
validated and recommended scale to use. 
If the CIWA-Ar scale is unavailable then the AWS should Fair
be used, however this scale is not validated despite it 
wide use in Australia.
All of the alcohol withdrawal rating scales are to be used Moderate
to monitor the severity of the withdrawal syndrome and 
are not intended as diagnostic tools.
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Home-based, outpatient and inpatient withdrawal management
A range of alcohol withdrawal management settings currently exist. The appropriateness of each
of these settings to an individual drinker’s case will depend upon good clinical judgement of the
actual or likely severity of the alcohol withdrawal syndrome; the presence of other physical and
psychiatric conditions; and the choice made by the drinker. A “triage” system with clear criteria
known by all staff for the different alcohol withdrawal management options should be in place to
screen all patients presenting for alcohol withdrawal management. 
These withdrawal management settings include:
• Home-based withdrawal is supervised medically or non-medically, which is conducted under
supervision.
• Outpatient withdrawal is supervised medically or non-medically, which is conducted under
supervision.
• Inpatient withdrawal deals with medical emergencies associated with alcohol withdrawal, such
as delirium tremens. 
Home-based, outpatient and inpatient withdrawal management settings are not for alcohol
withdrawal management alone. The majority of these settings will provide withdrawal management
for a range of substances such as heroin and diazepam. Therefore, staff training is required to detect
withdrawal symptoms from other substances besides alcohol. 
HOME-BASED WITHDRAWAL MANAGEMENT
Many people who choose to withdraw from alcohol can be managed in the home. Home-based
withdrawal management involves the patient withdrawing from alcohol at home in a supportive
setting or group accommodation, such as a hostel or halfway house. Patient’s withdrawal symptoms
are usually monitored by visits from a health care worker and telephone calls. Medications are
usually managed by the patient or lay carer and the through access to a 24-hour telephone support
line. 
Home-based withdrawal management may be appropriate for those who are likely to suffer from
mild to moderate alcohol withdrawal, may not require sedative medication, have no known co-
existing medical or psychiatric history, and for groups of people who may have difficulty reaching
inpatient withdrawal settings, such as women who have children at home, or people from cultural
groups who value intensive family or community support that cannot be readily provided by
residential settings. 
Alcohol withdrawal management at home may be attempted provided that: 
• There are no signs of severe alcohol withdrawal, such as severe tremor, tachycardia greater
than 110 beats per minute, seizures, delirium, clouding of consciousness or hallucinations at
the time.
• There is no history of severe alcohol withdrawal, such as delirium tremens or alcohol
withdrawal seizures. 
• There are supportive relatives or friends who could stay with the patient during the period of
alcohol withdrawal, supervise administration of medication and call for medical assistance if
it becomes necessary. 
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• There are no other significant medical illnesses, such as pneumonia or pancreatitis. Delirium
tremens is more common when such illnesses are present.
• There is no evidence of suicidal ideation, or severe depressive disorder.
• The patient does not have ready access to a supply of alcohol or other drugs at home.
There are some potential negative aspects to home-based withdrawal management. Mainly, the
failure rate of home-based withdrawal management may be higher than for inpatient withdrawal
management. The reasons for this include: 
• Patients withdrawing at home are less likely to be removed from the factors that have become
associated with regular drinking.
• Patients are thus less likely to complete the withdrawal process without drinking alcohol.
• It is not appropriate for some drinkers, for example, the homeless and those patients at risk
of severe alcohol withdrawal.
Readers are referred to the “Guide to home detoxification” by Saunders et al. (1996) [102] for further
information on home-based withdrawal management. 
OUTPATIENT WITHDRAWAL MANAGEMENT
Outpatient withdrawal management is similar to home-based withdrawal management; however
the patient attends a clinic or outpatient withdrawal management setting for observation, assessment
by trained staff and to collect alcohol withdrawal medication usually on a daily basis.
Outpatient withdrawal management, like home-based withdrawal management may be appropriate
for those who are likely to suffer from mild to moderate alcohol withdrawal, are not in need of
sedative medication, have no known coexisting medical or psychiatric history, and for groups of
people who may have difficulty attending inpatient services. The criteria for outpatient withdrawal
management are similar to home-based withdrawal management as discussed above, except that
the “support of family and friends” is not necessary because unlike home-based withdrawal
management, outpatient withdrawal management allows for close observation, assessment by staff
and access to other alcohol treatment services such as counselling. The main negative aspect of
outpatient withdrawal management is the possibility of relapse because the patient’s environment
remains the same, such as in the homeless.
INPATIENT WITHDRAWAL MANAGEMENT 
Inpatient withdrawal management settings may be a community residential setting or a dedicated
acute hospital bed with well-trained clinicians available for the care of dependent drinkers at risk
of alcohol withdrawal complications. Community residential settings are different to acute hospital
beds, in that they are more domestic/home like environment than clinical, patients are ambulatory
and are not lying in bed all day, patients are either supervised medically or non-medically, and
community residential settings may provide group programs focusing on, for example relapse
prevention, how to cope with symptoms, and stress management. 
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Circumstances where inpatient withdrawal management is indicated include; medical or psychiatric
disorders, unsafe environment, homelessness, living with other addicted individuals, and/or a
history of failed attempts to abstain in either a home-based or outpatient withdrawal setting.
Admission to inpatient withdrawal management settings should be based on meeting at least one
of the criteria outlined below. 
Inpatient withdrawal management criteria are set out below: 
• A history of severe alcohol withdrawal symptoms or episodes such as seizures, recurrent
alcohol withdrawal seizures, delirium or delirium tremens that should be managed in a
residential or inpatient basis.
• The probability of imminent and severe alcohol withdrawal syndrome, or else the actual
presence of a marked alcohol withdrawal state indicating the need for inpatient withdrawal
management or residential care.
• The presence of a known coexisting psychiatric or medical disorder, such as depression,
suicidal ideation, chest infection, pneumonia, or pancreatitis -each of which increase the
likelihood that the alcohol withdrawal will end in injury or death. 
• A home environment that is unfavourable to successful alcohol withdrawal, because of a lack
of supervision or because of the presence of heavy drinkers and alcohol that predisposes the
withdrawing drinker to relapse. 
• The lack of a suitably supervised home-based or outpatient withdrawal management settings.
However, inpatient withdrawal management may face some issues such as a lack of resources,
difficulties in managing patient care, occupational health and safety issues for staff, patients and
visitors, dealing with patient welfare issues, policing patient access to alcohol and other substances
and the cost of running an inpatient withdrawal management setting. 
Overall, home-based, outpatient and inpatient withdrawal management not only offers alcohol
withdrawal management but also provides advice, support and allows patients to be referred to
ongoing treatment such as counselling and accommodation.
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SUMMARY OF EVIDENCE:WITHDRAWAL MANAGEMENT LEVEL OF EVIDENCE
Home-based withdrawal management is appropriate I
when there are no signs of severe withdrawal, no 
history of severe withdrawal, there are supportive 
relatives or friends who can help to assist and look 
after the person and there are no known coexisting 
medical or psychiatric illnesses.
Outpatient withdrawal management patients attend II
a clinic or facility, usually on a daily basi,s for 
assessment and to collect withdrawal medication. 
It is appropriate for patients with no obvious se
vere withdrawal, or history of severe withdrawal 
and no known coexisting medical or 
psychiatric illnesses. 
Inpatient withdrawal management is required for II
people who have a severe history of alcohol 
withdrawal symptoms, a known coexisting 
medical or psychiatric illness and/or an 
unfavourable home environment.
RECOMMENDATIONS:WITHDRAWAL MANAGEMENT STRENGTH OF RECOMMENDATIONS
Home-based withdrawal management is Strong
recommended for patients with mild to 
moderate withdrawals who have a support 
network, no known coexisting medical or 
psychiatric illness and no history of 
withdrawal complications.
Outpatient withdrawal management is appropriate Strong
for patients with mild to moderate withdrawals who 
have no history of severe withdrawal or known 
coexisting medical or psychiatric illness.
Inpatient withdrawal management is required for Strong
people who have severe withdrawal complications, 
a history of withdrawal complications or a known 
coexisting medical or psychiatric history. 
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Supervised medicated and non-medicated withdrawal management
Alcohol withdrawal can be managed in either a supervised medicated by substituting a controlled
sedation for uncontrolled alcohol intoxication, or in a supervised non-medicated withdrawal
management setting.
Outlined below are the two options:
• Supervised non-medicated withdrawal monitors patients who are at risk of relapse but are
not at risk of serious alcohol withdrawal. Monitoring may take place in either a home-based,
outpatient or inpatient withdrawal management setting.
• Supervised medicated withdrawal treats patients who are at risk of serious alcohol withdrawal,
usually in an inpatient withdrawal management setting. However, patients experiencing mild
to moderate alcohol withdrawal may be treated in a home-based or outpatient withdrawal
management setting. 
A supervised non-medicated alcohol withdrawal is appropriate for patients with mild to moderate
alcohol withdrawal who have no known coexisting medical or psychiatric disorders. A supervised
non-medicated withdrawal may take place in either a home-based, outpatient or inpatient
withdrawal management setting. The rationale for this approach is that withdrawal symptoms,
including anxiety and agitation, are lessened and may be prevented by supportive counselling in
a non-stimulating, non-threatening environment. 
q
Patients in a supervised non-medicated withdrawal setting should be monitored
with an alcohol withdrawal rating scale. If alcohol withdrawal complications become
evident the patient should be given withdrawal medicated or transferred to a
supervised medicated withdrawal setting.
The essential elements of a supervised non-medicated withdrawal approach are outlined in Table
5.4. These supervised non-medicated withdrawal management principles are also helpful in the
context of medicated withdrawal.
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TABLE 5.4: PRINCIPLES OF SUPERVISED NON-MEDICATED ALCOHOL WITHDRAWAL
MANAGEMENT 
PRINCIPLES OF SUPERVISED NON-MEDICATED ALCOHOL WITHDRAWAL
• Use a quiet, non-stimulating, non-threatening and safe environment. 
• Employ a slow, steady, non-threatening approach to reduce anxiety.
• Explain all interventions clearly.
• Speak slowly and distinctly in a friendly manner.
• Maintain continuous eye contact when speaking.
• Avoid confrontation and arguments.
• Test the patient’s reality base and orientation repeatedly and, if necessary, re-acquaint the
patient with his or her environment.
• Attempt to explain to the patient that the unreal nature of illusions and hallucinations may
cause anxiety and are likely to be part of the alcohol withdrawal syndrome. 
• A night light reduces the likelihood of perceptual errors and an exacerbation of anxiety and
psychotic phenomena during the night.
• When the patient is endangering his life or threatening others, minimal restraint may be
necessary. If coercion is required, give clear directions to the patient.
• Sedation should be considered if restraint is required, or persistent or increasing disorien-
tation, delusions or hallucinations are present.
• Thiamine should be given in all cases, preferably 100mg intramuscularly, or failing that 100
mg orally three times daily. Administration of other B group vitamins and vitamin C is
advisable.
Source: Mattick and Jarvis (1993). [1]
A supervised medicated alcohol withdrawal is indicated for patients who may suffer or are suffering
a severe alcohol withdrawal. A supervised medicated alcohol withdrawal usually takes place in
an inpatient withdrawal management setting; however in mild to moderate cases a supervised
medicated withdrawal may take place in a home-based or outpatient withdrawal management
setting. 
q
Patients in a supervised medicated withdrawal setting should be monitored using
a withdrawal rating scale. Withdrawal medications should be provided to prevent
and treat withdrawal symptoms and complications.
The essential principle of a supervised medicated alcohol withdrawal is that the dose of the sedative
is titrated against the severity of the patient’s alcohol withdrawal syndrome. Drugs should not be
given to patients who are still intoxicated. The medication most commonly used for alcohol
withdrawal is diazepam (discussed later on in this section). These medications also have the
advantage of having some anticonvulsant properties. Medical practitioners and other health profes-
sionals are advised to become familiar with these drugs and gain experience on the dosage and
duration of treatment necessary for patients with alcohol withdrawal syndromes of different severity. 
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Procedural guidelines for the nursing management of patients who are intoxicated or are
withdrawing from alcohol have been developed in Australia. [103] These guidelines, Alcohol and
Other Drugs Policy for Nursing Practice in NSW: Clinical Guidelines, are presented in an easily
understood format and are recommended for general dissemination. 
At the time of writing draft clinical guidelines were being prepared for nurses and midwives called
Alcohol, Tobacco and other drugs: A framework for Policy and Clinical Practice for Nurses and
Midwives: Clinical Guidelines 2002-2005 by the Drug and Alcohol Services Council of South
Australia and Flinders University.
RECOMMENDATIONS:WITHDRAWAL MANAGEMENT STRENGTH OF RECOMMENDATIONS
A supervised non-medicated withdrawal Strong
management is appropriate only for people 
with mild to moderate alcohol withdrawal and 
no known coexisting medical or 
psychiatric illnesses.
A supervised medicated withdrawal is required Strong 
for people who are at risk of, or suffer from, 
alcohol withdrawal complications.
SUPERVISED MEDICATED WITHDRAWAL REGIMES
q
All health professionals planning on prescribing or using any of the medications listed
below are advised to first refer to MIMS Australia. [95]
Outlined below are the three most commonly used supervised medicated withdrawal regimes.
Symptom-triggered therapy
This regime administers medication only when the patient is symptomatic. It is suggested that this
form of regime should be restricted to patients without a history of alcohol withdrawal seizures,
other complications or acute concurrent medical illness, particularly as there have been no thorough
studies in this area.
Fixed-schedule therapy
Benzodiazepines given at fixed dosing intervals are a common therapy for alcohol withdrawal
management. For example, providing the patient is not at risk or experiencing complications,
diazepam 10mg is given every six hours for two days to prevent delirium and seizures. The dose
is usually tapered over the latter days of withdrawal and should not continue past day six. Additional
medication can be given if required depending on health status and withdrawal symptoms.
Loading dose
Loading dose regimes administer tailored and titrated doses of medication in the early stages of
alcohol withdrawal. For example, diazepam 20mg is given every two hours until the alcohol
withdrawal subside or the patient is sedated, reducing the chances of seizures, especially for those
patients who have experienced alcohol withdrawal seizures in previous alcohol withdrawal attempts.
SUMMARY OF EVIDENCE: MEDICATED WITHDRAWAL REGIMES LEVEL OF EVIDENCE
Symptom-triggered therapy offers alcohol withdrawal II
medication as symptoms appear (not appropriate for 
people with a history of severe alcohol withdrawal).
Fixed schedule therapy administers withdrawal II
medication at set interval times over a period of days. 
Loading dose regime administers tailored and titrated III-2
doses of withdrawal medication at the early stages of 
the alcohol withdrawal.
Pharmacological interventions in withdrawal management
q
All health professionals planning on prescribing or using any of the medications listed
below are advised to first refer to MIMS Australia. [95]
The administration of alcohol, chlordiazepoxide, barbiturates, beta-adrenergic blockers, clonidine,
acamprosate and gamma- hydroxybutyrate acid (GHB) as agents to facilitate alcohol withdrawal
are not recommended and will therefore not be covered in these guidelines. Chlormethiazole is
not recommended as a first line treatment and may only be useful in patients experiencing severe
withdrawal symptoms. Anticonvulsant medications should not be used in routine practice, as they
are not effective in preventing alcohol withdrawal complications such as seizures. However, anticon-
vulsants should be made available for patients currently taking them for other medical reasons.
The use of major tranquillisers or anti-psychotics medications should be reserved for patients with
hallucinosis and paranoid symptoms that occur during alcohol withdrawal and have not responded
to a conventional sedative regime. If psychotic symptoms persist, a psychiatric evaluation may be
required. All pharmacotherapy treatment listed below should be used with an alcohol withdrawal
rating scale and stored in a safe environment away from patient access. 
q
Diazepam is a suitable medication for use in alcohol withdrawal and is considered
to be the “gold standard” and first line treatment for alcohol withdrawal
management.
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DIAZEPAM 
Diazepam, an anti-anxiety agent or anxiolytic is widely used in medicated withdrawal from alcohol.
Diazepam can be given as a loading dose, where 20mg is given every two hours until the
withdrawal subsides or the patient is sedated after which a further dose is usually unnecessary.
However, the standard therapeutic (fixed-schedule therapy) regimen involves regular doses of
diazepam over two to six days. A regular starting dose is 10mg every six hours for two days. An
additional 10mg can be supplemented if required up to a recommended two doses. The dose is
usually tapered over the latter days and should not continue past day six. Outlined in Table 5.5 is
the diazepam regime for ambulatory withdrawal from the New South Wales Health Department
(1999) [97]. Table 5.6 is an example of a diazepam regime for home-based withdrawal from Saunders
et al. (1996) [102]. Both tables present very similar dosing regimes.
TABLE 5.5: TYPICAL DIAZEPAM REGIME FOR ALCOHOL WITHDRAWAL
Day 1 10mg six hourly with up to 2 additional 10mg doses PRN.
Day 2 10mg six hourly with up to 2 additional 10mg doses PRN. 
Day 3 10mg six hourly.
Day 4 5mg morning and night.
Tapering dose may be required over the next two days.
PRN - taken as required for symptom relief.
Source: New South Wales Health Department (1999) [97]
TABLE 5.6: DIAZEPAM REGIME FOR HOME -BASED ALCOHOL WITHDRAWAL
6 am 12 midday 6pm 12 midnight
Day 1 10mg 10mg 10mg 10mg
Day 2 10mg 10mg 10mg 10mg
Day 3 5mg 5mg 5mg 10mg
Day 4 5mg 5mg 5mg 10mg
Day 5 5mg - - 5mg
Day 6 5mg - - 5mg
*Additional 10mg dose can be given if required. 
Source: Saunders et al. (1996) [102]
For patients in severe alcohol withdrawal (such as DTs) an intravenous injection of 10mg to 20mg
diazepam may be given over two to five minutes. [1, 97] The patient should be observed continuously
and, if necessary a further two doses given over the next hour. [1, 97] A maintenance dose of one to
five mg per hour (gradually reducing) by intravenous injection may be necessary over the first 24
hours or 10 to 20mg diazepam every two hours for six hours as required followed by 10 to 20mg
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every six hours until 24 hours since the initial dose. [1,97] After 24 hours the patient can usually switch
to oral diazepam. [97] The patient should be kept under close supervision. 
Readers are referred to the NSW detoxification Clinical Practice Guidelines (1999) [97] for further
alcohol withdrawal diazepam treatment regimes in a specialist residential or hospital setting and
for severe alcohol withdrawal. 
CHLORMETHIAZOLE
Chlormethiazole is a short-acting sedative and anticonvulsant medication. Chlormethiazole is slowly
being phased out and is not recommended as first line treatment. It is also not advised for outpatient
withdrawal management because of its dependence-producing potential, sedative effects and lethal
interaction with alcohol. [1, 93] If intravenous diazepam is unavailable or is not suitable, chlorme-
thiazole is available in an intravenous preparation (of the edisylate salt) for patients with very
severe alcohol withdrawal syndromes, such as delirium tremens, or for those on no oral intake. [1]
However, intravenous chlormethiazole carries a significant risk of respiratory depression and
reduction in the gag reflex. [1] Chlormethiazole should be taken with caution and only in fully
medicated settings where the patient is closely monitored.
ANTICONVULSANT MEDICATIONS
Anticonvulsant medications such as carbamazepine have not been shown to reduce alcohol
withdrawal complications such as seizures. [104] The clinical utility of these drugs seems to be
outweighed by their side effects and are therefore not recommended as first line medications. The
preferred course of action is to institute or increase conventional sedation using benzodiazepines
such as diazepam. Anticonvulsant medications should only be made available for patients who
have been taking them on a regular basis before admission and patients with epilepsy not related
to withdrawal. [1] If a patient suffers two or more alcohol withdrawal seizures, has focal seizures or
develops status epilepticus, it should be assumed that the seizures are not a result of alcohol
withdrawal and should be investigated.
MAJOR TRANQUILLISERS
Major tranquillisers or anti-psychotic medication should only be made available to patients experi-
encing hallucinations where benzodiazepines are not effective. An initial dose of 2.5mg to 10mg
of haloperidol orally or intramuscularly can be given if benzodiazepines, such as diazepam, are
not effective in reducing or in alleviating hallucinations. Additional doses of haloperidol can be
given if the patient continues to experience hallucinations. [1, 97, 105] The patient should also be
monitored carefully for hypotension.
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VITAMINS
All patients in alcohol withdrawal and all alcohol-dependent patients should receive thiamine as
a preventive measure against Wernicke-Korsakoff’s syndrome. An intramuscular dose of at least
100mg of thiamine should be given each day for three days. [1, 94, 97, 106] If intramuscular administration
is not possible, 100mg of thiamine should be given orally three times a day for at least a week. [1,
94] A large dose such as this is necessary because oral thiamine is poorly and erratically absorbed
in alcohol-dependent patients. Thiamine should be given before any glucose infusion, since a
glucose load may further deplete thiamine and precipitate the onset of Wernicke-Korsakoff’s
syndrome. [1, 97] Deficiencies of other B complex vitamins and of vitamin C are not uncommon and
an oral multi-vitamin preparation should be given for a few days. 
FLUIDS AND ELECTROLYTES
The fluid status of patients must be carefully assessed and when necessary intravenous saline or
dextrose-saline should be administered. Dextrose solutions should not be given until the patient has
received at least one dose of thiamine 100mg parenterally, as a glucose load in a patient with
borderline thiamine status is likely to precipitate Wernicke-Korsakoff’s syndrome. [1, 97, 106] Low levels
of potassium and magnesium are common in severe withdrawal and may lead to neuromuscular
problems. Potassium and magnesium supplements can be administered, however, no evidence exists
to support the use of magnesium alone or with benzodiazepines for alcohol withdrawal. Patients
should be treated with the appropriate supplements of potassium (80 to 240mmol per day) or
magnesium (40 to 100mmol per day). [1, 97]
SUMMARY 
A number of medications have a place in the management of severe alcohol withdrawal:
• Diazepam is recommended as “gold standard” and as first-line treatment because of its
relatively long half-life and evidence for effectiveness for a number of reasons. 
• Chlordiazepoxide, barbiturates, beta-adrenergic blockers, clonidine acamprosate and GHB,
have no routine place in the management of the alcohol withdrawal syndrome given the
effectiveness of other treatments. 
• Chlormethiazole should be taken with caution and only in fully supervised medicated
withdrawal setting where the patient is closely monitored. 
• Major tranquillisers or anti-psychotic medications such as haloperidol should only be used for
alcohol withdrawal complications such as hallucinations when diazepam is not effective. 
• Intravenous chlormethiazole should be used only in severe alcohol withdrawal situations
when intravenous diazepam is not available or is not suitable. 
• Anticonvulsant medications should be made available for patients who have taken them on
a regular basis and for patients with epilepsy not related to withdrawal. 
• Electrolyte replacement may be a necessary adjunctive treatment for some patients. 
• All patients who are experiencing the alcohol withdrawal syndrome should receive thiamine
and an oral multi-vitamin preparation each day for a week. 
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SUMMARY OF EVIDENCE: PHARMACOLOGICAL WITHDRAWAL MANAGEMENT LEVEL OF EVIDENCE
Diazepam is the “gold-standard” and first-line treatment for alcohol I
withdrawal managemen.
Barbiturates, major tranquillisers or anti-psychotic medications, I
beta-adrenergic blockers, chlormethiazole, clonidine and 
chlordiazepoxide, have no routine place in the management of 
the alcohol withdrawal syndrome. 
Anticonvulsants are not recommended as first-line treatment for II
alcohol withdrawal, however should be given to patients who take 
them on a regular basis before admission and to patients with 
epilepsy not related to alcohol withdrawal.
However, major tranquillisers or anti-psychotic medication such as II
haloperidol should be made available for patients experiencing 
hallucinations when diazepam is not effective in reducing or 
alleviating hallucinations.
100mg of intramuscular or oral thiamine should be administered to I
any patient at risk of alcohol withdrawal. Thiamine needs to be given 
before any glucose intake to prevent Wernicke-Korsakoff’s syndrome.
Multi-vitamins should be given during the alcohol withdrawal phase. IV
Patients in alcohol withdrawal should have their fluid status I
monitored regularly, fluids given, and if needed, intravenous saline 
or dextrose-saline should be considered (only after 100mg thiamine 
has been administered).
RECOMMENDATIONS: PHARMACOLOGICAL WITHDRAWAL MANAGEMENT STRENGTH OF 
RECOMMENDATIONS
Diazepam is recommended as the “gold-standard” and first-line Strong
treatment for alcohol withdrawal symptoms.
Anticonvulsant medications are recommended for use with patients Moderate
who take them on a regular basis before admission and with patients 
who have epilepsy not related to alcohol withdrawal.
Haloperidol (a major tranquilliser or anti-psychotic medication) is Moderate
recommended for use with patients experiencing hallucinations 
and/or paranoid symptoms where diazepam is not effective in 
reducing or alleviating the hallucinations and paranoid symptoms.
100mg of intramuscular or oral thiamine should be administered Strong
before glucose to any patient at risk of alcohol withdrawal.
Multi-vitamins and fluids should be given to any patient Moderate
withdrawal from alcohol.
Chapter 6: Post-withdrawal treatment 
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Chapter 6: Post-withdrawal treatment setting
Given the range of needs and circumstances among alcohol dependent patients, it makes sense
to have different treatment options to meet these needs. The evidence reviewed for these guidelines
suggests that there is a valid role for the full spectrum of treatments, from brief interventions through
to intensive inpatient or residential rehabilitation. However, the evidence does not support
residential rehabilitation for most patients as most seem to do equally well in non-residential
settings. 
CHAPTER AIM
The aim of this chapter is to: 
• Describe the range of post-withdrawal treatment settings available in Australia.
• Present evidence about matching patients to treatment setting.
The 1993 guidelines [1] highlighted the debate about the relative efficacy of residential and non-
residential treatment settings. Since then, the emphasis has shifted towards identifying those who
benefit most from residential treatment, and those who are better treated on a non-residential basis.
Residential treatment is a less cost-effective option if it is used by those who would benefit equally
well from less intensive, less expensive interventions. There is no evidence of a need for residential
intervention for those who have mild to moderate levels of dependence, and some patients with
low alcohol involvement may fare worse in a residential setting. [107]
Nevertheless, it seems that residential treatment does confer specific benefits for some patients. 
q
The benefits are most evident for those with impaired cognitive functioning, serious
psychiatric disorders that may affect their progress, those who have failed repeatedly
with non-residential care, or those who are in a socially unstable environment that
might affect their success with non-residential care. [87, 107]
There is also some evidence that suggests that residential treatments differ in their effectiveness
[108, 109], and it may be that the more effective residential treatments might be superior to a non-
residential intervention3. However, as discussed in the 1993 guidelines there is insufficient evidence
to resolve this issue. 
KINDS OF RESIDENTIAL CARE
A distinction needs to be made between standard residential care, and the therapeutic community
(TC) approach. In the latter case, therapeutic communities emphasise a holistic approach to
treatment, which implies addressing the psychological and other issues behind substance abuse.
The community is viewed as both the context and method in the treatment process. In the former,
residential programs use similar treatment approaches to those seen in non-residential services,
albeit more intensively.
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3 The argument could be mounted in the reverse fashion. That is, outpatient interventions might be improved by
careful attention to the nature and appropriateness of the procedures used.
TCs are a complex mix of elements that can be difficult to define. However, the Australasian
Therapeutic Communities Association (ATCA) Better Practice Project identified the following features
of therapeutic communities: [110]
1. “Residents participate in the management and operation of the community.
2. The community, through self-help and mutual support, is the principal means for promoting
behavioural change.
3. There is a focus on social, psychological and behavioural dimensions of substance use”. (p.
10)
Who should receive residential treatment?
Matching clients to treatment setting remains a clinical decision, however Melnick’s (2001) Client
Matching Protocol (CMP) may be helpful in determining who should be referred to residential or
non-residential therapeutic community settings. [111] To date, only one study has evaluated the CMP,
which consists of a 30-item individually administered questionnaire and a decision tree. The
questionnaire is currently not available, but the decision points are outlined below:
1. Individuals with a low risk pattern of drug use are referred to non-residential treatment. High-
risk individuals enter into the second assessment point.
2. Individuals with one year or more of abstinence in the last four, or a drug history of less than
four years, are referred to non-residential treatment. Those not meeting this criterion move to
the third point.
3. If social factors (drug-free domicile, peer involvement with drugs, criminal behaviour) are
scored as high-risk, residential treatment is recommended. Others are referred to the final
assessment point.
4. Individuals who are not habilitated (do not have a high school diploma, technical training or
sufficient work skills and experience to earn a living) are referred to residential treatment.
Others are referred to non-residential treatment. [111]
Residential care should be considered in a number of circumstances set out below. 
• A residential intervention may be a suitable alternative option for chronic relapsing cases
when non-residential interventions have been unsuccessful. Indeed, residential services might
be particularly valuable for this chronic subgroup of drinkers who relapse and incur severe
damage to their health. 
• Residential care should be considered for those clients with severe dependence on alcohol
coming from an environment that will not support changes in drinking behaviour.
• For those with a high level of physical dependence on alcohol, who are most likely to require
medicalised care, including medical detoxification, brief residential care may be suitable. This
decision depends on the physical status of the patient as assessed by suitably qualified practi-
tioners, and the likelihood of an imminent severe withdrawal syndrome. Please refer to Chapter
5: Withdrawal management for more information. 
• Residential care should be considered where there are concurrent psychiatric complications
such as alcoholic hallucinosis, depression and psychotic states, especially where there is reason
to believe that these disorders will affect withdrawal management. 
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• A residential intervention can be particularly useful for those patients with moderate to severe
alcohol-related brain damage such as Wernicke-Korsakoff’s Syndrome and other alcohol
amnestic disorders that may affect the person’s ability to cope with, or to even attend regularly,
a non-residential intervention. [87] Not all such people require a residential program. However,
evidence of organic brain damage, plus an inability to live independently, a lack of support
in the community, and a likelihood of sudden relapse to heavy drinking need to be weighed
in the decision to admit a person with alcohol-related brain damage to a suitable program.
These patients are likely to benefit from a structured intervention within a residential setting
that includes: 
3 The opportunity to detoxify from alcohol
3 A clear daily routine
3 Presentation of therapeutic messages to decrease alcohol consumption using a simple and
repetitive approach
3 Participation in training aimed at helping them to deal with their memory problems, such
as notebooks, diaries, and other mnemonic devices and skill [112]
3 Practice in non-drinking social activities 
The content of a residential program that might best suit these patients is exemplified by, but is
not necessarily unique to those that use a 12-step approach. [113] This is not a general endorsement
of the 12-step approach to treatment without the addition of other interventions. 
• Residential care for the homeless and for the severely deteriorated, malnourished or socially
unstable alcohol dependent persons is required for therapeutic and humanitarian reasons.
While providing shelter and welfare services is not specifically treatment for alcohol
dependence, for severely affected and dependent patients the stability provided by residential
care it is a necessary prerequisite to treatment. Providing these services and general health
care must be continued for those who need it. 
Where residential intervention occurs, there is a further distinction to be made between the
therapeutic potential of the settings to produce changes in alcohol intake, and the welfare functions
that some of these facilities fulfil. The welfare functions fulfilled by some alcohol and drug residential
facilities include the provision of beds and shelter for those who need them, and providing a place
where the drinker can be away from drinking alcohol for a period, even though there could be a
return to drinking after leaving the facility. For some more chronically dependent patients, residential
facilities offer a place to belong, a sense of community and a safe and structured way to live in
times of need and crisis. Although the responsibility for the welfare needs of such people might
properly belong to another area of community service, for many patients this need may currently
only be provided by alcohol and drug facilities. 
Residential programs that intervene to alter drinking should include a full assessment of the patient.
They should offer a range of treatment modalities that can be tailored to the needs of the presenting
problem. They should have clearly articulated aims and objectives, and they should have an
evaluation component in place. They should also have a number of relapse prevention strategies
to support those who might relapse upon return to their normal environment. 
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Potential improvements to residential/therapeutic community care
The following comments are tentative, given the limited evidence to support them. No doubt, future
phases of ATCA Better Practice Project will provide more substantial recommendations than can
be made here. [110]
Given the consistent finding that motivation mediates residential treatment outcomes, using motiva-
tional interviewing as preparation for treatment may improve outcomes. [43] Motivational intervention
appears to exert its influence on treatment outcome by increasing treatment participation.
An important issue for all treatment services, including residential care, is the need to improve
retention. Structured and interactive information sessions conducted by experienced staff members
at the start of therapeutic community treatment appear to improve retention in treatment for clients
who lack motivation to change. Seminar themes reflected the therapeutic community approach to
treatment and recovery, for example self-esteem, self-help and recovery concepts, therapeutic
community philosophy and expectations, therapeutic community retention and success rates.
Problems of staying in treatment and client concerns were addressed. It has been suggested that
motivated clients are more likely to have higher therapeutic involvement, resulting in initial
improvement and in sustaining motivation for remaining and participating in treatment. [114] For more
detail on treatment retention, refer to Chapter 10: Extended care.
Finally, tailoring therapeutic communities to clients’ needs, specifically those associated with
psychiatric comorbidity and cognitive deficits, may produce better outcomes across a range of
areas. In a study conducted with a group of homeless, chemically dependent, psychiatrically
disordered males [109], changes made to improve treatment outcomes included:
• Administration of psychiatric medications
• Increased program flexibility
• Less confrontation
• Increased psycho-educational instruction
• Fewer sanctions
• More explicit affirmation for achievements
• Greater responsiveness to individual needs
• Greater freedom to come and go from the residential facility early in treatment
• Allowing clients to leave the residence to attend a day treatment program for mentally ill,
chemically dependent individuals
• Reduced therapeutic community duties
• Staff provided more assistance to clients in running program interventions and directing client
activities
• The program was structured to have fewer activities and shorter interactions
The above research is US-based. This modified approach is already offered by many therapeutic
communities in Australia, including shorter planned stays which appear to be a viable option for
many clients.
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SUMMARY OF EVIDENCE: POST-WITHDRAWAL TREATMENT SETTING LEVEL OF EVIDENCE
The evidence on non-residential versus residential treatment III-1
setting is equivocal. Variables such as client motivation and 
treatment modality appear to have more effect on treatment 
outcome than treatment setting.
Clients high in alcohol dependence may benefit more from II
residential than non-residential care; those with low alcohol 
dependence may fare better in non-residential settings. 
Clients low in cognitive functioning may benefit more from II
residential than non-residential care, although this finding 
appears to be moderated by AA attendance.
In some circumstances, the availability of inpatient/residential III-2
treatment is indicated, such as for chronic relapsers, those with 
significant comorbid mental disorders, an unstable social 
environment, severe cognitive impairment, medical 
complications requiring residential care, or homeless clients.
Retention in treatment may be improved by conducting structured, III-3
interactive induction sessions looking at the problems of staying 
in residential treatment and other client concerns.
Residential treatment programs modified to meet the needs III-1
of mentally ill, homeless clients appear to be more effective 
with this population than residential “treatment as usual”.
Strategies to increase treatment adherence, for example, II
motivational interviewing at the start of residential treatment 
may improve treatment outcomes.
RECOMMENDATIONS: POST-WITHDRAWAL TREATMENT STRENGTH OF 
RECOMMENDATIONS
Decisions about treatment setting should be based on the Strong
client’s treatment goals, preferences, severity of dependence, 
the presence of comorbid disorders, cognitive and social 
functioning, relapse history, and social circumstances. 
Residential programs should aim to increase retention in Moderate
treatment by conducting structured, interactive induction 
sessions looking at the problems of staying in treatment and 
other client concerns, by using motivational interviewing 
techniques, and by strengthening the client’s involvement in 
treatment and therapeutic alliances.
Residential programs should be modified to meet the needs of Moderate
particular groups, for instance those with comorbid disorders, 
those with childcare responsibilities, and the homeless.
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Chapter 7: Brief interventions
CHAPTER AIM
The aim of this chapter is to provide information about: 
• The common elements of brief interventions. 
• To whom brief interventions should be delivered. 
• In what settings brief interventions should be delivered.
• Who should deliver these interventions. 
There is strong evidence to support the effectiveness of brief interventions for the treatment of
alcohol problems. [115, 116] When implemented in primary care settings, brief interventions are aimed
towards risky drinkers who do not currently suffer from alcohol use disorders. Brief interventions
are more effective than no intervention in reducing consumption in risky drinkers who have not
sought treatment for alcohol problems. [115] Among patients who have sought treatment for alcohol
use problems, there is no evidence indicating that brief interventions are any less effective than
more intensive treatments. [115] The interventions offered to non-treatment seeking populations are
typically different from the interventions offered to treatment seeking clients. [117]
Brief interventions are now recognised as an important part of the overall approach to dealing
with risky drinking in Australia. Individuals targeted by brief interventions are not only those people
who have severe alcohol problems but also those who have a pattern of consumption that is
defined as at-risk for health, although they may not currently have any alcohol-related problems.
The aim of brief interventions is to reduce the prevalence of alcohol abuse and dependence by
detecting and intervening with risky drinkers before they progress to alcohol abuse and
dependence. 
WHAT IS A BRIEF INTERVENTION?
Brief interventions generally range from 5 to 30 minutes duration, although some are more
extensive, consisting of several sessions delivered over several months. The procedures used in
the delivery of brief interventions often involve a combination of motivational interviewing and
counselling. There are two broad classes of brief interventions: opportunistic interventions offered
to patients detected as drinking beyond recommended levels as defined by the Australian Alcohol
Guidelines [34]. These interventions are offered to patients who have not sought treatment and are
often offered in primary care settings. The other form of brief interventions are those offered instead
of more intensive interventions, usually to treatment-seeking people who often have more serious
alcohol problems. 
Opportunistic brief interventions are aimed at risky rather than dependent drinkers. The aim is to
inform patients that they are drinking at levels that could lead to health problems, and to encourage
them to decrease consumption so as to reduce the risk of future health problems. Targets for
opportunistic brief interventions are usually identified through screening. The AUDIT, discussed
further Chapter 3: Screening and assessment, is often used in primary care settings as a screening
tool. 
Although there are a variety of treatment interventions, which claim to be brief interventions, the
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acronym FRAMES (Table 7.1) provides an outline of the important components of a brief
intervention. As a general rule, brief interventions should include these six components. 
TABLE 7.1: COMMON ELEMENTS OF A BRIEF INTERVENTION
Common elements of a brief intervention
Feedback Personal Feedback about the risks associated with continued drinking, based
on current drinking patterns, problem indicators, and health status.
Responsibility Emphasis on the individual’s personal Responsibility and choice to reduce
drinking behaviour.
Advice Clear Advice about the importance of changing current drinking patterns. 
Menu A Menu of alternative change options. This emphasises the individual’s
choice to reduce drinking patterns and allows them to choose the approach
best suited to their own situation. Alternatives include setting a specific limit
on alcohol consumption, learning to recognise the antecedents of drinking
and developing skills to avoid drinking in high-risk situations, pacing one’s
drinking and learning to cope with everyday problems that lead to drinking. 
Empathy Empathy from the person providing the intervention is an important
determinant of patient motivation and change. A warm, reflective and
understanding brief intervention is more effective than an aggressive,
confrontational or coercive style.
Self-efficacy Self-efficacy involves instilling optimism in the patient that his or her chosen
goals can be achieved. It is in this step, in particular, that motivation-enhancing
techniques are used to encourage patients to develop, implement and commit
to plans to stop drinking.
Source: Bien, Miller and Tonigan (1993). Reproduced with permission. [116]
A typical five to ten minute brief intervention might involve advice on reducing consumption in
a persuasive but non-judgemental way. Personalised information contains an assessment and
discussion of the patient’s consumption level and how it relates to general population consumption.
The clinician should discuss the potential health problems that can arise from risky alcohol use
and help the patient set goals for changing patterns of consumption. Advice can be supported by
self-help materials which provide information about the potential harms of risky alcohol
consumption and can provide additional motivation to change.
Brief interventions are usually motivational. Although some patients who are identified as drinking
at risky levels do not perceive change as necessary, providing them with advice and information
about the potential consequences of continued use may help them recognise that they may have
a problem. Other patients may acknowledge that they are drinking too much and be aware that
risky alcohol use can be harmful. Brief intervention can be particularly successful for this group
of patients, as the clinician provides encouragement and support for these clients. 
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WHO SHOULD BRIEF INTERVENTIONS BE TARGETED AT?
Opportunistic brief interventions are generally targeted to people who are drinking beyond
recommended limits, but may not yet be experiencing health problems. The aim of brief
interventions is to identify risky drinkers and modify their behaviour to prevent them from
progressing to alcohol abuse and dependence. 
If a patient returns to the setting in which he or she was delivered a brief intervention, and is still
drinking to excess, the clinician should suggest to the patient that they may benefit from a more
intensive treatment program in an effort to reduce levels of drinking, and refer the patient to a
specialist alcohol and drug treatment service. 
WHERE SHOULD BRIEF INTERVENTIONS BE DELIVERED?
Opportunistic brief interventions can be delivered in a variety of settings including general practice
settings, general hospital wards, emergency hospital wards and community counselling centres. 
General practice settings
General practitioner (GP) settings are a good setting in which to deliver brief interventions as about
85 percent of the population visit their general practitioner each year [118], allowing for the detection
of a large proportion of risky drinkers. Further, current data suggests that about 25 percent of patients
presenting to general practitioner settings in Australia are likely to be drinking at risk levels. [119] Further,
GPs have the resources and skills to offer an intervention. Thus, the GP has the potential to have a
substantial effect on risky levels of drinking. 
General hospital wards
Clear associations have been found between admissions for traumatic incidents or medical problems
and alcohol consumption. [120] There is a high prevalence of problem drinkers among hospital
patients, making general hospital wards a good environment in which to offer brief interventions
to a large number of risky drinkers who show, or may be at risk of developing alcohol problems.
[121] Hospital wards can be a particularly effective setting for brief interventions, as patients appear
to be more motivated and willing to change their drinking behaviours after being hospitalised. [122]
Emergency departments
Many people attending accident and emergency departments have alcohol-related injuries.
Emergency wards are likely to be particularly effective settings for brief interventions, as patients
have usually through a traumatic experience, and preliminary data suggest that a recent life-
threatening experience increases the receptivity of patients to interventions, increasing the likelihood
of brief interventions being effective in reducing alcohol consumption among these patients. [122-126]
Community counselling services
Patients may present to community counselling services with a variety of complaints. Some of these
patients may be presenting with an alcohol or other drug problem, and others may have completely
unrelated concerns. Whether patients are presenting with a primary alcohol problem, or another
complaint, patients who are drinking alcohol at risky levels should be given a brief intervention. 
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Workplace settings
Rates of risky alcohol consumption are particularly high in some workplace settings. In particular,
Australia Post employees and police have been identified as having a large proportion of risky
drinkers. [127, 128] Brief interventions for risky alcohol consumption have been embedded within the
context of a broader health promotion campaign and delivered in workplace settings. [12, 129]
Workplace settings where there are high levels of risky alcohol consumption can be effective
locations for the delivery of brief interventions.
WHO CAN DELIVER BRIEF INTERVENTIONS?
Any health professional or treatment provider can deliver brief interventions, provided they have
been trained in the provision of brief interventions.
BARRIERS TO IMPLEMENTING BRIEF INTERVENTIONS
In spite of evidence supporting the effectiveness of brief interventions, their delivery has not been
integrated into general practice settings, general or emergency hospital wards or community
counselling services. 
Barriers to implementing brief interventions include:
• Practitioner’s lack of knowledge and skills
• Lack of time
• Lack of financial incentives
• Organisation of the health care system
• Lack of professional reward 
• Lack of diagnostic aids for alcohol-related problems. [13]
SUMMARY
• Brief interventions are typically of five to 30 minutes duration. 
• Brief interventions involve motivational interviewing and counselling techniques.
• The aim of brief interventions is to alert the drinker that they are drinking at levels that could lead
to health problems, and encourage them to reduce their consumption to reduce the risk of future
health problems.
• The acronym FRAMES provides an outline of the important components of a brief intervention.
• Brief interventions are usually targeted at individuals who are risky rather than dependent drinkers. 
• Brief interventions can be provided in a number of settings including general practitioner settings,
general and emergency hospital wards, community counselling centres and workplace settings.
• Any health care professional or treatment provider can deliver brief interventions, as long as that
person has training in the provision of brief interventions. 
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SUMMARY OF EVIDENCE: BRIEF INTERVENTIONS LEVEL OF EVIDENCE
Brief interventions are effective in reducing risky alcohol I
consumption among non-treatment seeking patients 
who drink excessively.
There is no evidence indicating that brief treatments are I
less effective than more intense interventions in 
treatment-seeking populations.
Patients who have recently suffered trauma are usually III-1
more receptive to treatment for alcohol problems and 
are therefore ideal patients for brief interventions.
RECOMMENDATIONS: BRIEF INTERVENTIONS LEVEL OF RECOMMENDATION
Brief interventions should be implemented into routine Strong
practice in general practice settings, general and 
emergency hospital wards, and community 
counselling centres. 
Brief interventions should consist of the six components Moderate
of the FRAMES acronym: feedback, responsibility, advice, 
menu, empathy and self-efficacy.
Where brief interventions are not successful in reducing Strong
alcohol consumption, a more intensive treatment should 
be offered to the client.
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Chapter 8: Psychosocial interventions
CHAPTER AIM
The aim of this chapter is to provide health care workers with knowledge and guidance about:
• the principles and goals of general counselling and specific psychosocial interventions
• general issues to do with psychosocial interventions, including the effect of clinicians on
treatment outcome, and of the importance of using standardised treatments. 
Characteristics of effective clinicians
The effect of clinician characteristics on treatment for alcohol use disorders has received far less
attention than therapy and client variables. The difficulty of studying clinician effects has contributed
to this lack of investigation. [130] However, there is some evidence on clinician effects which suggests
that the effect of therapy is mediated by clinician characteristics. Having strong interpersonal skills
has been most strongly and consistently associated with higher treatment effectiveness. [131, 132] Najavits
et al. [132, 133] found a marked effect of differing clinician style on the outcome of behavioural
interventions. Clients of clinicians who were more interpersonally skilled, less confrontational or
more empathetic were found to have better outcomes. [132] Differences in clinicians’ effectiveness were
not attributable to training, treatment orientation or experience. [134] When a supportive style is
compared with a confrontational style, confrontation is associated with increased client resistance
and higher levels of drinking. [134] In fact, the more clinicians confronted clients, the more clients
drank. An Australian study reported in 2002 that better treatment outcome was associated with client’s
perceptions of clinician expertise and empathy. [37]
Competence of clinicians is also likely to be related to treatment outcome. A study by Broome et al.
(1999) [135] looked at clinician competence based on clients’ ratings of organisation, self-confidence,
helpfulness and knowledge. Perceived competence was significantly related to re-arrest rates of the
279 clients, accounting for 42 percent of variance. 
Clinician effects are also related to adherence to treatment manuals (discussed later in this chapter).
According to a meta-analysis which included, but was not limited to, substance use disorder outcome
studies, clinician effects on treatment outcome decrease when adhering to treatment increases. [136]
Together, these findings suggest that clinicians who can form a warm, supportive relationship with
the client, and who can show empathy, are likely to achieve greater improvement in client functioning.
It also suggests that clinicians develop an organised approach to client management, keeping careful
case and progress notes, which helps in anticipating difficulties and makes planning and practising
methods to deal with difficult situations before they arise easier. 
SUMMARY
Clinicians should be trained in skills that enable them to: 
• show empathy 
• develop a supportive relationship with the client
• have an organised approach to each case.
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SUMMARY OF EVIDENCE: CLINICIAN CHARACTERISTICS LEVEL OF EVIDENCE
The impact of treatment interventions are partly II
mediated by clinician effects.
Interpersonal skills are the most studied clinician II 
characteristic, and clinicians with strong 
interpersonal skills are more effective.
Competent, empathetic clinicians achieve better III-1
treatment outcomes for clients
RECOMMENDATIONS: CLINICIAN CHARACTERISTICS STRENGTH OF RECOMMENDATION
Clinicians should receive interpersonal skills Strong
training which focuses particularly on empathy.
Clinicians should have an organised approach to Moderate 
treatment, and take careful case and progress notes. 
Counselling
General counselling and associated skills are effective for counselling people who have problems
with alcohol. Counselling skills such as listening and empathy should form the basis of any
therapeutic relationship. However, counselling is not usually sufficient to change drinking behaviours
and should be supported by more specific techniques. 
The basic counselling skills advocated by “the skilled helper” model are recommended for
developing rapport with clients, and for dealing with distress and ambivalence about receiving
treatment and about the goals of treatment. [137] The two principal goals of counselling are:
1. To help clients manage their problems in order to live more effectively, and to develop unused
resources and missed opportunities more fully.
2. To help clients become better at helping themselves in their everyday lives. 
Egan (2002) [137] has developed a model which provides a general framework for the counselling
process, and covers all aspects of dealing with the client, except for specific treatment interventions.
According to Egan, all worthwhile helping frameworks help clients ask and answer for themselves,
four fundamental questions: 
1. “What’s going on?” 
What are the problems, issues, concerns, or opportunities I should be working on? This stage
involves helping clients clarify the key issues calling for change.
2. “What solutions make sense for me?” 
What do I want my life to be like? What changes would make me happier? This stage involves
helping clients identify anticipated outcomes from treatment. 
3. “How do I get what I need or want?” 
What plan will get me where I want to go? This stage involves helping clients develop strategies
for accomplishing goals. 
4. “How do I get results?”
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How do I turn planning and goal setting into solutions, results, outcomes or accomplishments?
How do I get going and keep going? This stage represents the implementation stage of the
model. 
These four questions, turned into three “stages” and an action phase, provide the basic framework
for the helping process (Table 8.1). There are three steps within each stage, and the goal of each
stage is to help the client move towards better management of problems and taking advantage of
opportunities. The three stages overlap and interact with one another.
TABLE 8.1: STAGES AND STEPS OF THE SKILLED HELPER MODEL 
STAGE I: WHAT’S GOING ON?
Step I-A: Help the clients tell their stories.
Step I-B: Help clients break through blind spots that prevent them from seeing
themselves, their problem situations, and their unexplored opportunities as
they really are.
Step I-C: Help clients choose the right problems and/or opportunities to work on.
STAGE II:WHAT SOLUTIONS MAKE SENSE FOR ME?
Step II-A: Help clients use their imaginations to spell out possibility for change.
Step II-B: Help clients choose realistic and challenging goals that are real solutions to
the key problems and unexplored opportunities identified in Stage I.
Step II-C: Help clients find the incentives to help them commit themselves to their
change agendas.
STAGE III:WHAT DO I HAVE TO DO TO GET WHAT I NEED OR WANT?
Step III-A: Possible actions: Help clients see that there are many different ways of
achieving goals.
Step III-B: Help clients choose best-fit strategies.
Step III-C: Help clients craft a plan.
Source: The Skilled Helper. Reproduced with permission. [137]
Figure 8.1 represents the basic framework of the skilled helper model. For more detail about the
model, see The Skilled Helper: A problem-management and opportunity-development approach to
helping. [137]
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Source: Egan (2002). Reproduced with permission. [137]
While the model provides a general framework for the counselling process, effective communi-
cation is also viewed as a key element of good counselling. The basic communication skills for
effective counselling are: 
• Visibly tuning in to the client, which refers to the clinician giving their complete attention to
the client.
• Active listening, in which the clinician focuses on understanding what their client is saying,
both directly and indirectly.
• Checking that there is a shared understanding between clinician and client of what is being
communicated. [137]
The arrow of the model represents the action phase of the model. While the nine steps of the
model revolve around planning for change, action should be incorporated into the counselling
process. The action stage of the process will often incorporate more specific treatment interventions
that help the client deal with specific problems or deficits. 
As noted above, it is not expected that counselling alone is sufficient to change the drinking
behaviour of most clients. Rather, the goal of counselling is to develop a relationship between the
clinician and the client, which supports implementing specific strategies designed to combat the
drinking problem. 
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Stage 1: Stage 2: Stage 3:
“What’s going on?” “What solutions make “How do I get what 
sense for me?” I need or want?”
Story Possiblities Possible strategies
Blind spots Change agenda Best fit
Leverage Commitment Plan
How do I make it all happen?
FIGURE 8.1: THE SKILLED HELPER MODEL
q
The counselling process aims to:
• Build a trusting relationship in which the client and the clinician cooperate in
planning and implementing the intervention. This mutual activity provides a
supportive situation in which the client can actively work towards change.
• Reduce the client’s fear and distrust of treatment programs and thereby encourage
the client to continue attending treatment and follow-up appointments.
• Provide a non-threatening and supportive environment in which the client can
address sensitive issues. [1]
SUMMARY
Supportive and empathic counselling skills are recommended as the basis from which to deliver
appropriate treatment interventions that may be required to deal with problems and deficits that
predispose the client to risky drinking. 
RECOMMENDATIONS: COUNSELLING STRENGTH OF RECOMMENDATION
General counselling skills should form the basis Strong
of a therapeutic relationship.
General counselling skills should be supported Strong
by more specific techniques aimed at initiating 
a change in behaviour.
Motivational interviewing
Motivational interviewing is a procedure which was introduced by Miller and Rollnick in 1991. [138] They
define motivational interviewing as “a client-centred, directive method for enhancing intrinsic motivation
to change by exploring and resolving ambivalence”. [139] The goal of motivational interviewing is to
steer the client towards motivation for change by eliciting reasons for change from the client.
Motivational interviewing is client-centred, emphasising that behaviour change is voluntary, and that
responsibility for decisions and results of behaviour change rests with the client. It is directive, aimed
toward a resolution of ambivalence. 
Motivational interviewing is viewed as a method of communication rather than a set of techniques, or
a specific strategy. Motivational interviewing can be delivered as a prelude to treatment and as a stand-
alone treatment, or can be integrated with other treatment interventions. There is reasonable evidence
supporting the effectiveness of motivational interviewing as an effective stand-alone treatment for risky
and dependent drinkers. The evidence on motivational interviewing as a prelude to treatment is
equivocal. 
Miller and Rollnick suggest three general processes through which motivational interviewing may
achieve its effects, namely, collaboration, evocation and autonomy (Table 8.1). [139] A collaborative
relationship between the clinician and the client is a key element of motivational interviewing. The
counsellor should communicate a partner-like relationship, providing support rather than persuasion
or coercion. Evocation refers to the role of the counsellor to elicit resources and motivation for change
from within the client. Autonomy relates to the client’s independence and responsibility for change,
which must be affirmed and supported by the counsellor. 
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TABLE 8.2: THE SPIRIT OF MOTIVATIONAL INTERVIEWING
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Fundamental approach of 
motivational interviewing
Mirror-image opposite approach to
counselling
Collaboration. Counselling involves a
partnership that honours the client’s
experiences and perspectives. The
counsellor provides an atmosphere that is
conducive rather than coercive to change
Confrontation. Counselling involves
over-riding the client’s impaired
perspectives by imposing awareness
and acceptance of “reality” that the
client cannot see or will not admit. 
Evocation. The resources and motivation
for change are presumed to reside within
the client. Intrinsic motivation for change
is enhanced by drawing on the client’s
own perceptions, goals and values.
Education. The client is presumed to
lack key knowledge, insight, and/or
skills that are necessary for change to
occur. The counsellor seeks to address
these deficits by providing the requisite
enlightenment. 
Autonomy. The counsellor affirms the
client’s right and capacity for self-direction
and facilitates informed choice.
Authority. The counsellor tells the
client what he or she must do. 
There are four broad, guiding principles that underlie motivational interviewing: express empathy,
develop discrepancy, roll with resistance and support self-efficacy (Table 8.2). An empathetic
counselling style is a fundamental and defining characteristic of motivational interviewing. Empathy
is seen as the foundation on which motivational interviewing is built. The expression of empathy
refers to an attitude of acceptance and respect for the drinker, and involves reflecting the individual
drinker’s concerns about risky alcohol consumption. A second general principle of motivational
interviewing is to create a discrepancy between the client’s present behaviour and his or her broader
goals and values. The notion of developing discrepancy is aimed at clarifying important life goals
with the drinker, and exploring the consequences of continued drinking that conflict with those
goals. The technique of rolling with resistance is related to avoiding argumentation, as argumen-
tation is counterproductive. Rather, resistance of a client can be reframed to create momentum
towards change. The last principle of motivational interviewing involves the concept of self-efficacy
which refers to a person’s belief in his or her ability to carry out and succeed with a specific task. 
Source: Miller and Rollnick, 2002. Reproduced with permission. [139]
TABLE 8.3: THE GUIDING PRINCIPLES OF MOTIVATIONAL INTERVIEWING 
Principle 1: • Acceptance facilitates change
Express empathy • Skilful reflective listening is fundamental 
• Ambivalence is normal
Principle 2: • The client should present arguments for change
Develop discrepancy • Change is motivated by a perceived discrepancy between present
behaviour and important personal goals or values
Principle 3: • Avoid arguing for change
Roll with resistance • Do not directly oppose resistance
• New perspectives are invited but not imposed
• The client is a primary resource in finding answers and solutions
• Resistance is a signal for the counsellor to respond differently 
Principle 4: • A person’s belief in the possibility of change is an important motivator
Support self-efficacy • The client is responsible for choosing and carrying out change
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Source: Miller and Rollnick, 2002. Reproduced with permission. [139]
PERSONALISING THE HEALTH EFFECTS OF RISKY DRINKING
To design an optimally effective intervention to enhance motivation, the clinician should employ
strategies that: 
• Promote awareness of the risk associated with risky drinking.
• Offer the client acceptable and effective behaviour change options within an accepting and
empathic atmosphere.
q
Personalising the adverse health effects of risky drinking is viewed as integral in
motivating drinkers to change their behaviour.
Personalising health effects can be based on the following:
1. A discussion about the client’s drinking-related symptoms and illnesses.
2. Feedback of medical information on the effects of alcohol consumption on the client’s health,
such as measures of liver function, for instance gamma-glutamyl transferase (GGT). [1]
Measures of liver function can indicate that alcohol is having a deleterious effect on the body.
These tests are most appropriately conducted in medical settings because the necessary equipment
is usually available. In non-medical treatment settings testing can be conducted elsewhere with
the results forming the basis of a discussion between the clinician and the client. Results of liver
tests should be explained to the client in a way that the client understands and can process. 
Drinkers who have developed symptomatic health problems are likely to react more strongly to
such information than those who have not. However, this information can still have a motivating
effect in “healthy” drinkers, because feedback of selected medical information at teachable moments
can have a positive effect. [124] The information gathered at the beginning of the treatment can also
form a baseline against which later test results can be compared to demonstrate to the client the
health improvements associated with a reduction in consumption of alcohol. 
Although medical results within the normal range can have a motivating effect, they should be
dealt with carefully. The client could, for example, take normal liver function to indicate that
drinking is having no harmful effects. However, the clinician can explain that: 
• Good health may not be maintained should the client continue to drink.
• Results in the normal range do not necessarily mean that drinking is not having a deleterious
effect on health and functioning might have been higher if the person were not drinking
excessively. [1]
SUMMARY
Motivational interviewing is advocated for use with problem drinkers who are experiencing ambivalence
or conflict about their drinking behaviour and modifying it. If the client is highly motivated to change,
the clinician may find it useful to increase the client’s level of self-efficacy and to reinforce their
motivation by exploring what the client hopes to achieve by changing. Personalising the health effects
of risky drinking is an integral part of the motivational interviewing approach. It is different from the
simple provision of information on the negative effects of alcohol consumption which is thought to
be much less likely to affect drinking behaviour. 
SUMMARY OF EVIDENCE: MOTIVATIONAL INTERVIEWING LEVEL OF EVIDENCE
Motivational interviewing is a moderately effective I
stand-alone treatment intervention which helps to 
reduce alcohol intake and to improve psychosocial 
outcomes.
Motivational interviewing can be delivered as a II
treatment prelude to increase motivation to change.
RECOMMENDATIONS: MOTIVATIONAL INTERVIEWING STRENGTH OF RECOMMENDATION
Motivational interviewing is recommended as a Strong
treatment intervention.
Motivation is recommended particularly for clients Moderate
who are ambivalent about changing their behaviour.
Personalising information about the adverse health Strong
effects of risky drinking is recommended as a 
strategy to increase motivation to change.
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Cognitive-behavioural interventions
The term “cognitive behavioural” refers to an approach covering a range of strategies and techniques
based on learning principles, based around the idea that modifying and re-learning behaviour is
influenced by how people view themselves and others. 
q
Cognitive behavioural interventions give the client a set of thinking and behaving
strategies that can be used to assist in lifestyle change.
Most treatment approaches that have been demonstrated to be effective in treating alcohol use
disorders fall within the broad rubric of cognitive behavioural approaches. [140] In addition to their
effectiveness, advantages of cognitive behavioural interventions are that they: 
• Are often detailed, making them amenable to training and dissemination.
• Can easily be developed into clear procedural guidelines which can be used to assess the
quality of treatment delivery. [1]
In this way the use of these techniques makes it easier to monitor the activities that occur in practice
and thereby assure the integrity of treatment implementation. 
On the basis of evidence supporting the effectiveness of cognitive behavioural interventions, well
articulated procedures and protocols for implementation, and acceptance and popularity within the
Australian treatment community, cognitive behavioural interventions are likely to provide an effective,
practical basis for the treatment of risky drinkers and alcohol dependence. They are delivered in a form
that allows for a rapport and trust to be developed between clinician and client in a non-confronting
and empathic atmosphere. These approaches are compatible with other interventions such as pharma-
cological interventions and motivational interviewing techniques. 
SUMMARY
It is recommended that a range of cognitive behavioural interventions (described below) be adopted
in the management of alcohol dependence and associated problems. 
KEY POINTS
• Cognitive behavioural interventions encompass a range of strategies and techniques including
skills training, behavioural self-management, cognitive restructuring, cue exposure and
behavioural couples therapy. 
• Cognitive behavioural interventions aim to give the client a set of thinking and behaving
strategies that can be used change problematic behaviours.
SUMMARY OF EVIDENCE: COGNITIVE BEHAVIOURAL INTERVENTIONS LEVEL OF EVIDENCE
Cognitive behavioural interventions are effective treatments that I
reduce alcohol consumption and improve psychosocial outcomes.
RECOMMENDATIONS: COGNITIVE BEHAVIOURAL INTERVENTIONS STRENGTH OF 
RECOMMENDATION
Various interventions that fall under the umbrella of cognitive Strong
behavioural interventions should be implemented in treatment settings.
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Skills training
Skills training is a form of cognitive behavioural treatment intervention. It involves teaching people
social skills that might help them function without the use of alcohol. There is consistent evidence
that skills training helps to reduce alcohol consumption in both the short term and the long term
among risky drinkers and alcohol dependent persons. 
Skills training can be used to compensate for skills deficits that have led to the use of drinking as a
coping strategy. It has also been linked to Marlatt and Gordon’s model of relapse prevention and may
help clients to deal with high risk situations. [141] Skills training is recommended for use with clients
who have a high risk of relapse (see Chapter 9: Relapse prevention). There are various skills training
approaches briefly described below, and although there is some overlap in the techniques in each of
these procedures, there is sufficient difference in procedure and purpose to divide them into separate
sections. These procedures are of most benefit to those clients who lack the relevant skills, and should
be offered to those clients whom clinicians perceive as lacking relevant skills. Although it is often
difficult to ascertain which skills clients possess, particularly without appropriate assessment, asking
clients what problems they experience and how they cope with them can expose the areas in which
clients are lacking social skills. 
Skills training can be used with clients aiming at moderation or abstinence. Several approaches may
be appropriate for the one person and skills training approaches are often offered in combination.
The intervention chosen should be relevant to the client’s needs. Training in social skills and other
coping skills will require some commitment on the part of the client as these methods are enhanced
when the client actively participates in therapy and continues to practise outside therapy. It is inappro-
priate to train a client in skills in which they are already adept. 
In skills training an emphasis is placed on ensuring that clients:
• Learn to listen and to communicate effectively with others
• Give and receive compliments and criticism
• Learn to refuse unwanted requests
• Learn to communicate non-verbally and verbally
• Begin to build a social support network [142]
A key element of skills training is breaking down behaviour into component steps. This is essential
if learning new ways of behaving is to occur, because most behaviours are engrained and occur
without the person’s knowledge of what he or she is doing. 
PROBLEM-SOLVING SKILLS TRAINING
Problem solving skills training provides clients with a set of general skills that may assist in resolving
life problems which may threaten their commitment to change their drinking behaviour. [1] The basics
of problem-solving skills training do not take long to teach, but they require practice to be effectively
learnt. Therefore, problem-solving skills should be practised, refined and reinforced in treatment
both after they have been taught and by the client at home. 
q
Problem solving skills training is appropriate for all clients, regardless of their drinking
goal, and is suitable for implementing in either an individual or group session,
although learning through practice is probably facilitated by working in groups of
clients rather than on an individual basis.
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The goals of problem solving skills training are to teach clients to: 
• Recognise when a problem exists
• Generate a variety of possible solutions
• Select the most appropriate option
• Generate a plan for action
• Evaluate the effectiveness of the selected approach [142]
ASSERTIVENESS SKILLS TRAINING 
An inability to express feelings to others in an appropriately assertive and clear way can create
anxiety, frustration and anger, which can contribute to a return to risky drinking. Assertiveness
training is likely to have an important role in the management of interpersonal situations that have
the potential to produce negative mood states and thereby predispose the drinker to relapse to
drinking. The procedure has evidence of efficacy, especially if “booster” sessions are used to ensure
that the learnt skills are maintained, see Connors 2001 [143]. 
q
Assertiveness skills are recommended particularly for clients who have difficulty in
expressing their emotions.
In drink refusal skills training the client learns that he or she has the right to express personal
opinions and feelings, to request that other people change behaviour that affects the client, and
to accept or reject other people’s requests. Underlying this approach is the development of self-
respect and respect for the rights of others. Assertive skills training typically focuses on developing
overt behavioural skills through repeated role playing and practice of “difficult” situations, and the
concurrent change in the person’s thinking as he or she develops the confidence and ability to be
assertive.
q
• Assertiveness skills are equally effective for goals of moderation or abstaining.
• Group settings are ideal for teaching this technique as role-play is an essential
part of learning assertiveness skills.
COMMUNICATION SKILLS TRAINING 
Communication skills training shares substantial overlap with assertiveness skills training and the
two can and often are taught together. Communication skills can help to reduce feelings of social
embarrassment and tension. Communication skills training aims to teach the client how to:
• Start and continue conversations in a comfortable manner.
• Cope with silences and pauses in conversations.
• Interpret social cues.
• Actively listen to others.
• Comfortably communicate personal feelings and opinions. 
q
Communication skills training can be used regardless of clients’ drinking goals.
Communication skills training is best implemented in group settings, where clients
can practice communication skills through role-play and modelling.
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DRINK REFUSAL SKILLS TRAINING 
Drink refusal skills training teaches the drinker to confidently and assertively say no to offers of
alcohol or to social pressure to drink. Social pressure to have a drink can be substantial, and the
client needs to develop and practise strategies that allow him or her to respond effectively. 
q
Drink refusal skills training should be offered to all clients who indicate a lack of
confidence in dealing with social pressure to drink.
In the training an emphasis is placed on speaking directly to the person making the offer or placing
pressure on the drinker. Drinkers are given instructions about how to suggest alternatives to alcohol,
dealing with pressure in an appropriately assertive way, and not feeling guilty about refusing.
Drink refusal skills training can be used for clients with a goal of either abstinence or moderation.
For clients with a goal of abstinence, drink refusal skills are a very important aspect of relapse
prevention. They can also be helpful for clients with a goal of moderation to keep to pre-
determined limits in the face of temptation or pressure to over drink. Drink refusal skills can be
taught on an individual basis, although group settings are more appropriate as they give clients
the opportunity to practise the skills taught and to learn from one another in role-play activities. 
q
Drink refusal skills training can be used for clients with a goal of either abstinence
or moderation.
Drink refusal skills training can also be used with behavioural self-management (discussed below),
to assist the client to deal with situations in which alcohol is present. This procedure has been
incorporated into many interventions which have shown sustained effects in reducing drinking. 
RELAXATION TRAINING AND STRESS MANAGEMENT SKILLS TRAINING
Relaxation and stress management procedures represent a wide range of interventions that attempt
to train the client in methods to deal with daily tension that may be associated with risky drinking.
The tension is often physical tension, but it can also be psychosocial or mental tension. There are
a number of relaxation procedures available for this. 
In this set of procedures the client learns techniques for inducing relaxation that might include
deep-muscle relaxation, relaxing imagery, and letting go of physical stress. There is evidence of
the efficacy of these procedures, both generally for reducing anxiety and tension, and more specif-
ically in the context of programs aimed at reducing drinking. 
q
• Relaxation training is appropriate when clients have mentioned or displayed signs
of tension.
• Relaxation training is suitable for clients with abstinence or moderation goals,
and it can be implemented in individual or group settings.
The goals of relaxation and stress management training are to teach clients to:
• Recognise when tension is present.
• Relax his/her body when tension is detected to reduce tension.
• Use mental imagery or meditative methods to reduce psychosocial tension.
SUMMARY
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Skills training approaches are advocated as appropriate interventions for clients with varying severity of
alcohol problems where assessment shows the need for such intervention. Included are: 
• problem solving skills training
• drink refusal skills training
• assertive skills training
• communication skills training
• relaxation training and stress management skills training.
SUMMARY OF EVIDENCE: SKILLS TRAINING LEVEL OF EVIDENCE
Skills training can be used to compensate for I
skills deficits and help to reduce alcohol 
consumption and increase psychosocial 
outcomes for those who have an alcohol 
use disorder.
Skills training is effective in both the long and short II
term among risky and dependent drinkers.
Skills training is appropriate for goals of moderation II
and abstinence.
Different types of skills training are more effective in II
combination than in isolation.
RECOMMENDATIONS: SKILLS TRAINING STRENGTH OF RECOMMENDATION
Skills training should be offered to clients who lack Strong
the relevant skills.
Problem solving skills training, assertiveness skills Strong
training, communication skills training, drink refusal 
skills training, and relaxation and stress management 
skills trainings are recommended to reduce or 
eliminate alcohol consumption among risky and 
dependent drinkers.
Although appropriate for individual settings, skills Moderate
should be implemented in group settings to allow 
for role-playing and modelling.
Skills training is recommended for clients who have Strong
a high risk of relapse.
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Behavioural self-management
Behavioural self-management is a cognitive behavioural treatment intervention. Behavioural self-
management training involves a series of strategies such as:
• self-monitoring
• setting drinking limits
• controlling rates of drinking
• identifying problem drinking situations
• self-reward for limited drinking
q
The goal of behavioural self-management is to teach clients specific skills so that
they can reduce drinking to stable, low-risk levels.
Behavioural self-management is intended for those clients who wish to cut down rather than abstain
from drinking. However, these procedures could be usefully taught as relapse prevention strategies
to drinkers who have a goal of abstinence. This procedure might be especially useful for those
drinkers whose lives are enmeshed in a drinking culture where non-drinking is extremely unlikely. 
In a typical behavioural self-management intervention, the client learns about the concept of blood
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alcohol concentration and the recommended levels of alcohol consumption, which have been
defined for Australia by the National Health and Medical Research Council as: [34]
for men,
• No more than six drinks on any one day (60g), for risk of harm in the short term, and 
• No more than four standard drinks of alcohol per day (40g), or 28 standard drinks (280g)
per week for risk of harm in the long term.
for women,
• No more than four standard drinks on any one day, for risk of harm in the short term, and 
• No more than two standard drinks of alcohol per day (20g) or 14 standard drinks (140g)
per week for risk of long-term harm. 
A plan for reducing the client’s drinking should be formulated, based on drinking patterns as
identified through self-monitoring. 
Specific strategies for reducing consumption through behavioural self-management include:
• Keeping a diary to monitor how much alcohol they drank, where they drank, what time of
the day they drank, who they drank with, and how they were feeling at the time.
• Setting a limit on the number of standard drinks to be consumed on a given occasion.
• Timing how long it takes to consume a drink and placing a minimum time on each drink.
• Taking small sips to reduce the amount of alcohol consumed and to allow each drink to last
longer.
• Resting in between sips, by putting the glass down on the table, rather than holding it contin-
uously.
• Diluting drinks with non-alcoholic mixers, or drinking low alcohol beer
• Alternating alcoholic drinks with non-alcoholic drinks such as soft drinks, mineral or soda
water.
• Avoiding participation rounds, or sitting out one or more rounds as necessary. 
This procedure requires that the client is familiar with the definition of a standard drink as it applies
to different beverages (see Table 8.4). 
One potential problem arising from this procedure is that drinkers for whom abstinence is advisable
may see this strategy as a means of “safe” drinking. If drinkers with a goal of abstinence are warned
that these procedures should only be used if there is a lapse to drinking, then there may be a role
for behavioural self-management in interventions for those with a goal of abstinence. If there is
doubt about a client’s ability to deal with this information appropriately, it is recommended that
the technique not be used. 
TABLE 8.4: STANDARD UNITS OF ALCOHOL
Type of Alcohol Volume Percentage of Alcohol Number of
by Volume % Standard Drinks
Full Strength Beer 425 ml 4.5 1.5
Full Strength Beer 375 ml 4.5 1.3
Full Strength Beer 285 ml* 4.5 1.0
Mid Strength Beer 425 ml 3.4 1.13
Mid Strength Beer 375 ml 3.4 1.0
Mid Strength Beer 285 ml* 3.4 0.8
Light beer 425 ml 2.8 1.0
Light beer 375 ml 2.8 0.8
Light beer 285 ml* 2.8 0.5
Wine 100 ml 12.5 1.0
Fortified Wine 60 ml 21.0 1.0
Spirits 30 ml 42.0 1.0
Premixed Alcoholic Soda 300 ml 5.0 1.2
*NSW, WA, ACT = Middy; QLD, VIC, TAS = Pot; NT = Handle; SA = Schooner
Note: Alcohol content varies according to brand.
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SUMMARY
Behavioural self-management is recommended as a treatment strategy when both client and clinician
agree that moderation is the appropriate treatment goal. If used in the context of a goal of
abstinence, it should be presented as a strategy to cope with a temporary lapse to drinking.
SUMMARY OF EVIDENCE: BEHAVIOURAL SELF-MANAGEMENT LEVEL OF EVIDENCE
Behavioural self-management is a moderately effective II
strategy to reduce alcohol consumption among risky and 
dependent drinkers with a goal of moderation.
RECOMMENDATIONS: BEHAVIOURAL SELF-MANAGEMENT STRENGTH OF 
RECOMMENDATION
Behavioural self-management should be offered to clients Strong
with a goal of moderation.
Behavioural self-management should be taught to clients Strong
who are extremely unlikely to stop drinking. 
The client should be introduced to the National Health and Strong
Medical Research Council’s Alcohol Guidelines. 
Clients should be taught about standard drink sizes to assist Strong
in monitoring levels of consumption.
Cognitive restructuring
Cognitive restructuring is a cognitive behavioural intervention. Cognitive restructuring works with
current beliefs and attitudes of the client and is designed to help the client identify and change
irrational or counterproductive beliefs, especially where these contribute to continued drinking.
Cognitive restructuring should be viewed as a collaborative process between the clinician and
client. It can be offered in a group or individual setting. Cognitive restructuring is not recommended
for clients with cognitive deficits because of its abstract nature. 
Cognitive restructuring has been shown to be effective when combined with other strategies, partic-
ularly skills training. In addition to its effectiveness in treating alcohol problems, cognitive
restructuring techniques have been shown to be effective in the treatment of other disorders, partic-
ularly anxiety and depression [144], which occur at significant rates in problem drinkers. 
q
The goals of cognitive restructuring are for clients to recognise when they are thinking
in a way that is likely to lead to drinking and to interrupt and challenge these
thoughts. Cognitive restructuring is appropriate for clients with a goal of either
moderation or abstinence.
Cognitive restructuring needs to be practised during treatment sessions so that the client can use
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the skills effectively after treatment ends. 
There are several areas in which the clinician can help the client identify and change irrational
beliefs, attributions and self-statements. These include beliefs relating to drinking behaviour, relapse,
emotional discomfort, and oneself. 
Cognitive restructuring aims to encourage clients to base their beliefs about drinking and about
their self-worth in the experiences of reality. The restructuring involves active participation by the
client, and the development of new perspectives should reflect the client’s own values, not those
of the clinician. 
SUMMARY
Cognitive restructuring is designed to help the client identify and change irrational or counterpro-
ductive beliefs, attributions and self-statements, especially where these contribute to continued
drinking. Cognitive restructuring procedures are recommended as part of more comprehensive
interventions that rely upon providing the client with specific skills. The areas where cognitive
restructuring can prove useful include erroneous views about drinking behaviours, about oneself,
and about relapse.
SUMMARY OF EVIDENCE: COGNITIVE RESTRUCTURING LEVEL OF EVIDENCE
Cognitive restructuring is a moderately effective II
technique to assist in reducing alcohol 
consumption among risky drinkers and 
alcohol dependent people.
Cognitive restructuring works equally well for II
goals of moderation and dependence.
RECOMMENDATIONS: COGNITIVE RESTRUCTURING STRENGTH OF RECOMMENDATION
Cognitive restructuring procedures are Strong
recommended as part of more comprehensive 
interventions that rely upon providing the client 
with specific skills.
Cognitive restructuring is not recommended for Strong
clients with cognitive deficits.
Cognitive restructuring should be practised Strong
throughout the treatment process.
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Cue exposure
Cue exposure is a cognitive behavioural intervention. Cue exposure is based on the associative
learning principle [145], which assumes that people, places and events that regularly precede drinking
become associated with the pleasant effects of alcohol, and alcohol consumption becomes a
conditioned response to these cues. Alcohol-related cues include the sight and smell of an alcoholic
drink, mood states or situations in which drinking has previously occurred, and people, places and
times that have previously been associated with the pleasant effects of alcohol. Two models -
classical learning theory, and social learning theory - have been used to explain the relationship
between alcohol-related cues and relapse to drinking. Treatment can therefore vary according to
the theory on which the treatment is based. 
According to classical learning models, the client only needs to be exposed to alcohol repeatedly
without being allowed to drink in order to prevent the usual drinking response to those cues. Social
learning theory models assume that the chance to practise coping skills in the presence of alcohol
cues is important in reducing relapse. Consequently, some cue exposure approaches focus on pure
exposure to alcohol cues, whereas other approaches include coping skills training in the presence
of alcohol cues. [146] Most studies of alcohol use have offered adjunct treatment in addition to cue
exposure. 
Another variation among different approaches is the nature of the cues that are used during the
exposure trials. Because of the diversity of the settings associated with drinking, it is very difficult to
expose drinkers to all possible real-life settings associated with drinking. Thus, some treatments use
imaginary exposure, and ask clients to imagine a situation in which drinking has occurred previously.
Many cue exposure treatments use an alcoholic beverage as a cue, since the sight and smell of alcohol
is a cue that every drinker is exposed to before drinking. Some approaches, particularly those with
a goal of moderation rather than abstinence, use the consumption of a small amount of alcohol as
the cue. Thus, the choice of cues is based on treatment goal - either moderation or abstinence - and
the constraints of the setting in which treatment is being conducted, that is, the extent to which real-
life settings can be replicated. [146]
The goal of cue exposure is to decrease the likelihood of a relapse to drinking by either:
• Decreasing the strength of association between alcohol-related cues and the urge to drink, or 
• By increasing the use and effectiveness of coping skills by drinkers, when confronted with
alcohol-related cues in real-life situations. 
Cue exposure therapy is appropriate where the goal of treatment is either moderation or abstinence.
Cue exposure therapy usually consists of between six and twelve sessions, each session lasting
between 50 and 90 minutes. Treatment sessions can be run daily or can be spaced across a number
of days. [147]
The length of time to which a client is exposed to a cue is determined either by:
• A set amount of time which is pre-determined before the start of therapy (e.g. smelling a glass
of alcohol for three minutes).
• When the participant’s self-reported craving or urge level drops to half the peak intensity
experienced during exposure to the cue.
Cue exposure is a specialist treatment intervention and should only be offered by suitably qualified
professionals.
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KEY POINTS
• Two models - classical learning theory models, and social learning theory - have been used
to explain the relationship between alcohol-related cues and relapse to drinking.
• Some cue exposure approaches focus on pure exposure to alcohol cues, whereas other
approaches include coping skills training in the presence of alcohol cues.
SUMMARY OF EVIDENCE: CUE EXPOSURE LEVEL OF EVIDENCE
Cue exposure is a moderately effective II
intervention for the treatment of alcohol 
dependence and risky drinking.
RECOMMENDATIONS: CUE EXPOSURE STRENGTH OF RECOMMENDATION
Cue exposure should consist of six to twelve Moderate
sessions of 50 to 90 minutes.
Cue exposure should only be offered by Strong
treatment specialists who have appropriate 
training in the strategy.
Couples and family therapy 
Although couples and family therapy are often grouped together as a single intervention, there are
a number of reasons why they should be viewed as distinct interventions. 
Couples therapy involves the partner of the problem drinker, while family therapy involves the
partner in addition to other family members. 
Family therapy requires a clinician with specialist skills and training in the provision of family
therapy. It is unlikely that suitably skilled clinicians will be available in most drug and alcohol
agencies. 
There is scant research on the effectiveness of family therapy in the area of alcohol and substance
abuse. Thus, this section focuses on couples therapy, in particular, behaviourally-oriented couples
therapy. 
Data suggests that problem drinking is associated with negative functioning, not only for the person
with the alcohol problem, but also for the non-alcoholic partner and for the relationship. Evidence
that marital/relationship problems precede heavy alcohol use is limited, but relationship problems
have been associated with relapse after treatment. 
Research on behaviourally-oriented couples therapy indicates that: 
• Intervening at the couples level can motivate an initial commitment to change in the alcohol
dependent person who is unwilling to seek help.
• Behavioural couples therapy alone or in addition to individual treatment can produce better
relationship and/or drinking outcomes during the six months following treatment than
approaches which do not include the partner. [148]
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Behavioural couples therapy is a cognitive behavioural treatment intervention. It is only appropriate
when there is agreement between the client, the client’s partner and the clinician that the partner’s
involvement is likely to be beneficial. It is very important to avoid blame in couples therapy. The
therapy should emphasise that drinking is the problem, and focus on drinking behaviour as the
problem, which needs to be fixed. It is not designed to address entrenched relationship problems
or to counteract violence.
Couples therapy includes several treatment elements, which are discussed elsewhere in this section.
These include skills training for partners, cognitive restructuring and behavioural self-management.
Different models place emphasis on different elements of the treatment. Implicit in the model is
the need for detailed assessment to determine the primary factors contributing to the problem, the
skills and deficits of the individual and the couple, and sources of motivation to change behavioural
patterns. 
The overall goal of couples therapy is to improve the couple’s relationship and communication
in a way that will strengthen the capacity and commitment to achieve and sustain a change in
drinking. In particular, couples therapy aims to:
• Change alcohol-related interactional patterns and develop interactions that support a change
in drinking behaviour.
• Help the couple confront and resolve relationship conflicts without the alcohol dependent
person resorting to the use of alcohol. 
• Mend relationship problems that have been aggravated as a result of the alcohol problem.
• Help the couple develop shared activities that are rewarding and do not involve alcohol. [142]
As this therapy requires partners to work together, it is most appropriate for couples with moderate
to low problems in their relationship, couples who are living together, are at least high school
educated and are employed. [149]
BEHAVIOURAL COUPLES THERAPY
There are four guiding components of couples therapy. [150] The first is aimed at the individual rather
than the couple. This component helps the client assess potential and actual reinforcers for continued
drinking, and in assessing the negative consequences of continued use. At this level, skills training,
behavioural self-management and cognitive restructuring are important elements of the intervention.
These interventions are explained in more detail above. 
The second component of couples therapy revolves around the coping skills of the partner. This
component involves teaching the partner ways to deal with risky drinking. These skills may include
learning new ways to discuss drinking, learning new responses to the partner’s drinking and behaviour
when drinking, or individual skills to enhance his or her own individual functioning. 
The third component of couples intervention focuses on interactions between the two partners, around
both drinking and other issues. In this component, basic communication and problem-solving skills are
taught to the couple. Topics relating to the drinking behaviour of the client are discussed with the clinician
present as a vehicle for teaching communication skills. 
The fourth component focuses on other social systems in which the drinker and partner are currently
involved. Clients and partners are helped to identify situations and persons who appear to be associated
with heavy drinking, and also to identify persons and situations that would be supportive of abstinence
or moderate drinking, depending upon the goal of treatment.
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• Clinicians who deliver behavioural couples therapy should be suitably trained in
the delivery of this intervention.
• The interventions they deliver should be supported by research.
BEHAVIOURAL MARITAL THERAPY
Behavioural marital therapy (BMT) is a particular type of behavioural couples therapy on which
much of the research examining behavioural couples therapy has been based. This is the approach
developed by O’Farrell and his colleagues. [149] Two alcohol-focused methods have been used to
reduce alcohol consumption in this approach:
• A behavioural contract between the alcohol dependent person and the partner to maintain
disulfiram ingestion.
• “Alcohol-Focused Spouse Involvement” which rearranges reinforcement contingencies in the
family to decrease family member behaviours that trigger or enable drinking and to increase
positive reinforcement for sobriety. [149]
BMT also works on general marital issues including: 
• Direct instigation of positive couples and family activities.
• Teaching of communication and conflict resolution skills.
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SUMMARY OF EVIDENCE: COUPLES AND FAMILY THERAPY LEVEL OF EVIDENCE
Couples therapy is moderately effective in reducing II
alcohol consumption and improving psychosocial outcomes.
Intervening at the couples level with a non-alcohol dependent III-1
partner can motivate an initial commitment to change in the 
alcohol dependent person who is unwilling to seek help.
Behavioural couples therapy alone or in addition to individual III-1
treatment can produce better relationship and/or drinking 
outcomes during the six months following treatment than 
approaches which don’t include the partner.
RECOMMENDATIONS: COUPLES AND FAMILY THERAPY STRENGTH OF 
RECOMMENDATION
Behavioural couples therapy should emphasise that drinking Strong
is the problem, and focus on drinking behaviour as the 
problem which needs to be fixed.
Behavioural couples therapy should not address entrenched Strong
relationship problems or be used to counteract violence.
Behavioural couples therapy is recommended for couples with Fair
moderate to low problems in their relationship, couples who are 
living together, are at least high school educated and are employed.
Clinicians who deliver behavioural couples therapy should be Strong
suitably trained in the delivery of this intervention.
Self-guided materials 
Self-guided materials have been available to help individuals to change problematic drinking
behaviours since the 1970s. [151] Self-guided materials can be used either with other treatment
interventions or as a stand-alone intervention. There are now several self-help manuals available
for use by drinkers who wish to cease or cut down drinking without the aid of professionals [152,
153] and there is evidence that the use of these manuals is associated with a marked diminution of
drinking. [154, 155]
Self-help manuals have been recognised as an important addition to treatment interventions as
they may target a portion of the population that does not usually receive treatment. These drinkers
are likely to include women and those who live in remote or isolated areas. Other attractive
components of self-help manuals include: anonymity, low time commitment, the absence of travel
and specific appointments, and the absence of costs. [156]
Brief guidelines provided by the West Australian Alcohol and Drug Authority are thought to be
useful for drinkers who require basic information or hints on reducing consumption of alcohol to
moderate levels. [152] More detailed books and booklets have been produced and are recommended
for general distribution. The Guide to healthier drinking: A self-help manual prepared for the
Alcoholscreen Team [157] has straightforward coverage of practical and understandable approaches
to moderated drinking. For those drinkers who are pursuing the goal of abstinence, appropriate
self-help materials are less apparent, although many of the strategies covered within the texts
mentioned above are likely to be of value. 
Although self help materials have some support, and have an important place in the treatment of
alcohol problems, applying self-help approaches is not always sufficient to change behaviour. The
use of self-help materials is most appropriate for risky drinkers rather than those suffering from
alcohol abuse or dependence. Self-help books can be used when there is professional intervention
as they enhance the messages that are provided through more formal face-to-face intervention. 
Some self-help books can be written at too high a reading age for some drinkers, and they need
to be altered for presentation to non-English speaking people. More attention is needed on these
aspects of presentation of self-help materials to ensure that the messages about altering alcohol
consumption reach all parts of the Australian community. 
SUMMARY
Self-help materials should be well advertised and distributed in the community for drinkers who
do not wish to be involved in professional interventions or in self-help groups. The materials are
also important resources for clinicians and professionals to use in formal intervention. Further
materials of this type, suitable for people from non-English speaking backgrounds, and for people
with a low reading age, need to be developed. Computer and internet-based self-help materials
may provide helpful materials to a population of problem drinkers who may not ordinarily seek
treatment. 
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SUMMARY: SELF-HELP MANUALS LEVEL OF EVIDENCE
There is evidence that the use of self-help manuals is II
associated with a marked diminution of drinking.
Self-help manuals are an important addition to II
treatment interventions as they may target a portion 
of the population who do not usually receive treatment.
RECOMMENDATIONS: SELF-HELP MANUALS STRENGTH OF 
RECOMMENDATION
Self-help manuals should be made readily available Strong
to the general public to assist drinkers who wish to 
cease or cut down drinking without the aid 
of face-to-face help.
Self-help materials are most appropriate for risky Moderate
drinkers rather than those suffering from alcohol 
abuse or dependence.
Self-help manuals should be modified to suit people Strong
from non-English speaking backgrounds and 
those with a low reading age.
Computer and internet-based self-help materials Strong
should continue to be developed as they may provide 
helpful materials to a population of problem drinkers 
who may not ordinarily seek treatment.
Standardised versus tailored treatment
The goal of standardised treatment, through the provision and use of treatment manuals, is to
improve the quality of treatment by standardising it in written form. 
Advantages of standardised treatments are that:
• They are often empirically validated.
• Because they are structured and time limited, they are often more focused than individualised
therapy.
• They are easier to disseminate than other clinical methods, resulting in greater ease in learning
specific treatment strategies and acquiring skill in using them.
• They are useful in training and supervision. [158]
In addition, according to a meta-analysis, clinician effects on treatment outcome decrease when
adherence to treatment increases. [136] This suggests that implementing treatment manuals into clinical
practice results in standard practice being conducted by clinicians, decreasing variability in outcome
that is not attributable to treatment. This should result in increased effectiveness as treatments are
being delivered as intended.
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Treatment manuals are often criticised by clinicians, and there has been some resistance to
implementing them in clinical settings. Perceived disadvantages of treatment manuals are that:
• They are conceptually at odds with fundamental principles of cognitive behavioural therapy,
which emphasises the importance of tailoring interventions to each client’s needs.
• They preclude individual case formulation and undervalue the importance of assessment and
case formulation.
• They undermine clinicians’ clinical artistry.
• They apply primarily to research samples which differ from the clinical samples. 
• They promote particular schools of psychosocial therapy. [158]
Although these objections are not unfounded, they do not necessarily impede clinical judgement.
[159]
Manual-based treatment does not mean that therapy is not individualised. Although strict adherence
to treatment manuals is often required in research studies, in clinical practice clinicians can be more
flexible. Manuals can and should: 
• Allow for tailoring the timing of the intervention to the needs of each client.
• Offer multiple techniques, all of which need not be included in treatment for every client.
• Allow for interrupting the manual if a more salient problem arises which is not addressed by
the techniques in the manual. [159] 
For individual case formulation, numerous studies have shown that clinicians make cognitive biases
in drawing inferences and judgements about clients. Clinicians’ confidence in their judgements is
unrelated to their accuracy, and they tend to overestimate their ability to accurately assess clients
and to evaluate the success of treatment. [159] A greater reliance on standardised treatments is a
means of minimising errors to which clinical judgement is vulnerable.
The importance of developing rapport and building a positive therapeutic alliance is no less
important in manual-based therapy than in conventional therapy. Rather than undermining clinician’s
clinical artistry, Wilson [159] argues that manual-based therapies require specific clinical skills in
developing effective therapeutic alliances with clients. 
Despite disagreement about the use of treatment manuals, and possible limitations resulting from
implementing them in practice, the use of manuals is advocated as they are thought to promote
the delivery of effective treatment. Furthermore, many of the criticisms of treatment manuals do
not necessarily apply in clinical practice. 
If clinicians are to be maximally effective, there must be detailed knowledge of the treatments to be
provided, and there should be a protocol to follow. This approach also assists greatly in the
performance and evaluation of new staff members, who may otherwise be unsure and confused
about what is required in treatment and who may bring inappropriate components of their
background into the clinical setting. Where clinicians are not clear about the content or aims of
treatment, clients will also be uncertain and the overall effort is likely to become confused and less
effective. Clinicians should be adequately trained in the procedures involved.
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SUMMARY OF EVIDENCE: STANDARDISED VERUS TAILORED TREATMENT LEVEL OF EVIDENCE
The use of treatment manuals decreases clinician effects on I
treatment outcome.
RECOMMENDATIONS: STANDARDISED VERSUS TAILORED TREATMENT STRENGTH OF 
RECOMMENDATION
Treatment procedures should be clearly specified in a Strong
written form.
Clinicians should be adequately trained in the Strong
procedures involved.
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Chapter 9: Relapse prevention
CHAPTER AIM
The aim of this chapter is to:
• Identify the factors that are likely to cause or to trigger a relapse.
• Outline the assessment of the relapse risks.
• Outline relapse prevention strategies to help reduce the risk and/or severity of relapse.
• Provide information on pharmacological relapse prevention.
• Identify strategies for increasing clients’ compliance with pharmacotherapies.
The evidence for using relapse prevention strategies with alcohol dependent clients is strong. Because
relapse is one of the most important problems for those attempting to overcome addictive behaviours,
addressing the problem is an essential aspect of treatment and one that poses major difficulties in the area
of drug and alcohol dependence. There is a substantial relapse rate within the first year after treatment of
about 60 percent when relapse is defined as a return to problem drinking. [160]
Relapse prevention aims to maintain long term abstinence or moderate drinking behaviours, and to
decrease the severity of relapse if it does occur. The conceptual model of relapse prevention views
relapse as a natural part of the process of change: lapses and relapses are viewed as opportunities for
clients to understand their behaviour and develop new skills to deal with high-risk situations. [161]
Traditionally, relapse prevention refers to the model of relapse prevention developed by Marlatt and
colleagues. [141] This model includes a variety of cognitive and behavioural approaches designed to
target each step of the relapse process. These approaches include specific intervention strategies that
focus on the immediate determinants of relapse as well as global self management strategies that focus
on the covert antecedents of relapse. [162] Both the specific and global strategies fall into three main
categories: skills training, cognitive restructuring and lifestyle balancing. Such strategies are designed
to address the immediate precursors of relapse and involve the training of coping skills, challenging
positive outcome expectancies associated with alcohol use and how to cope with lapses. Effective
relapse prevention also requires that longer term factors in relapse are addressed.
Identifying factors associated with relapse
The factors most frequently, but not exclusively,4 associated with relapse to alcohol and drug use
are thought to include: [163, 160]
1. Negative emotional states such as frustration, anger, anxiety, depression, boredom (this
association may be stronger for women than men). Negative emotions might also be the result
of other factors such as social isolation, lack of coping skills, and the negative effect of alcohol
on interpersonal, social and occupational functioning.
2. Inadequate coping skills: when faced with high risk situations, the client’s coping skills determine
whether relapse occurs or not.
3. Social isolation and family factors: interpersonal conflicts within marital, social, family or work
relations, being unemployed.
4. Alcohol involvement before treatment.
5. Craving post-treatment.
6. Beliefs: self-efficacy ratings and disease model beliefs, that is, the view of alcohol dependence
as a loss-of-control disease.
4 For example, relapse can also occur when the patient is in a positive emotional state.
Strategies for assessing relapse risk
The overall goal of the specific intervention strategies is to teach the drinker to recognise and cope
with the high-risk situations that might precipitate a lapse, and to modify the drinker’s reaction to
a lapse so that it does not develop into a full-blown relapse. The first step taken is to assist the
client to recognise those particular high-risk situations that might precipitate a relapse. Typically
this involves reviewing a list of common relapse situations, identifying those that are likely to cause
difficulty for the drinker, and devising methods to either avoid these situations or cope with them
without drinking. Self-monitoring of drinking-related behaviours before cessation can provide
information about specific risk situations, and can highlight the situations and skills deficits
associated with risky consumption. It is also important to recognise that drinkers can relapse in
unexpected situations. This possibility should be discussed with the drinker, and strategies
developed that will allow the drinker to manage these situations if they arise. However, the drinker
should be encouraged initially to avoid high-risk situations. 
Qualitative information can be obtained by clinical interview by asking Marlatt’s original questions:
1. In your own words, what is the main reason why you drink?
2. Are there any other reasons why you drink, which you consider important? If Yes, what are
they?
3. Do you have any inner thoughts or emotional feelings, or things within you as a person which
“trigger off” your need or desire to take a drink at a particular moment in time?
4. Are there any particular situations or set of events, things which happen to you in the outside
world which would be most likely to make you feel like having one or more drinks? [164]
Clients can be asked about the circumstances under which they have relapsed or drank heavily
in the past. Other questions should explore the relapse factors identified above, for example
exploring the client’s beliefs about alcohol dependence as a disease, beliefs about their capacity
to avoid relapse and cope with lapses, their strategies for coping with high-risk situations, mood,
and social/family support.
Psychometric instruments include: 
• The Reasons for Drinking Questionnaire (RFDQ) can also be used to identify antecedents
of relapse for individual clients. [165]
• The Inventory of Drug Taking Situations (IDTS) assesses situations in which the client has
consumed heavily or relapsed in the past. Its companion is the Drug Taking Confidence
Questionnaire (DTCQ) which assesses the client’s self-efficacy about high-risk situations,
one of the factors associated with relapse. [166]
• The Situational Confidence Questionnaire [166] provides a basis for the identification of
high-risk situations.
• The Coping Behaviours Inventory [167] to help identify the client’s coping skills.
128 Guidelines for the Treatment of Alcohol Problems
C
H
A
P
T
E
R
 9
R
elap
se p
reven
tio
n
Reducing the risk of relapse
Relapse prevention is not an intervention in and of itself, but rather a component of an overall
treatment strategy that looks at a number of risk factors and assists the drinker to develop strategies
to minimise the risk of a return to risky or problem drinking. 
Relapse prevention strategies can be used successfully with a variety of clients in different contexts,
including residential and outpatient settings. The methods described in the model of relapse
prevention developed by Marlatt and Gordon (1985) [141] are separated into two types: specific
intervention strategies and global self-control strategies. 
Specific intervention strategies
The next step following assessment of risk involves teaching the drinker alternative coping
responses that might be used in these situations. Dimeff and Marlatt (1995) noted that a number
of areas may be covered, including cognitive restructuring, contracts to limit extent of use, reminder
cards, relapse rehearsal, and stress management. [168] As has been set out in sections that refer to
these procedures, practice of coping responses should be performance-based, and personalised
to the drinker. There is also some potential benefit from conducting the relapse prevention skills
training in pairs allowing buddy support for the client. Role plays, modelling of new behaviours,
video-assisted and direct feedback of performance will be valuable in developing skills for dealing
with potential relapse situations. 
Behavioural coping responses are: physical or some distracting activity, the consumption of food
or non-alcoholic drink, escaping the situation, and relaxation procedures. Cognitive coping includes:
thinking of the positive health consequences of not drinking and the negative health and other
consequences of resuming risky drinking, and using thoughts related to delay or distraction. The
range of methods used in training drinkers in these procedures includes mainly rehearsal, real or
imagined, with evaluation and feedback of performance. Saunders and Allsop (1991) have
developed these procedures further within the stages of change model, and the procedures they
set out assist in developing a comprehensive relapse prevention approach. [169] Dimeff and Marlatt
(1995) have provided a session-by-session guide to relapse prevention. [168]
The relapse prevention approach is also designed to deal with the lapse to drinking. The client’s
reaction to such lapses is viewed as crucial in determining whether drinking will continue or not.
A single lapse can result in a complete return to drinking because the drinker sees the lapse as an
indication of powerlessness over alcohol. [168] The relapse prevention model teaches the client to
view a lapse as a temporary return to drinking or risky drinking and not as a complete failure.
Moreover, there is an emphasis on learning from the events preceding the lapse and making
strategic plans for limiting future lapses. 
GLOBAL INTERVENTION STRATEGIES
A final part of the approach is developing global intervention strategies where the client changes
his or her lifestyle in ways which decrease the likelihood of drinking. The aim is to increase the
client’s capacity to cope effectively with pervasive stress factors. For example, therapy may focus
on encouraging the client to take up recreational activities and behaviours that are incompatible
with drinking alcohol, substituting indulgences, using coping imagery, and balancing perceived
external demands (shoulds) with perceived desires (wants). [168]
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• Individual assessment of risk factors should be undertaken before identifying
relapse prevention strategies.
• Relapse prevention should include immediate and global strategies that increase
the client’s ability to avoid relapse and to cope with more pervasive stressors.
• Clinicians should make arrangements for the client to continue contact after the
relapse prevention program is complete.This can be done by phone, or in person.
See Chapter 10: Extended care for more details.
Pharmacotherapies for relapse prevention
Both naltrexone and acamprosate have been shown to improve treatment outcomes when added
to other components of alcohol treatment. For clients who are motivated to take the medication,
both are potential tools in preventing relapse to heavy or dependent drinking. For some, medication
is associated with a critical period of sobriety, during which the client can learn to maintain
abstinence without the help of medication.
Acamprosate is thought to reduce drinking by modulating the brain glutamate function which is
implicated in withdrawal symptoms. Naltrexone is an anti-craving drug that reduces the chance of
a lapse becoming a relapse. It acts upon the brain’s opiate receptors. Both acamprosate and
naltrexone have been approved for use as part of a comprehensive treatment plan for alcohol
dependence. 
The evidence for disulfiram is weaker. However, it is included here as one option for relapse
prevention. There is some evidence that the combined use of psychosocial intervention, acamprosate
and disulfiram is more effective in preventing relapse than one or the other medication alone. [170]
A head to head open label trial of acamprosate and naltrexone found that naltrexone was more
effective than acamprosate in achieving abstinence, reducing craving, increasing the risk of and
time to relapse, and reducing average drinks per drinking day. One randomised controlled trial
suggests that combined naltrexone and acamprosate may be more effective than acamprosate alone,
but no more effective than naltrexone alone. [171]
q
Prescribers are referred to the MIMS Annual for detailed information about disulfiram,
naltrexone and acamprosate (listed and marketed respectively as Antabuse (r), Re
Via (r) and Campral (r)). The product information should be reviewed before
prescribing these medications.
INTEGRATION WITH PSYCHOSOCIAL TREATMENTS
Pharmacotherapy for relapse prevention should always be accompanied by close follow-up by
the prescribing doctor. Each client requires a comprehensive treatment plan, which includes dealing
with psychosocial issues, as described in the previous section of this chapter. 
q
Treatment is significantly more successful when the client is receiving psychosocial
treatment and is compliant with the medication, so psychosocial interventions should
address this issue. Referral to a specialist alcohol and drug counselling service may
also be appropriate.
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INCREASING MEDICATION COMPLIANCE
Naltrexone has been shown to be more effective than placebo only among highly compliant partic-
ipants [172] Results from another trial suggest that the poor outcomes for naltrexone participants were
owing to more adverse effects and hence, poor medication compliance. [173]
An analysis of data from two clinical trials showed that the gastrointestinal side effects of naltrexone
- nausea, decreased appetite, dry mouth, vomiting, stomach pain, constipation and diarrhoea -
reduced medication compliance, but not treatment retention. [174] Conversely, the neuropsychiatric
effects - fatigue, dizziness, light-headedness, weakness, insomnia, sleepiness, confusions, blurred
vision, headache, drowsiness and poor coordination- reduced treatment retention but not
compliance.
Those more likely to experience moderate to severe nausea in response to naltrexone include:
• Lighter drinkers with shorter periods of abstinence
• Female clients
• Younger clients
There may be several other reasons that a patient is reluctant to comply with pharmacological
treatment [175]:
• For some, there is a stigma attached to taking medication for an alcohol use disorder. Many
patients see taking medication as cheating and believe that they should have sufficient willpower
to conquer the disorder unassisted. This belief may be reinforced by others in the patient’s social
network.
·• Unlike medications that relieve distress, naltrexone blocks the reinforcing effects of alcohol.
Although it probably reduces craving for alcohol, there is no inherent reward for complying with
naltrexone or acamprosate.
• Related to this is that for some patients, these medications have unpleasant side effects. For these
patients, not only is the medication inherently unrewarding, it is actually aversive. The commonest
side effect is nausea, which usually abates after one or two weeks.
• Fears about the safety and side effects of the medication. Many patients probably do not know
anything about the medication and may be quite fearful about taking it. 
• Cost. In Australia, acamprosate and naltrexone are subsidised by the Pharmaceutical Benefits
Scheme, provided the correct procedures are followed. However, patients may be reluctant to
make co-payments and this should be clarified at the time of starting treatment.
Compliance therapy, based on cognitive-behavioural and motivational interviewing techniques,
has demonstrated effectiveness with psychotic patients. [176] A pilot trial of compliance therapy with
alcohol dependent patients being treated with acamprosate currently underway in Sydney, Australia
has shown promising results. [177] The six session intervention is outlined below:
• Sessions one and two: Elicit beliefs about problem and treatment. Review history, examine
benefits of treatment. 
• Sessions three and four: Explore ambivalence towards treatment, the pros and cons of
treatment, direct and indirect benefits. Correct erroneous beliefs about medication, for instance
side effects vs. symptoms.
• Sessions five and six: Highlight the need for treatment maintenance; enhance self-efficacy by
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focusing on achievements, frame medication and treatment as a choice that helps the client
stay well to achieve goals, relapse prevention.
At the time of writing, the trial was incomplete. There was a trend towards longer time using
acamprosate and longer time to relapse in the experimental group. A larger trial will start in 2003.
In a review of compliance therapy, a combination of educational/cognitive, behavioural and
affective strategies was found to work better than any single-focus strategy: [178]
• Educational/cognitive strategies were those designed to convey information through one-to-
one or group teaching, written and audiovisual materials, and telephone instructions. 
• Behavioural interventions used targeting, modelling, contracting, packaging and dosage modifi-
cations, tailoring, rewards, reminders, skills building and practice activities, shaping, or
reinforcing of specific behavioural patterns. 
• Affective interventions used appeals to feelings and emotions or social relationships and
supports, such as family support, counselling, and supportive home visits. Interventions
targeting patients with mental health problems were successful across the board, with
reminders and education delivering the most consistent improvements.
Another review suggests that the most important single intervention is recalling patients who miss
appointments and making every effort to keep them in care. [179] 
Compliance with pharmacotherapies may be assisted by:
• Eliciting the patient’s thoughts and concerns about taking medication and using cognitive
restructuring techniques to help them change unhelpful or maladaptive thoughts about taking
medication.
• Providing the patient with a realistic view of the way in which the medication can help, its
side effects, and any risks associated with its use. This includes education about pain relief
for emergencies, that is, no opioid-based pain relief can be administered whilst the patient is
using naltrexone.
• Using motivational interviewing techniques to help the patient to identify their personal costs
and benefits of taking the medication.
• Providing the patient with some take-home reading material about the medication.
• Suggesting AA for patients with an abstinence goal.
• Tailoring the psychosocial intervention according to the patient’s drinking goal: some studies
show that coping skills training combined with naltrexone is better for helping patients cope
with lapses and relapses, whereas supportive therapy is more effective in helping patients to
maintain abstinence (see Chapter 8: Psychological Interventions for more information on these
treatments).
• Following up clients who miss appointments.
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ACAMPROSATE
Suitability for acamprosate 
There is little evidence to inform decisions about who is suitable for acamprosate. However, some
evidence and clinical expertise suggests that the following patients may benefit: [175]
• Patients who are moderately to severely alcohol dependent and are medically stable
• Those who are willing to be in a collaborative relationship with a health care worker or a
support group. It is a Pharmaceutical Benefits Scheme requirement that acamprosate is provided
for “use within a comprehensive treatment program for alcohol dependence with the goal of
maintaining abstinence”. 
• Patient’s willingness to take and comply with acamprosate is an important factor in assessing
suitability.
• Acamprosate is contraindicated in patients with a known hypersensitivity to the drug, renal
insufficiency or severe hepatic failure (Childs Pugh classification C). [95]
• The safety of acamprosate in pregnancy or lactation has not been established so it should not
be administered to women who are pregnant or breastfeeding. [95]
Interaction with other drugs
• Acamprosate does not interact with alcohol.
• There is some debate about whether tetracyclines are rendered inactivate by the calcium
component in acamprosate during concurrent administration. 
Starting treatment
• Acamprosate dosing is recommended to begin within one week of the patient’s last drink (within
one month is acceptable). [180]
• Acamprosate has been shown to be safe during detoxification. However, it is preferable to start
acamprosate once withdrawal has settled so that withdrawal symptoms are not confused with
medication side effects.
• Some clinicians do not prescribe acamprosate to patients who refuse to stop drinking alcohol.
This is not because of drug interactions, but because they consider that patients who are
unwilling to stop drinking lack the motivation to change their behaviour, hence, an adjunctive
medication such as acamprosate or naltrexone would be a waste of time.
• Medical history should be taken, as per Chapter 3: Screening and assessment.
• Physical examination may include assessment for signs of chronic liver disease and hepatic
failure. The assessment of hepatic insufficiency is done via clinical examination and liver function
tests. 
• Testing may include tests of kidney function (urea and electrolytes), since 90 percent of
acamprosate is excreted through the kidney, and liver function tests, since it is contraindicated
for patients with hepatic failure.
• Once assessment is complete, discuss treatment goals and plan with the patient
• Patient education should cover how the medication works, what side effects to expect, and
realistic expectations about reductions in cravings. Explain that patients typically do not feel
any different on treatment, and that the drug only reaches desired levels in the brain after one
to two weeks.
• Arrange for a follow-up visit within one week, as early drop-out is common.
134 Guidelines for the Treatment of Alcohol Problems
C
H
A
P
T
E
R
 9
R
elap
se p
reven
tio
n
Dosage
Acamprosate is formulated in tablets of 333 mg, with the recommended dose for adults being
1998mg (six tablets) orally in three divided doses, with meals. Adults under 60kg should take 1332
mg/day (four tablets/day in three doses: two, one and one). 
Ongoing treatment
Treatment should continue even if the patient lapses; psychosocial relapse prevention techniques
should be used to deal with the lapse or relapse.
Adverse effects and their management
Acamprosate is well tolerated and its predominantly gastrointestinal adverse effects, commonly
diarrhoea, usually resolve spontaneously. Mild abdominal pain has been reported in four percent
of acamprosate patients and two percent in placebo patients. Rash or isolated pruritus, parasthesiae,
decreased (and sometimes increased) libido and confusion have all been reported at low
frequencies. 
The following strategies are recommended:
• Patient education about expected side effects and duration.
• To limit confusion between prolonged alcohol withdrawal symptoms and side effects of
acamprosate, it is preferable to start acamprosate once withdrawal has settled.
Treatment duration
The usual treatment period is three to six months, but the decision on the duration of treatment
should be made by the patient and the doctor on a case by case basis after discussion of both the
positive and negative effects of the medication.
Clinical considerations during treatment
• Dealing with continued drinking (see earlier material in this chapter on psychosocial relapse
prevention, and Chapter 8: Psychosocial interventions, specifically motivational interviewing
and goal setting).
• Monitoring and attending to physical and mental health.
• Using acamprosate in conjunction with disulfiram is a possibility for patients who can be
supervised and are motivated to abstain from alcohol.
• Medication compliance - some patients will have difficulty remembering to take pills three
times per day. Reminder and reward systems may be necessary. See earlier material in this
chapter on compliance therapy.
• Acamprosate therapy does not preclude participating in other treatment or support activities
such as counselling, AA, and/or other support networks.
Ending acamprosate therapy
At present there is no evidence of a withdrawal syndrome following the use of acamprosate or
developing dependence on acamprosate, so patients should not experience withdrawal symptoms
when they cease taking it. [180] Nevertheless, dose reductions may have psychological benefits for
the patient. Psychosocial relapse prevention interventions should continue beyond the end of
pharmacotherapy. 
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NALTREXONE
Naltrexone is an anti-craving drug that reduces the chance of a lapse becoming a relapse. It acts
on the brain’s opiate receptors. It has been approved for use as part of a comprehensive treatment
plan for alcohol dependence. 
Suitability for naltrexone 
There is little evidence to inform decisions about who is suitable for naltrexone. However, some
evidence and clinical expertise suggests that the following points should be taken into account:
[175]
• Patients who are moderately to severely alcohol dependent, medically stable, and who are
not currently using opioids, may be suitable candidates. Narcan challenge is not required
unless recently opioid dependent.
• Naltrexone is indicated for patients who experience strong cravings for alcohol after a priming
dose. [180]
• The patient’s willingness to comply with the medication should be assessed and discussed.
• Naltrexone is contraindicated for people with acute hepatitis or liver failure, or with a history
of sensitivity to naltrexone.
• There are no well controlled studies of the safety of naltrexone during pregnancy or lactation.
The safety of naltrexone with patients younger than 18 years old has not been established. [95]
• Patients requiring opiate-based pain relief are not suitable candidates.
• One study found that naltrexone patients had worse outcomes on depression scores than
placebo patients. [181] This result should be interpreted with caution. However, given the high
prevalence of depression among alcohol dependent patients, regular monitoring of depression
using an instrument such as the Beck Depression Inventory is recommended. [67]
• Naltrexone may be more effective for preventing relapse to heavy or problem drinking than
for maintaining abstinence from alcohol.
• In combination with naltrexone, coping skills therapy appears to be more effective than
abstinence-oriented supportive therapy in reducing relapse risk and alcohol consumption.
Coping skills therapy may help clients to cope with lapses. However, supportive therapy with
naltrexone produces higher rates of abstinence.
Interaction with other drugs
q
Naltrexone induces precipitated opiate withdrawal in patients who are currently
opiate dependent. It is contraindicated in patients currently being maintained on
methadone.
· Naltrexone does not appear to alter the absorption or metabolism of alcohol; however some
patients have reported nausea from drinking alcohol while taking naltrexone.
· Caution should be taken with other drugs, as the interaction of naltrexone and most other
medications has not been tested. It is not ordinarily recommended for use with disulfiram
because both are potentially hepatotoxic.
Starting treatment
• Treatment should begin after the symptoms of acute alcohol withdrawal have subsided, usually
three to seven days after the patient’s last drink. 
• As for acamprosate, there is some debate about starting naltrexone while the patient is still
drinking. The issue here is not drug interaction, but motivation for treatment. 
• A medical history should be taken, as per Chapter 3: Screening and assessment.
• Physical examination may include assessment signs of chronic liver disease and hepatic failure.
The assessment of hepatic insufficiency is done via clinical examination and liver function
tests.
• Once assessment is complete, discuss treatment goals and plan with the patient.
• Patient education should cover how the medication works, what side effects to expect, realistic
expectations about reductions in cravings. 
• Arrange for a follow-up visit within one week, as early drop-out is common.
Dosage
Naltrexone is administered orally at 25mg for one to two days and then increased to the standard
dose of 50mg daily. Naltrexone is available in 50mg tablets. Maintenance doses of less than
50mg/day may be considered for patients who do not tolerate to the standard dose. It may be
preferable to reduce the dose to 25mg/day to avoid non-compliance because of adverse side
effects. Some women may not need as high a dose as men; this should be monitored by the
prescribing doctor.
Doses of up to 100mg/day have been used with patients who report persistent feelings of craving,
discomfort, and brief relapses. Medical monitoring of such patients is critical. Intensifying other
treatment components should be considered first and the reason for treatment failure explored.
However, it would appear that some patients do metabolise naltrexone more quickly than others
and therefore need a higher dose.
Continuing treatment
• There is some evidence to support the targeted use of naltrexone, i.e. using it only when
cravings are severe, or at high-risk relapse times.
• Treatment should continue even if the patient lapses; psychosocial relapse prevention
techniques should be used to deal with the lapse or relapse.
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Adverse effects and their management
Common adverse effects include nausea, headache, dizziness, fatigue, nervousness, insomnia,
vomiting, and anxiety in about 10 percent of patients. 
The following strategies are recommended:
1. Patient education about expected side effects and duration, reassurance that these effects are
not serious and resolve with cessation of therapy.
2. Timing of doses: establishing a routine; ideally taken in the morning with food; or timed to
prevent strongest cravings.
3. Splitting the dosage: half in the morning and half in the evening.
4. Management of nausea: patients should be advised to take naltrexone with food. Consider
dose reduction, slow titration, and stopping the medication for three to four days before
reintroducing it at a lower dose.
5. Gradual introduction of medication (see dosage information).
6. Distinguishing between prolonged alcohol withdrawal symptoms and side effects of naltrexone.
Treatment duration
The usual treatment period is three months, but six to twelve months may be necessary in some
cases. This decision should be made on a case-by-case basis between the patient and the doctor,
based on side effects, history of relapse, social and family circumstances, and other individual
factors.
Clinical considerations during treatment
• Dealing with continued drinking: encourage continuation of medication, also see earlier
material in this chapter on psychosocial relapse prevention, and Chapter 8: Psychosocial
interventions, specifically motivational interviewing and goal setting.
• Monitoring and attending to physical and mental health as depression and dysphoria are
recognised side effects of naltrexone.
Ending naltrexone therapy
Naltrexone does not appear to produce dependence so patients should not experience withdrawal
symptoms when they cease taking it. [180] Patients can safely come off naltrexone straightaway. Even
so, dose reductions may have psychological benefits for the patient. Psychosocial relapse prevention
should continue beyond the end of pharmacotherapy. 
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TABLE 9.1: SUMMARY OF ACAMPROSATE AND NALTREXONE CHARACTERISTICS
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Drug Naltrexone Acamprosate
First-line treatment for moderate to
severely dependent patients
First-line treatment for moderate to
severely dependent patients
Recommendation
Antagonism of opiate receptor Mechanism unknown (involves
restoration of normal activity in
glutamate and GABA systems)
Mechanism of action
• No aversive reaction
• Prevents pleasant “high” effect
of alcohol
• Sedation and adverse
psychomotor effects still occur
• No aversive reaction
• No alteration of CNS effect of
alcohol or withdrawal symptoms
Evidence of reduction 
Reaction with alcohol
Yesin craving 
Yes
Yes YesEvidence of reduction 
in alcohol intake 
Yes YesEvidence of increased
abstinence 
No YesEvidence of effect post-
drug therapy
• Opiate dependence
• Chronic pain requiring treatment
with opiates
• Hepatic failure or active hepatitis
(ALT >3x normal)
• Renal impairment
• Pregnancy (ADEC B3)
• Lactation (safety not established)
• Renal impairment (excreted
unchanged in the kidney)
• Pregnancy (ADEC B2)
• Lactation (no data in humans)
Contraindications
• Opioids (antagonism of action)
• Disulfram (combination may result
in increased hepatotoxicity)
None with diazepam, disulfiram or
imipramine
Drug interactions
• Nausea*
• Headache*
• Dizziness
• Anxiety 
• Fatigue
• Insomnia
• Somnolence 
• Rarely hepatotoxicity
• Diarrhoea*
• Nausea, vomiting
• Abdominal pain
• Rash, pruritis
• Rarely libido changes and
bullous skin reactions
Adverse effects
• Start after acute alcohol
withdrawal but presence of
alcohol is not a contraindication
• Ensure not dependent on opiates
Start after acute alcohol withdrawal
but presence of alcohol is not a
contraindication
Preparation before
commencing treatment
50 mg daily (can start on 25 mg
for 2-3 days to reduce incidence of
side effects)
>60kg 2 tabs tds,
<60kg 2 mane, 1 noon and 1 nocte
Dose
Provided at no cost to the client at
some specialist D&A agencies. Can
also be obtained as an authority
script on the PBS.
Obtained as an authority script on
the PBS.
Cost
*Common side effects
Reproduced with permission from Next Step Drug and Alcohol Services, Western Australia. Sim, 2002. 
DISULFIRAM
Disulfiram aims to assist the drinker to achieve and maintain abstinence by interacting with alcohol
to create an unpleasant reaction. The research evidence indicates that maximal effect is achieved
when the disulfiram is provided to the patient under supervision. Despite some evidence for its
effectiveness, disulfiram is rarely used in practice. [1] The drug is costly and is not readily available,
although some pharmacists will order it in on receipt of a script. Disulfiram is a useful adjunct to
treatment in the short term, provided that it is supervised to ensure that the patient takes an
adequate dose regularly. 
Disulfiram primarily works by inhibiting the action of enzymes (aldehyde dehydrogenase) involved
in the metabolism of alcohol. The results of consuming alcohol while on disulfiram are unpleasant.
They include flushing, dizziness, nausea and vomiting, irregular heart beat, breathlessness and
headaches. Disulfiram acts as a deterrent to drinking because the patient expects to experience
these negative consequences if they drink alcohol. [182]
Eligibility for disulfiram
Disulfiram is an appropriate medication for patients who:
• Are motivated to abstain from alcohol.
• Accept that there is a need for an external control on their drinking.
• Display no medical or psychosocial contraindications.
• Are prepared to be supervised in the daily dosing of the medication. 
Interaction with Other Drugs
• As described above, disulfiram interacts with the metabolism of alcohol.
• Refer to MIMS for other interactions, that is, with isoniazid, phenytoin, some benzodiazepines,
anticoagulants, metronidazole, paraldehyde. [95]
Starting Treatment
• Discuss treatment goals and plan with the patient.
• Treatment should begin after detoxification. At a minimum, the patient should abstain from
alcohol at least 24 hours before taking disulfiram.
• Medical history should be taken as per Chapter 3: Screening and assessment 
• Patient education is critical. Discussion of the effects of the drug when alcohol is taken is an
important part of the therapeutic strategy, as the patient’s anticipation of its effects will greatly
enhance the drug’s effectiveness as a deterrent against drinking. 
• Discuss motivation and supervision with the patient. The patient needs to understand
supervised disulfiram as a useful strategy to assist in the maintenance of the choice of
abstinence. In that way, the patient sees disulfiram as an aid that assists but does not detract
from the patient’s own responsibility and choice in maintaining abstinence.
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Dosage
A dose of 200 to 400mg of disulfiram per day is appropriate (tablets are 200mg each), although
some commentators have suggested that much higher doses are required before a reaction to
alcohol ingestion can be assured. [183] Although there is a risk that this dosage regimen is insufficient
to guarantee a reaction upon drinking in some people, dosages above this level expose the patient
to possible side effects. An aversive reaction to the drug can be tested for by prescribing a dose
of 400mg and then reducing to 200mg according to the patient’s response.
Continuing treatment
Disulfiram is likely to be a useful treatment for the first three to six months of treatment. After that
time its use should be discontinued and the patient should be encouraged to maintain abstinence
without disulfiram. 
Ongoing treatment should include psychosocial relapse prevention strategies. Treatment should
be continued even if the patient relapses.
Supervision 
Supervision of disulfiram dosing is likely to have a marked effect on compliance, and to greatly
improve the effectiveness of this intervention. Supervision can present problems for some patients.
It might be difficult to organise: the patient needs to be prepared for public disclosure either with
the clinician or some other person who is chosen to supervise. 
The patient’s spouse/partner is an obvious choice for married/de facto patients, and can play a
valuable role in treatment. However, the non-alcohol dependent partner might feel the disulfiram
contract places the responsibility for the drinking (inappropriately) on their shoulders. He or she
has probably learned that they cannot control the partner’s drinking. It is therefore important to
stress to the patient’s partner that:
• The spouse cannot be expected to control the other person’s drinking, and emphasise that
their responsibility as supervisor is simply to observe the partner taking the disulfiram.
• The supervision should not be viewed as a coercive checking-up operation.
Summary
Oral disulfiram is not recommended as a first-line strategy. It may be an appropriate short term
strategy when the clinician and patient agree that there is a need for some form of external control
over drinking behaviour to be present, and provided that the patient’s compliance with dosing is
adequately supervised either by a spouse or a health professional involved in treatment. Disulfiram
is, however, difficult to obtain in Australia.
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SUMMARY OF EVIDENCE: RELAPSE PREVENTION LEVEL OF EVIDENCE
Psychosocial relapse prevention strategies are effective in reducing I
alcohol intake, reducing the severity of relapse, and improving 
psychosocial outcomes. 
Relapse prevention works equally well across treatment settings, in II
combination with different types of treatment, and in group or 
individual sessions.
The optimum duration and intensity of relapse prevention is unclear, IV
and may vary from client to client with different problems and needs.
Acamprosate is moderately effective as an adjunctive therapy in I
reducing relapse risk in the short term.
Acamprosate appears to be moderately effective as an adjunctive II
therapy in the longer term (up to two years).
Acamprosate appears to be safe for use during alcohol withdrawal, II
that is, no interactions were observed with withdrawal medications.
Acamprosate therapy should be started within one week of III-3
completing withdrawal.
One trial found acamprosate to be equally effective irrespective of II
compulsory participation in counselling.
Clients who receive treatments that include strategies to increase II
compliance have better outcomes.
Naltrexone as an adjunctive therapy is moderately effective in I
reducing relapse risk and alcohol consumption in the short term.
Naltrexone may be more effective for preventing relapse to heavy or II
problem drinking than for maintaining abstinence from alcohol.
Targeted naltrexone in response to cravings may be of some use II
in reducing relapse risk.
In combination with naltrexone, coping skills therapy appears to be II
more effective than abstinence-oriented supportive therapy in 
reducing relapse risk and alcohol consumption. Coping skills 
therapy may help clients to cope with lapses. However, supportive 
therapy with naltrexone may produce higher rates of abstinence.
One trial found naltrexone without compulsory II
psychosocial intervention to be effective in reducing relapse.
At present, there is no substantial evidence base from which to choose III-1
between acamprosate and naltrexone. One open trial found naltrexone 
to be more effective than acamprosate across a range of outcomes. One 
controlled trial found that combined acamprosate and naltrexone was 
more effective than acamprosate but not naltrexone. However, 
outcomes for naltrexone and acamprosate patients were not 
significantly different.
One pilot trial with acamprosate patients and evidence from other III-2
areas of mental health suggests that an intervention based on 
motivational interviewing and cognitive-behavioural strategies can 
increase medication compliance and lead to better treatment outcomes.
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RECOMMENDATIONS: RELAPSE PREVENTION STRENGTH OF RECOMMENDATION
Psychosocial relapse prevention strategies are Strong
recommended for use with all moderate to severely 
alcohol dependent clients.
Psychosocial relapse prevention is best delivered Moderate
after acute withdrawal symptoms have subsided. 
Identify high risk situations. Assess for risk factors: Strong
cravings, disease beliefs, coping skills.
Assessment for relapse prevention suitability should Strong
take into account comorbid disorders, current 
coping skills, social skills, cognitive impairment, 
other drug use
Acamprosate is recommended as an adjunct to Strong
psychosocial relapse prevention for moderate to 
severely alcohol dependent clients, with the 
exception of those contraindicated as per table 9.1.
Naltrexone is recommended as an adjunct to Strong
psychosocial relapse prevention for moderate to 
severely alcohol dependent clients, with the 
exception of those contraindicated as per Table 9.1.
Patients who are opioid dependent should not be Strong
prescribed naltrexone. All patients should be 
warned of the potential for opioid withdrawal 
syndrome if any form of opiates is taken, that is, 
heroin, methadone, and opioid analgesics.
For some patients, general practitioner management Moderate
to accompany acamprosate and naltrexone will be 
sufficient. Others (e.g. chronic relapsers) will need 
more intensive psychosocial interventions. Thus, 
psychosocial treatment should be tailored to the 
needs of the patient and should include relapse 
prevention strategies.
Acamprosate and naltrexone should be started Moderate
within one week of detoxification.
Acamprosate and naltrexone are usually taken for Moderate
three to six months, and in some cases up to 
12 months. Optimum treatment duration has not 
been established.
Many patients find it difficult to comply with a Strong
medication regimen. This issue should be addressed 
with compliance therapy which is based on 
motivational interviewing and cognitive-behavioural 
strategies.
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Chapter 10: Extended care
CHAPTER AIM
The aim of this chapter is to describe:
• The range of extended care strategies available for patients with an alcohol use disorder
(abuse or dependence).
• The Alcoholics Anonymous (AA) approach and how AA participation might fit with other
interventions for alcohol problems.
Successful treatment of any condition which is subject to relapse, such as alcohol dependence,
often requires ongoing and extended assistance. The key issues include retention in treatment,
assertive outreach, and effective referral. AA is included as an aftercare strategy because there is
some evidence suggestive of its suitability for this purpose. However, many patients choose to
attend, and may benefit from, AA sessions before or during the initial treatment, as well as using
the self-help group to maintain sobriety post-treatment.
Treatment retention
The chronic nature of alcohol dependence means that treatment is often long term. The factors
that retain clients in treatment include:
• Client variables (pre-treatment motivation and therapeutic involvement, see chapters three
and eight).
• Treatment variables (strength of the therapeutic relationship, perceived helpfulness of the
treatment services, empathy of the clinician, removal of practical barriers such as transportation,
and the inclusion of relapse prevention training). [38, 39] Clinician characteristics and the
therapeutic relationship are crucial to engaging the client in treatment (see Chapter 8:
Psychosocial interventions). [37]
Alcoholics Anonymous
AA is the mainstay of the self-help approach to alcohol problems in Australia, although there are
other group approaches. It is the prototype of the self-help approach to assisting people with
alcohol problems, and is the major organisation available of this kind. AA was formed in the USA
in 1935 and came to Australia in 1945. There are now approximately 1700 AA groups in Australia.
Currently, women make up about 35 percent of the membership5. 
The essence of the self-help group approach to alcohol problems is that change is not facilitated
or mediated by professionals, but is the result of the group members’ own initiatives and support
of each other. Because of the essential nature of self-help initiatives this form of intervention is
not conceptualised as a form of treatment. It is a self-help organisation that assists people in working
together to maintain abstinence from alcohol. Its wide availability and prominence in the community
offers continuing support and assistance outside formal treatment. 
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5 Retrieved from the World Wide Web: http://www.alcoholicsanonymous.org.au
HOW EFFECTIVE IS AA?
The research into the effectiveness of conventional AA meetings suggests that it has a place as an
adjunct to formal treatment, since participation predicts more positive long term outcomes for
many clients. However, there are serious limitations to the research that has been conducted. First,
few randomised controlled trials exist. Other limitations of the research are that many studies have
lacked the statistical power to detect differences in treatment outcomes, many have used only
drinking outcomes, and participation in AA meetings is an inherently heterogeneous experience.
[184] That is, AA operates differently even within a single region, so it is difficult to generalise about
its processes.
HOW AND FOR WHOM DOES IT WORK?
AA participation has been shown to predict higher rates of abstinence post-treatment. Participants
with more severe symptomatology are more likely to participate in AA. The practice of AA activities
may lead to increased self-efficacy to abstain from alcohol. [143]
Given the poor outcome of participants coerced into AA participation, it would appear that
mandating AA as a treatment is counterproductive. [185] Individuals with higher network support for
drinking may benefit most from AA participation. [186] This is also the case when AA is used an
aftercare strategy. [143, 186] The extent of active participation in AA processes may also predict better
outcomes. [187]
HOW SHOULD IT BE USED?
Although these results provide limited evidence of the value of AA, they do suggest that AA assists
in the reduction of alcohol problems at least for those clients who choose to attend the meetings.
In summary, attendance at AA meetings is useful as an adjunct to therapy, and as an aftercare
strategy for relapse prevention, particularly for clients with high network support for drinking.
Table 10.1 outlines the 12 steps used in AA.
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TABLE 10.1: THE 12 STEPS OF ALCOHOLICS ANONYMOUS
We: 
1. Admitted we were powerless over alcohol and that our lives had become unmanageable.
2. Came to believe that a power greater than ourselves could restore us to sanity.
3. Made a decision to turn our will and our lives over to the care of God as we understood Him.
4. Made a searching and fearless moral inventory of ourselves.
5. Admitted to God, to ourselves, and to another human being the exact nature of our wrongs.
6. Were entirely ready to have God remove all these defects of character.
7. Humbly asked Him to remove our shortcomings.
8. Made a list of all persons we had harmed, and became willing to make amends to them all.
9. Made direct amends to such people wherever possible, except when to do so would injure them or
others.
10. Continued to take a personal inventory and when we were wrong promptly admitted it.
11. Sought through prayer and meditation to improve our conscious contact with God as we understood
Him, praying only for knowledge of His will for us and the power to carry that out.
12. Having had a spiritual awakening as the result of these steps, we tried to carry this message to
alcoholics, and to practise these principles in all our affairs.
Awareness of local AA activity, contact with the AA general service officer, familiarity with AA
literature and attendance of some open AA meetings assist counsellors at times of referral. In
particular, counsellors should be acquainted with a range of AA sponsors, so they can help clients
meet others with similar interests. This process reassures the client that like-minded people attend
AA. There are also AA groups that accommodate special needs, such as all-female meetings or
meetings for homosexual members. AA is most appropriate for clients with alcohol dependence,
who wish to work towards abstinence. Because it takes time to understand the full benefits of AA,
these clients should be encouraged to attend AA meetings at least three times before making a
decision about continued involvement. 
Since AA is not viewed as a treatment it is not a sufficient intervention for alcohol problems. As
noted earlier AA does not see itself as a treatment, and it fully acknowledges the need for drinkers
to access professional assistance when required. Yet AA is available without charge to support
changes in drinking to ex-drinkers, in many locations throughout Australia, and it will continue to
be available after time-limited interventions have been terminated. 
There is a risk that those with serious problems that are not dealt with within the self-help group
will continue to suffer problems that could be ameliorated though professional assistance. The AA
literature recognises this limitation, and states clearly the need to access the assistance of health
professionals for serious problems that cannot be addressed by the self-help group. It is important
for those on both sides of the debate to recognise the danger of making decisions or advising
others on the basis of personal bias. 
Assertive outreach and structured aftercare
Conventionally, aftercare is thought of as continuing contact between the client and clinician, once
the initial treatment phase is completed. This can be “booster sessions” to maintain skills learnt in
treatment, telephone contact initiated by the patient or clinician, or support and monitoring of
progress as the drinker reintegrates into the community. Living without risky drinking may present
unexpected problems that the patient needs assistance to deal with. This assistance should be a
part of the overall intervention, and not seen as an optional “add-on” either by the patient or by
the clinician. The patient should understand the importance of continued contact with the clinician
and should be made to feel that contact is not only acceptable, but is also expected. It is too easy
for a patient to feel unable to recontact, especially if a lapse occurs. Yet this is the critical time that
requires assistance be available. 
CONTENT AND FORMAT OF AFTERCARE
A highly structured approach to scheduling aftercare increases the likelihood of maintaining
abstinence. [188]. In this study, aftercare consisted of individual problem-oriented treatment sessions.
Patients had aftercare sessions scheduled on a calendar, which they were instructed to display
prominently. They were instructed to attend aftercare regardless of drinking status and to reschedule
missed appointments. A structured aftercare program is more effective than assistance on request.
[189], [190] The structured approach in this instance significantly reduced the risk of relapse, decreased
self-reported crime, and assisted unemployed persons to find employment. 
Group aftercare is probably as effective as individual delivery. The content of aftercare depends
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upon the type of intervention used initially if the follow-up is to take the form of booster sessions,
or it is determined by the problems and issues that arise for the patient within the post-intervention
period. If the aftercare is run on an individual basis there is room for tailored problem solving
approaches, and this has advantages. Run on a group basis, aftercare is less tailored but allows
patients to form important support networks and to learn from each other’s mistakes and successes.
Relapse prevention strategies can form an important part of this aftercare and it allows lapses to
be dealt with without becoming relapses. Self-help can be integrated, but it is recommended that
there be a structure to the aftercare just as there needs to be to the intervention. The mix of self-
help and structured professionally run aftercare in the McAuliffe and Ch’ien (1986) study provides
a useful model for those agencies that wish to incorporate both a self-help and a relapse prevention
approach. [190]
SUMMARY OF EVIDENCE: EXTENDED CARE LEVEL OF EVIDENCE
Factors involved in long term recovery include treatment retention, III-1
social support networks, and assertive aftercare and follow-up.
Assertive, structured aftercare is more effective in reducing relapse II
than aftercare on request.
Evidence from natural recovery studies highlights the importance III-1
of social support and an intact sense of self-worth in maintaining 
controlled drinking or abstinence.
Voluntary participation in AA meetings may assist clients to III-1
maintain abstinence or reduce alcohol intake.
Coerced attendance at AA meetings is likely to be counterproductive. III-2
Those with higier network support for drinking may benefit most III-1
from AA participation.
RECOMMENDATIONS: EXTENDED CARE STRENGTH OF 
RECOMMENDATION
Attention should be given to the client’s retention in treatment Strong
and social support networks.
Aftercare should be structured and assertive, with follow-up of Strong
missed appointments.
Clients who show signs of dependence on alcohol should be Moderate 
made aware of the service offered by meetings of Alcoholics 
Anonymous (AA). Mandated AA participation is not recommended.
Conventional AA meetings should not be viewed as treatment Moderate
for alcohol dependence.
Chapter 11: Interventions for specific client
groups.
C
H
A
P
T
E
R
 11
S
p
ecific clien
t g
ro
u
p
s
Guidelines for the Treatment of Alcohol Problems   151
C
H
A
P
T
E
R
 11
S
p
ecific clien
t g
ro
u
p
s
Chapter 11: Interventions for specific client groups 
CHAPTER AIM
The aim of this chapter is to highlight specific treatment needs of 
• adolescents and young adults
• clients with cognitive impairment.
• clients with comorbid disorders
• men and women
• Indigenous clients
Although the interventions described above are recommended for all clients - taking into
account the severity of the alcohol problem, the treatment goal, and other indications from the
assessment - certain groups have specific needs that should be addressed in the treatment
program. The following notes, therefore, are in addition to the general recommendations. 
Adolescents and young adults 
The adolescent years are a period for experimentation, socialisation and engaging in high-risk
substance use behaviours. [191] Alcohol consumption is now occurring earlier in adolescence. Binge
drinking and deliberate drinking to become intoxicated is common, with 11.7 percent of those
aged 14 to 19 years and 14.7 percent of those aged 20 to 29 years drinking at risky or high risk
levels. [6]
ASSESSMENT
The DSM-IV criteria for alcohol use disorders may have limitations when used with adolescents. [192]
Some symptoms have a very low prevalence in adolescents, that is, withdrawal and alcohol-related
medical problems, which generally emerge only after several years of heavy drinking. Other
symptoms such as hazardous use and alcohol-related legal problems are highly correlated to male
gender, increased age and symptoms of conduct disorder. Some symptoms such as tolerance to
alcohol may have low specificity for adolescents. 
DSM-IV alcohol symptoms have been found to develop in three distinct stages among adolescents,
with some dependence symptoms developing before some abuse symptoms. [193] During the first
stage, which generally occurs after three to four years of exposure to alcohol, adolescents typically
develop three dependence symptoms: tolerance, drinking greater amounts or for a longer period
of time than intended and spent more using alcohol; and two abuse symptoms: role obligation
problems and social problems.
The second stage is characterised by three dependence symptoms: unsuccessful attempts to quit
or cut down on drinking, reduced activities because of alcohol use and continued use despite
physical or psychological problems; and three abuse symptoms: blackouts, hazardous use and
alcohol-related legal problems. This stage of adolescent alcohol symptoms is often described as
“psychological dependence”.
The third stage is characterised by the dependence symptoms of withdrawal. This stage is often
referred to as “physiological dependence” of the adolescent alcohol symptoms.
These findings suggest that a flexible approach to diagnosis and treatment is needed with adolescent
drinkers. Whilst some adolescents may not meet strict diagnostic criteria for an alcohol use disorder,
this should not be a barrier to treatment. 
The differences between adult and adolescent problem drinkers may have important implications
for treatment. [194] These differences include shorter drinking histories, more polydrug use, greater
binge drinking, rapid social and physical changes and a wider range of co-existing life problems
such as homelessness, poor performance at school, difficult parental relationships and low
employment prospects, and a familial history of heavy alcohol and drug use. [194, 195] 
For information about assessment methods and instruments, refer to Chapter 3: Screening and
assessment. 
ENGAGING ADOLESCENTS IN TREATMENT
Engaging adolescents in treatment is a critical issue, given their low treatment retention rates. The
Clinical Practice Guidelines: Depression in Young People [196] recommend a number of useful
strategies for clinicians to engage adolescents in treatment. 6
TREATMENT 
In comparisons of treatment settings and types for adolescents, few differences in outcome have
been found. [194, 197, 198] One study evaluating inpatient and outpatient treatment found that better
outcomes were obtained with longer treatment retention, although a short stay in treatment was
better than no treatment at all. [194]
Research with adolescents for substance use and other disorders, , mood disorders suggests that
cognitive behavioural therapy (CBT) may be the treatment of choice. Relaxation therapy, therapeutic
support groups, social skills training, interpersonal therapy, and family therapy may also be effective.
[196]
Brief and motivational interventions appear to be effective for adolescent heavy or binge drinkers,
and have been useful in emergency department, high school, and college settings. 
One review of an Australian adolescent residential treatment facility found that more than 50 percent
of female clients of an adolescent drug and alcohol treatment facility have experienced sexual
abuse. Seventy five percent of admitted clients had either attempted or contemplated taking their
own life. Thirty percent were living on the street, and 18 percent in a refuge, and most of their
clients had left school in or before year nine. [195] There may be comorbid mental health disorders
that require attention, and assessment should be especially careful to detect these problems. Risky
drinking may interfere with the developmental life experiences of the young person, and therefore
treatment is also aimed at teaching appropriate skills and compensating for skills deficits. 
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6 see pages 46 to 51, http://www.health.gov.au/nhmrc/publications/pdf/cp37.pdf
The implications of this include:
• Suicide risk should be assessed in all adolescent clients presenting with alcohol-related
problems or signs of depression
• Adolescent drinkers may be more chaotic than many adult drinkers. Therefore harm reduction,
outreach and crisis intervention will be a priority. Office-based therapy is not always be
appropriate.
• Family members should be included in some sessions if possible, to deal with
family/relationship issues.
• Brief interventions suit some adolescent drinkers who are in the early stages of their drinking
pathway, and are a critical part of reducing the risk of ongoing alcohol problems. However,
many young people will do better by forming ongoing relationships with counsellors. They
may need to be encouraged to return when they want to or need to. 
• A developmental approach of tolerance and acceptance accompanied by clear boundaries, is
appropriate for many adolescent clients.
• Polydrug use is the norm among adolescent problem drinkers so other drug use should be
assessed, and where necessary, addressed.
• Problem-solving, social, coping, vocational, educational and other life skills training may be
helpful in preventing relapse once the client has stabilised.
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SUMMARY OF EVIDENCE: ADOLESCENTS AND YOUNG ADULTS LEVEL OF EVIDENCE
Many adolescents do not fit DSM-IV criteria for alcohol use III-1
disorders, even though they may still be experiencing 
negative physical, social, educational and vocational 
consequences because of alcohol.
There is no evidence to suggest that any one form of IV
treatment or treatment setting is superior for adolescents 
with alcohol problems. However, research in other fields 
suggests that CBT may be the treatment of choice. 
Brief and motivational interventions help to reduce alcohol II
consumption among adolescent heavy or binge drinkers, 
across a range of treatment settings.
RECOMMENDATIONS: ADOLESCENTS AND YOUNG ADULTS STRENGTH OF 
RECOMMENDATIONS
Given the limitations of DSM-IV criteria for alcohol use Strong
disorders with adolescents, a flexible approach to diagnosis 
and treatment is needed. Whilst some adolescents may not 
meet strict diagnostic criteria for alcohol dependence or 
abuse, this should not be a barrier to treatment.
Clinicians should focus on building and maintaining a Strong
relationship with adolescent clients through outreach, 
crisis intervention and harm reduction activities, and 
the use of an empathetic, non-judgemental, developmental 
approach to counselling.
Brief and motivational interventions help to reduce alcohol Strong
consumption among adolescent heavy or binge drinkers,
across a range of settings.
Younger drinkers who require more intensive intervention Strong
may have different treatment needs to older drinkers. These 
needs should start to be identified during the assessment 
phase, and may include crisis intervention, assertive 
outreach, and building social support networks.
The recommended psychological treatment is CBT. Other Moderate
potentially useful treatments include social skills training, 
family therapy, therapeutic support groups, and 
interpersonal therapy.
Cognitive impairment
Although the examination of the effect of cognitive functioning on treatment outcome is in its early
stages, several recommendations can be made. [199] Many studies suggest that impaired cognitive
functioning is related to poorer treatment outcome, particularly for treatments that require the
acquisition of new skills. Thus, a brief assessment of cognitive functioning should be an integral
part of the assessment procedure and results should be used to guide treatment planning. [200]
If significant impairment is suspected, a more thorough assessment by an appropriately qualified
professional is indicated. Where severe cognitive impairment is present, treatment in an inpatient
facility may be more effective than outpatient treatment. [107] It should be noted that impairment
can improve once drinking is stopped.
q
• Screening for cognitive deficits should be an integral part of the assessment procedure.
• Where cognitive impairment is confirmed, treatment elements that require heavy
cognitive processing should not be employed as they are likely to be ineffective. [199] 
• Information presented to patients should be concrete and patients should be
given opportunities to practise behaviours taught.
Although it has been recognised for some time that many persons who suffer from risky drinking
and alcohol dependence also suffer from cognitive impairment, there is little evidence on which
treatments are most effective. Nevertheless, level of cognitive functioning should be used to guide
treatment planning. Even subtle cognitive deficits could affect how treatment effectiveness in a
number of ways. 
Firstly, people who suffer from alcohol abuse or dependence may have difficulty processing all
the relevant information about their problem and may be inflexible about changing behaviour.
[199] It is important that the clinician realises that this inflexibility results from an inability to
understand the need to change, rather than denial of a problem and refusal to change behaviour.
In these situations, particularly where cognitive deficits are temporary, different treatment
approaches may be used to engage the person in treatment. 
ENGAGING THE CLIENT IN TREATMENT 
Many of the following strategies apply to all clients. However, they may be particularly important
for engaging patients who suffer from cognitive deficits. 
The following strategies may increase the client’s engagement in treatment: 
• Providing information to the client about treatment
The client may be more likely to enter treatment if they understand what treatment will
involve, the process of treatment, and what they will be required to do. 
• Discussing different treatment options with simple explanations 
Although clients suffering from cognitive impairments should only be offered treatment
interventions, which do not require complex cognitive processing and keep information
and tasks concrete, the different options available to them should be discussed. Where the
clinician judges that the client is capable of making a decision, the client should be
involved in deciding which treatment to partake in. 
• Establishing a positive relationship with the client by:
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3 Keeping information simple and structured without being patronising.
3 Adopting an empathetic, non-judgemental, and non-authoritarian approach.
3 Listening carefully to what the client has to say.
3 Scheduling sufficient time for consultations.
3 Treating clients with respect.
3 Respecting confidentiality except where there is a threat to life or in cases of abuse.
• Maintaining contact
Maintaining contact with clients with cognitive deficits is very important. To increase the
likelihood that clients attend appointments, clinicians should:
3 Ring before a consultation to remind the patient they have an appointment.
3 Keep the appointment at the same time on the same day to decrease the likelihood
forgetting.
3 Ring if an appointment has been forgotten and arrange an alternative time.
3 Refer the patient to aftercare once treatment has been completed. 
Cognitive deficits can also affect treatment by limiting the patients ability to effectively express
their thoughts and feelings and to understand communication from the clinician. [199] The clinician
should keep all communication as simple as possible, and repeat information several times. The
clinician should frequently check: 
• That the client understands what is being said by the clinician.
• That the clinician understands what the client is saying.
Cognitive impairment can impair motivation, attention span, the capacity to evaluate situations
critically and the ability to acquire new skills, but they can and often do improve with a period of
abstinence from alcohol. [199] Therefore, the possibility of improvement in cognitive functioning
should be taken into account by allowing a sufficient period of abstinence from alcohol to elapse
before finalising treatment planning. Interventions during the early stages of treatment may need
to be kept relatively simple until or unless it is apparent that the client can cope with more complex
information. Where cognitive impairment is apparent, treatment elements that require heavy
cognitive processing should not be used as they are likely to be ineffective. [200] Information should
be concrete and clients should be given opportunities to practise behaviours taught. 
There is some evidence that cognitive impairment is associated with an increased risk of relapse.
[200, 201] To avoid the chance of relapse, cognitively impaired patients should participate in psychosocial
relapse prevention or be prescribed a pharmacotherapy (see Chapter 9: Relapse prevention for
details). 
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SUMMARY
Although evidence about the effect of cognitive deficits on treatment outcome is limited, available
research indicates that treatment outcome may be adversely affected by cognitive impairment. Cognitive
deficits are associated with an increased risk of relapse. There is less evidence about which treatments
are more or less effective. However, one viable explanation is that poor treatment outcome is because
of an inability of cognitively impaired patients to process the information imparted in therapy. Therefore,
treatments that are simple, structured, and require less cognitive processing are thought to be more
effective for patients with cognitive deficits.
SUMMARY OF EVIDENCE: COGNITIVE IMPAIRMENT LEVEL OF EVIDENCE
Cognitive impairment adversely affects treatment outcome. III-2
Cognitive impairment is associated with an increased risk of relapse. III-2
Cognitively impaired patients have better outcomes with treatments III-2
that require little cognitive processing, are simple and well structured. 
RECOMMENDATIONS: COGNITIVE IMPAIRMENT STRENGTH OF 
RECOMMENDATION
A brief assessment of cognitive functioning should be a routine part Strong
of assessment upon treatment entry.
More detailed assessment should be carried out where brief Strong
intervention suggests that a patient suffers from significant 
cognitive deficits.
Where cognitive impairment is confirmed, information presented Strong
to patients should be concrete and patients should be given 
opportunities to practise behaviours taught treatment.
Cognitively impaired patients should be engaged in treatment by Moderate
the clinician by: 
· providing information about treatment.
· discussing different treatment options.
· establishing a positive relationship.
· maintaining contact with the client. 
The clinician should frequently check that the client understands Strong 
what is being said, and that the clinician understands what the 
client is saying.
The possibility of improvement in cognitive functioning should be Strong
taken into account by allowing a sufficient period of abstinence 
from alcohol to elapse before finalising treatment planning.
Cognitively impaired patients should be taught relapse Moderate
prevention strategies 
Comorbid disorders
Little controlled research has been conducted to evaluate the effectiveness of treatment for comorbid
clients, despite the fact that a sizeable proportion of alcohol dependent clients have a comorbid
mental disorder. In total, six percent of the National Survey of Mental Health and Well Being sample
met the criteria for an alcohol use disorder. Just under two percent (1.9 percent) met the criteria
for alcohol abuse, and 4.1 percent met the criteria for alcohol dependence. Of this group about
one in five (20 percent) met the criteria for an anxiety disorder and nearly one in four (24 percent)
met the criteria for an affective disorder (mood disorder). Other disorders associated with alcohol
dependence include other substance use disorders, and psychosis. [202]
ASSESSMENT 
Given the high prevalence of other mental disorders among patients with an alcohol use disorder,
it is essential that checking for particularly common problems such as anxiety and depression
symptoms is a routine part of the assessment. The Beck Depression Inventory and the Beck Anxiety
Inventory are short but useful instruments for this purpose. [67, 68] The Kessler 10 Symptom Scale is
a scale of psychological distress, suitable for use as an outcome measure in people with anxiety
and depressive disorders. It is likely to become the standard scale for use by general practitioners
and mental health workers, since its use does not require the practitioner to have specific qualifi-
cations. 
The AUDIT appears to be a suitable screening tool for identifying risky, problem and dependent
alcohol consumption among psychiatric patients. [203] Assessment for comorbidity is covered in more
detail in Chapter 3: Screening and assessment.
PSYCHOSOCIAL INTERVENTIONS
Several treatment issues arise with comorbid disorders. Should treatment be integrated, parallel or
adjunctive? If the latter, which disorder should be treated first? What combination of therapies
should be used? What implications does the order of onset have for treatment? The research to
date, while providing some clues, does not adequately answer these questions. 
Cognitive behavioural therapy (CBT) appears to be more beneficial than general counselling for
drinkers with comorbid depression. [204] Project MATCH data suggests that CBT was more effective
than 12-step facilitation (TSF) for female, alcohol dependent patients with comorbid social phobia.
For socially phobic males, there was a trend towards better outcomes in the TSF group. [205]
Integrating motivational interviewing, CBT and family intervention with routine psychiatric care
produced greater benefits for patients with comorbid schizophrenia and substance use disorders
than routine psychiatric care alone. [206] At 12-month follow-up, the integrated treatment group had
better general functioning, a reduction in positive symptoms, and an increase in the percentage
of days abstinent from alcohol or drugs.
Patients with a serious mental illness and a substance use disorder who received an integrated
mental health and substance use treatment program had superior outcomes to patients assigned
to a standard hospital treatment program. [207]
Differentiating between primary and secondary depressive disorders may have implications for
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treatment strategies, since secondary depression often abates once the alcohol use disorder is
addressed. [208] Almost 42 percent of dependent drinkers in Schuckit’s study met criteria for a
diagnosis of a major depressive episode at some time during their alcohol dependence. Of those,
more than 60 percent reported a substance-induced depressive episode. Those with primary
depression had a higher prevalence of independent depressive disorders in first-degree relatives.
They were also more likely to be married, Caucasian, and female, or if male, to have a stable marital
history. They typically had experience with fewer drugs and less treatment for alcohol problems,
and were more likely to have attempted suicide. However, the clinical presentation of symptoms
did not differ substantially between substance induced and primary depressive disorders, so
determining the order of onset may be the best way to distinguish between primary and secondary
depression. 
According to Kavanagh, “Effective treatments focus on developing and maintaining motivation and
promote re-entry after lapses. Studies with stronger effects tend to have assertive case management
and (in the relatively chronic or severely affected populations usually studied) they extend over
several months.” (p. 63, [209])
PHARMACOTHERAPIES
There is no sound evidence for the capacity of SSRIs to reduce alcohol intake in the longer term.
Although they do not seem to reduce alcohol consumption, [210, 211] they have been effective in
reducing depression scores in alcohol dependent patients. [212]
Only one trial to date has specifically examined the effectiveness of SSRIs with comorbid patients.
Cornelius et al (1997) administered fluoxetine or placebo to a randomised group of 51 alcohol
dependent patients diagnosed with major depressive disorder, over a 12-week period, in an inpatient
setting. [213] Depression and alcohol consumption ratings were collected weekly during the 12-week
period. Both depressive symptoms and total alcohol consumption over the trial were significantly
lower in the fluoxetine group than in the placebo group. However, other studies have found either
little effect on alcohol consumption, or that the effect dissipates quickly.
Buspirone, an anxiolytic, has been tested in one controlled trial with anxious alcohol dependent
outpatients with some success. Buspirone patients were more likely to remain in treatment for the
12 weeks, had reduced anxiety, a slower return to heavy alcohol consumption, and fewer drinking
days during the follow-up period. [214]
A controlled trial with desipramine (a tricyclic antidepressant) showed reduced relapse in alcohol
dependent patients diagnosed with major depression, but not in those without major depression.
[215] A controlled trial found that nortriptyline, a noradrenergic antidepressant, reduced drinking in
patients diagnosed with antisocial personality disorder, but not those patients with affective/anxiety
disorders or those without a comorbid disorder. [216]
Finally, there is limited evidence that among schizophrenic patients, two atypical antipsychotics
(risperidone and clozapine) may reduce alcohol misuse, smoking, and possibly some other
substance misuse. [217]
Currently, only naltrexone and acamprosate are available under the Pharmaceutical Benefits Scheme
for alcohol dependence.
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SUMMARY OF EVIDENCE: COMORBID DISORDERS LEVEL OF EVIDENCE
The AUDIT is an appropriate alcohol screening tool for 
psychiatric populations. II
Patients with alcohol dependence or abuse are likely to have depression and II
anxiety symptoms or disorders. Some symptoms may abate once alcohol 
consumption is reduced or is ceased. However, some patients present with 
comorbid disorders which require specific intervention (see next point).
Cognitive behavioural therapy appears to be effective in treating II
clients with comorbid disorders. 
Psychosocial interventions above and beyond normal hospital II
treatment may assist those with schizophrenia.
To date, there is equivocal evidence on the use of SSRI antidepressants II
as first-line therapy for reducing alcohol consumption in patients with 
comorbid mood or anxiety disorders. This is a separate issue to their 
use in treating mood or anxiety disorders.
There is limited evidence that some other pharmacotherapies, for II
example, desipramine, buspirone, and nortriptyline may reduce alcohol 
consumption in clients with anxiety or mood disorders. More evidence is 
required before a strong recommendation can be made.
There is limited evidence that risperidone and clozapine (atypical IV
neuroleptics) may reduce alcohol misuse among schizophrenic patients. 
More evidence is required before a strong recommendation can be made.
RECOMMENDATIONS: COMORBID DISORDERS STRENGTH OF 
RECOMMENDATION
The AUDIT is recommended for screening psychiatric populations. Strong 
Assessment for comorbid disorders should take place once the client’s Strong 
withdrawal syndrome has diminished, since some anxiety and depressive 
symptoms may abate once alcohol consumption is reduced or ceased. 
Comorbid mood and anxiety disorders which do not abate after alcohol Strong
withdrawal is complete should be treated with integrated/concurrent 
cognitive behavioural therapy for the cormorbid disorder. 
Alcohol dependent patients with comorbid anxiety should be considered Moderate
for treatment with buspirone, depending upon the severity and nature 
of their symptoms.
Alcohol dependent patients with major depression should be considered Fair 
for treatment with desipramine, depending upon the severity and 
nature of their symptoms.
Schizophrenic patients who are risky drinkers should be considered for Fair 
treatment with clozapine or risperidone, depending upon the severity
and nature of their symptoms.
Alcohol dependent patients with antisocial personality disorder should Fair
be considered for treatment with nortriptyline, depending upon the 
severity and nature of their symptoms.
Gender
Much of the research investigating patterns of alcohol use and treatment effectiveness has been
conducted in studies focusing either exclusively or primarily on men. [218] However, there is no
reason to believe that treatment needs of men and women are the same. There may be different
factors associated with risky drinking and alcohol dependence in men and women, and thus
treatment may need to adapt according to the gender of the client. 
Although risky drinking and alcohol dependence is more common among men than women, a
substantial proportion of those who consume alcohol in a risky manner are women. However,
most of the research on treatment effectiveness includes only men, and studies that include both
men and women often fail to assess gender differences in outcome. Hence, less is known about
the characteristics, treatment needs and treatment outcomes of women with alcohol problems than
these issues in men. 
Studies that have examined the characteristics of women with alcohol and other drug problems
suggest that these women may be a distinct group. [218] Because of differences in metabolism, where
men and women drink at the same rate, women are at higher risk for liver disease, brain damage,
heart disease, violent victimisation, and traffic fatalities. [219] Further, risky alcohol consumption in
women who are of childbearing age is particularly problematic as risky alcohol consumption can
cause harm to the foetus. 
A study of the characteristics of women who receive treatment for alcohol or other drug
dependence in Australia reported that more than half of the women were mothers, of whom about
one-third did not have custody of their children. [218] Polydrug use was the norm, although alcohol
use was the primary drug of concern in 20 percent of the sample. Further, a sizeable proportion
of the sample in this study suffered from physical and psychological health problems, particularly
comorbid anxiety, depression and eating disorders. Almost three-quarters of the sample had
experienced physical or sexual violence at some stage in their lives, with 37 percent having been
sexually abused in childhood. Thus, women with alcohol problems are likely to present to treatment
with a range of problems. Although clinicians cannot be expected to possess the expertise to
address all of these issues, the issues should still be identified by clinicians. 
In a study of the treatment needs of women, Australian women who had received treatment for
alcohol and other drug problems were asked about their experience(s) in treatment, aspects of
treatment that they found helpful and aspects perceived as needing improvement. [220] Despite the
women’s general satisfaction with the services they had received, recommendations about the way
in which services address the special needs of women can be made.
First, agencies should try to improve the recruitment of women to their services. Many barriers to
seeking treatment were identified. [220] Apart from perceived negative attitudes of general society,
and feelings of guilt and shame, many women were unaware of available services and felt that
agencies could improve recruitment of women. Possible methods included improving outreach,
setting up referral networks, advertising facilities specifically targeting women who may be unaware
of available treatment services, and the provision of more detailed information about the services.
These methods would increase the awareness of women with problems of treatment services
available to them, and increasing knowledge of what treatment involves, may decrease any
Guidelines for the Treatment of Alcohol Problems   161
C
H
A
P
T
E
R
 11
S
p
ecific clien
t g
ro
u
p
s
reservations or fears women may have about entering treatment. 
The provision of a safe therapeutic environment is essential for both men and women, as the
prevalence of physical and sexual abuse is high, particularly among women with alcohol problems.
[220] Among the sample in this study, almost three-quarters had experienced physical or sexual
violence at some stage in their lives and one-quarter had been sexually or physically harassed
while attending a treatment service. Staff should be aware of the potential risks of sexual harassment
within residential units and of the need to ensure that clients are protected. Further, women who
are admitted to residential or inpatient facilities should have single residential facilities, which
would ensure privacy and freedom from sexual harassment. 
Treatment agencies should offer both men and women the opportunity to receive information
about, and address health and other issues such as depression, anxiety and sexual and physical
assault. [220] Staff should be trained to address these issues in a sensitive and appropriate manner,
and offer referral to a service, which specialises in the area of concern. 
Although it may not always be possible, in treatment agencies where there are clinicians of both
gender available to give treatment, patients should be given the choice of clinician gender. 
There is a need for treatment providers to be sensitive to issues particular to women with alcohol
problems, provide them with a range of treatment options, and refer women to other specialist
services where necessary and appropriate. 
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SUMMARY OF EVIDENCE: GENDER LEVEL OF EVIDENCE
Studies that have examined the characteristics of women with III-2
alcohol and other drug problems suggest that these women have
a range of characteristics which make them distinctive from men. 
Because of differences in metabolism, where men and women III-2
drink at the same rate, women are at higher risk for liver disease, 
brain damage, heart disease, violent victimisation, and traffic fatalities.
Polydrug use and comorbid psychological disorders are III-2
common among risky and dependent female drinkers. 
There appear to be gender differences in treatment outcome, with II
women having slightly better results than men in the first twelve 
months after treatment, and men having slightly better outcomes in 
follow-ups longer than twelve months.
There is evidence that brief interventions are effective in II
reducing alcohol consumption in excessive female drinkers.
There is no evidence suggesting which treatment modalities 
are effective for risky and dependent female drinkers.
RECOMMENDATIONS: GENDER STRENGTH OF 
RECOMMENDATION
Clinicians need to be aware of and sensitive to issues Strong
particular to women with alcohol problems.
Treatment agencies should try to improve the recruitment of Moderate
women to their services by improving outreach, setting up 
referral networks, advertising facilities specifically targeting women, 
and providing more detailed information about services. This would 
increase women’s awareness of treatment services available, and 
may decrease any reservations or fears about entering treatment
All clients should be provided with a safe therapeutic Strong
environment, as the prevalence of physical and sexual abuse
is high, particularly among women with alcohol problems.
Treatment agencies should offer all clients the opportunity Strong
to receive information about, and address health and other 
issues such as depression, anxiety and sexual and physical assault.
There should be a range of services available to women. Moderate
Women should be referred to other specialist services where Strong
necessary and appropriate.
Where possible, clients should be given the option of having Moderate
a clinician of the same or opposite gender, as preferred. 
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Indigenous clients
The harms caused to Australian Indigenous communities by risky alcohol consumption are evident
in their higher rates of alcohol-related deaths and greater hospitalisation rates, compared to the
non-Indigenous population. This section provides an overview of some of the issues to be
considered in providing treatment to Indigenous drinkers. The National Recommendations for the
Clinical Management of Alcohol-Related Problems in Indigenous Primary Care Settings provides
more detailed advice on the use of direct questioning, overcoming barriers to discussing alcohol
within Australia’s Indigenous cultures, screening and brief intervention, and treating physical and
psychological comorbidities. [5]
The key issues from the recommendations include:
• A public health approach is required, that is, interventions at a community and systemic
level, to address the social and economic drivers of alcohol misuse. Relapse rates among
Indigenous clients who have completed treatment are likely to be high when clients return
to a poor socioeconomic situation. Treatment services therefore need to be supported by
effective, culturally appropriate interventions at the population level. This should include
education about the effects of drinking and the availability of treatment and interventions
aimed at improving the socio-economic situation for Indigenous people.
• A person’s location affects drug choice and availability, drinking styles and consumption rates.
For example, drinkers in a “dry” community are more likely to binge drink irregularly,
whereas a person living in a city may have more regular drinking patterns.
• Cultural sensitivity should not be confused with treatment efficacy. Brief interventions may
still be effective with Indigenous drinkers, but ways of communicating and knowledge of
issues such as gender roles are important issues in their implementation. Hunter, Brady and
Hall (2000) [5] state that it would be counterproductive to be prescriptive when the lifestyle
and socio-cultural norms of Indigenous Australians are so diverse, but suggest some
readings on cross-cultural issues for those who are working with Indigenous clients,
including: 
3 Brady, M. (1998). The Grog Book: Strengthening Indigenous Community Action on Alcohol.
Available from Government information shops in each State or Territory, Cat. No. 9807357.
3 Hollinsworth, D. & Cunningham, J. (1998). Indigenous Health: Cultural Awareness Program
for Medical Education. Produced by Yunggorendi First Nations Centre for Higher Education
and Research, Flinders University, South Australia.
3 Eckermann, A. (1992). Binang Goonj. Bridging Cultures in Aboriginal Health. University
of New England Press, Armidale.
3 For more readings, see Hunter, Brady & Hall (2000). [5]
• Rates of general practitioner consultations are comparable across Indigenous and non-Indigenous
Australians. However, Indigenous people are three times more likely to attend an outpatient clinic
than go to a doctor’s practice. There is great potential for opportunistic intervention by medical
staff in hospitals, and in other settings such as in sobering-up centres, workplaces, correctional
facilities, and community health services. The recommendations provide information on and
examples of non-judgemental brief interventions. Also see Chapter 7: Brief interventions. Risky
and high-risk drinkers who are not dependent may respond to low-intensity intervention.
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• Although the recommendations suggest the use of the AUDIT for screening alcohol problems,
subsequent qualitative research by Brady et al. (2002) [221] suggests that the AUDIT may have
limited acceptability with Indigenous health workers: it was thought to be intrusive, question 8
(how often during the last year have you had a feeling of guilt or remorse after drinking?)
sometimes needed clarification, and health workers believed that clients sometimes “fudged”
their responses. The authors suggest instead using “two carefully worded questions on the
frequency of binge drinking, and average daily consumption.” p. 378, [221]. Brief intervention
seemed to be culturally appropriate in this particular urban Aboriginal health service. It should
be noted that Indigenous clients were not interviewed about their thoughts on the AUDIT. There
was also evidence that the health workers became increasingly comfortable with the AUDIT
questions over time.
• This same article identified a number of constraints to delivering brief interventions in Indigenous
primary-care settings: lack of time, patients who became annoyed when alcohol was raised as an
issue in addition to their presenting problem, “...the severity of illness and the complexity of the
physical, social and psychological problems with which patients present.” p. 378, [221]. There was
some client resistance to intervention, however the authors note that this is probably not specific
to Aboriginal settings.
• Experience suggests that clinics in Indigenous settings are often visited by intoxicated individuals.
Some intoxicated individuals may present with an insignificant complaint, but may have other
concerns they do not volunteer. Communication with intoxicated clients should be direct, in a
calm and slow manner, dealing with one thing at a time. It is not the right time to engage in
complex health promotion activities.
• Intervention with alcohol dependent clients who present with other problems should deal with
the client’s primary clinical needs and at the same time draw attention to the contribution of
alcohol to the client’s problems. Developing and maintaining a non-judgemental and honest
relationship is essential to keeping the client engaged in treatment. Dependence indicates
abstinence as a goal.
• Medical comorbidity among Indigenous drinkers is common and may include cardiovascular
disease, hypertension, respiratory disease, diabetes, liver disease, neurological disorder, for
instance, seizures, injury and poisoning, and sexually transmitted infections. Risky alcohol
consumption may be associated with violence and sexual assault. Management of comorbid
illness may be neglected because of the clinician’s reactions to the client’s alcohol problem, or by
the fatalistic belief that nothing can be done.
• Psychiatric comorbidity, such as anxiety, depression, psychosis is also common. Self-harm and all
threats of self-harm should be treated seriously. Primary-care practitioners are advised to develop
close working relationships with the relevant area mental health service.
• Not withstanding the high rates of comorbidity among Indigenous clients, and the
exclusion of such clients from much of the research, it seems reasonable to assume that
research on pharmacotherapies for alcohol dependence, that is, naltrexone, acamprosate
and disulfiram) will apply to Indigenous people. However, increasing compliance with the
medication may entail dealing with a slightly different set of issues which will, in turn,
depend upon the client’s cultural environment. 
• Practitioners should attempt to remain engaged with drinkers, whether or not the drinking
behaviour changes. Many clients do not change their behaviour immediately. In the
meantime, support, advice and help can be offered to the client’s family and community in
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providing a safe environment while not condoning harmful drinking or associated
behaviours. If the client does reduce or stop drinking, they may feel worse for a time. The
practitioner’s focus should be on helping deal with these, rather than insisting that not
drinking always leads to better outcomes.
The services available for Indigenous clients need to provide a greater quality and diversity of
treatment options. Particularly in rural areas, one model of treatment (12-step facilitation or AA-
based residential treatment) tends to dominate the current services. 
RECOMMENDATIONS: INDIGENOUS CLIENTS STRENGTH OF 
RECOMMENDATION
Relapse among Indigenous clients who have completed treatment Moderate 
is likely to be high when clients return to a poor socioeconomic 
situation. Treatment services therefore need to be supported by 
effective, culturally appropriate interventions at the population level.
Clients may present to health care clinics with minor complaints Strong 
without volunteering information about alcohol consumption. 
Carefully worded questions about the frequency of heavy drinking 
and average daily consumption can help to identify risky drinking.
Cultural sensitivity should not be confused with treatment efficacy. Moderate 
For instance brief interventions may still be effective with Indigenous 
drinkers, but ways of communicating and knowledge of issues such as 
gender roles are important issues in their implementation.
Increasing compliance with medication such as acamprosate and Moderate 
naltrexone may entail dealing with a slightly different set of issues 
which will, in turn, depend upon the client’s cultural environment.
There is great potential for opportunistic intervention by medical staff Strong 
in hospitals, and in other settings, such as in sobering-up centres, 
workplaces, correctional facilities, and community health services.
The services available for Indigenous clients need to provide a Strong 
greater quality and diversity of treatment options. 
Health care practitioners should seek to keep clients engaged in Strong 
treatment, whether or not the drinking behaviour changes. In the 
meantime, support can be offered to the drinker’s family and community.
Primary care practitioners are advised to develop close working Moderate 
relationships with the relevant area mental health service to help 
them deal with psychiatric comorbidity.
Communication with intoxicated clients should be direct, in a calm and Moderate 
slow manner, dealing with one thing at a time. It is not the right time to 
engage in complex health promotion activities.
Chapter 12: How to put it together
C
H
A
P
T
E
R
 12
H
o
w
 to
 p
u
t it to
g
eth
er
Guidelines for the Treatment of Alcohol Problems   169
C
H
A
P
T
E
R
 12
H
o
w
 to
 p
u
t it to
g
eth
er
Chapter 12: How to put it together
CHAPTER AIM
This chapter provides a basis for designing an intervention that is appropriate for different levels
of dependence and the severity/complexity of problems. 
There is a continuum of care from residential to non-residential, and from intensive to brief, and
from carefully structured approaches delivered by specialist professional drug and alcohol counsellors
through to less structured simple advice from primary health care workers. These components form
the overall strategy that now needs to be put in place to deal with alcohol problems in our society.
Figures 12.1 and 12.2 below provide an overview of the basic decision making process.
The time available is an important factor in determining the nature and the content of the
intervention. Beyond this parameter the severity and complexity of the presenting problem(s)
determine duration, setting and content. 
The following sections look at situations where there is:
• No time available to intervene with risky drinkers, for instance in emergency wards. 
• Brief treatment of risky drinkers, that is, hazardous and early stage problem drinkers
identified within a routine screening where the intervention is provided over a few
minutes.
• Brief treatment for those drinkers with more severe alcohol problems over a few
sessions. 
• Longer duration outpatient treatment over a large number of sessions, and over an
extended period, where the alcohol problems or dependence suggests the need.
• Inpatient/residential and day patient interventions for the most seriously affected and
dependent people. 
The emphasis throughout is on providing clinicians with a structured set of procedures that they
can use and that are thought likely to maximise the effect of the intervention of choice. 
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Screen for alcohol and
other drug use (chapter
3) 
Drinking beyond
recommended levels?
(Appendix 1)
Encourage continued
low 
risk use
FIGURE 12.1: SCREENING AND INTERVENTION FOR ALCOHOL PROBLEMS
Signs of dependence?
(Appendix 3)
Arrange for more 
intensive treatment
Drinking reduced to safe
levels?
Continue
to monitor
Brief intervention and
follow-up (Chapter 7)
See figure 12.2
for more detail
no
no
no
yes
yes
yes
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FIGURE 12.2: INTENSIVE TREATMENT FOR ALCOHOL DEPENDENCE
Assess severity &
complexity as per
Assessment and
Withdrawal 
(chapters 3 and 5)
Managed withdrawal
required?
Comorbid mental 
health problems needing
specialist treatment?
Start psychosocial
intervention 
(Chapter 8)
Moderate to high risk?
Monitor and use aftercare,
follow-up and treatment
retention strategies
(Chapter 10)
Assess relapse risk
(Chapter 9)
Client referred for 
more intensive assessment
and treatment
(Figure 12.1)
no
yes See withdrawal
management 
Chapter  5
Refer for specialist
mental health treatment 
(use case management)
Provide psychosocial
relapse prevention
strategies (Chapter 9)
Consider pharma-
cotherapies 
(Chapter 9)
no
yes
no
yes
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When there is no time available
In a number of settings there is no time available to screen and detect people with alcohol-related
problems, let alone provide an intervention for risky drinking, or alcohol dependence. The most
obvious example of such a setting is the accident and emergency wards of larger hospitals. In these
settings it is recommended that pamphlets be made available that set out the currently accepted
“safe” limits for alcohol consumption, and list the strategies for cutting back drinking, as well as
appropriate contact points for referral. 
If there is evidence of risky alcohol consumption from the clinical interview there should be a
notation to that effect made on the chart or record of the patient to allow later discussion of drinking
level, and/or referral for more specialist assistance, as seems necessary. These strategies should be
adopted in all general medical, health and welfare settings where it is not possible to deal with the
issue of risky drinking directly. 
RECOMMENDATIONS STRENGTH OF RECOMMENDATION
In those settings that do not allow for screening and Strong 
intervention with risky drinkers it is recommended 
that written material setting out the “safe” levels of 
alcohol consumption, methods for cutting back, and 
referral points, be made available. 
BRIEF, ONE SESSION, FACE-TO-FACE INTERVENTIONS
Frequently there is time for a brief single session face-to-face intervention, and for many risky
drinkers this is all that is required to alter drinking habits. In the context of these brief interventions
it is recommended that at a minimum there should be:
• screening and identification of risky alcohol consumption.
• clear and firm advice to cut down consumption. 
• description of the safe level of consumption. [34] 
• a follow-up visit.
It should be possible to deliver that intervention in a relatively brief period. In those settings where
there is more time to provide assistance, or where there is a specialist drug and alcohol counsellor
providing screening and intervention within a large health care facility: 
• The negative health effects of risky consumption should be described in a way that person-
alises them to the person being counselled, and an empathic counselling style should be
used. 
• There should be further brief assessment of the extent of the problem and the readiness of
the drinker to attempt to reduce consumption. 
• Methods of limit setting and general self-management procedures should be discussed. 
• If resources allow, a self-help manual/pamphlet should be made available.
• A follow-up visit or some other form of follow-up/referral should be organised. 
It is not appropriate in these settings to introduce complex explanations of interventions that require
some substantial time and effort in training, such as skills-based approaches. Similarly, the
assessment that can be conducted is necessarily brief. 
RECOMMENDATIONS STRENGTH OF RECOMMENDATION
In brief, one session, face-to-face interventions for Strong 
risky drinkers, it is recommended that there be clear 
advice to cut down to a “safe” level of alcohol 
consumption and that a follow-up visit arranged.
Where there is more time available to counsel the drinker: 
•The negative health effects of risky consumption 
should be personalised.
•Further brief assessment of the problem and the 
readiness to reduce consumption conducted and 
methods of limit setting and self-management 
should be set out.
A self-help manual made available. Strong 
For those whose risky consumption does not decrease, Strong 
it is recommended that referral for specialist 
assessment is offered. 
BRIEF SESSIONAL OUTPATIENT INTERVENTIONS
For many clients brief intervention over a few sessions, for example one session up to five sessions
will be all that is required, and often all that is wanted by the individual. In this circumstance the
treatment should incorporate all of the interventions that are described in Chapter 7: Brief
Interventions, and the following:
• An assessment of alcohol dependence and, if there is time, of other areas of the drinker’s
functioning, especially mental health status (see Chapter 3: Screening and Assessment). 
• Motivational interviewing if the drinker appears to be unsure or ambivalent about changing
the drinking behaviour (see Chapter 8: Psychosocial interventions).
• The identification of high-risk situations and provision of relapse prevention strategies,
including the identification of strategies, such as drink refusal skills to minimise the risk of
relapse (see Chapter 9: Relapse prevention). 
• Arrangement of a follow-up visit. 
RECOMMENDATIONS STRENGTH OF 
RECOMMENDATION
Outpatient interventions conducted over a few sessions should Strong
include those interventions that have been recommended for 
brief, one session, face-to-face interventions and: 
•Assessment of level of dependence and associated problems
•A motivational intervention based on the client’s readiness for change
•Assessment of high-risk relapse situations and provision of relapse 
prevention procedures 
•A follow-up appointment.
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Longer multi-session outpatient interventions
Where assessment or previous failures in treatment suggest the need, longer outpatient intervention
extended over multiple sessions is required. This form of intervention might occur for up to 15 or
more sessions, however no precise guide can (or should) be made about the length of intervention
required. In this circumstance the treatment should incorporate all of the interventions that are
described in the previous sections, and the following:
• A comprehensive assessment covering motivation to alter drinking patterns, pattern of
drinking, dependence on alcohol and need for a supervised detoxification,
psychological/psychiatric problems and disorders, and familial or interpersonal factors that
may be exacerbating drinking, and assessment of cognitive functioning if that is necessary
(see Chapter 3: Screening and assessment). 
• A motivational intervention and personalisation of the health effects of risky drinking,
especially if the drinker appears to be unsure or ambivalent about changing the drinking
behaviour (see Chapter 8: Psychosocial interventions).
• Referral for intervention for comorbid mental health problems that are detected if there are no
suitably skilled staff available in the agency to deal with such problems (see Chapter 11:
Interventions for specific client groups).
• Naltrexone or acamprosate should be considered for patients who are medically stable and
willing to comply with the medication. Pharmacotherapies should be used only as an adjunct
to a comprehensive treatment program.
• After the development of a client-centred relationship aimed to help the client to explore
methods of overcoming their dependence, the use of selected training in skills-based
approaches as necessary to deal with communication skills deficits, social skills deficits, lack
of assertiveness, relaxation or stress management problems, and relationship difficulties may
be helpful (see Chapter 8: Psychosocial interventions).
• An introduction to Alcoholics Anonymous (AA) may be discussed (see Chapter 10: Extended
care).
• Relapse prevention should be undertaken to minimise the risk of a return to problem drinking
(see Chapter 9: Relapse prevention).
• Scheduled aftercare or booster sessions should form an integral part of the intervention. 
RECOMMENDATIONS STRENGTH OF 
RECOMMENDATION
It is recommended that in the case of extended outpatient Strong
intervention that there be: 
•a comprehensive assessment
•referral for treatment of serious comorbid disorders
•introduction of pharmacotherapy if appropriate
•the development of a client-centred relationship and 
training in selected skills based approaches
•relapse prevention 
•referral to AA when there is a goal of abstinence
Aftercare, via scheduled booster or follow-up sessions, should Strong
be an integral part of the treatment package.
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Brief inpatient/residential withdrawal management
The guidelines for managing withdrawal from alcohol are set out in Chapter 5. Many brief inpatient
programs aimed at detoxification can provide some intervention for the drinker. Patient’s needs for
further intervention should be assessed after detoxification. A motivational interview incorporating
the personalisation of health effects should be conducted and the range of treatment options
available should be fully described to the drinker. Where the goal of abstinence seems appropriate
the drinker may be linked into an AA group that is suitable to his or her background and charac-
teristics. Thereafter the patient should be offered an outpatient or residential intervention as required,
based on the assessment. 
RECOMMENDATIONS STRENGTH OF 
RECOMMENDATION
It is recommended that withdrawal facilities should assess Strong
drinkers for further intervention, provide a motivational 
intervention where necessary, and describe the range of 
interventions available. 
Day patient and inpatient/residential interventions
For some clients, assessment indicates that a more intensive and extensive day patient or residential
intervention conducted over several weeks is required. This is the case where outpatient treatment
has repeatedly failed and where the severity of the problems indicates the need. The circumstances
wherein such an intervention is indicated are set out in Chapter 6. Where inpatient/residential
intervention is desirable, the treatment should incorporate all of the interventions that are described
in the previous sections, and the following:
• A comprehensive assessment covering motivation to alter drinking patterns, pattern of
drinking, dependence on alcohol and need for a supervised detoxification,
psychological/psychiatric problems and disorders, and familial or interpersonal factors that
may be exacerbating drinking, and an assessment of cognitive functioning if that seems
necessary (see Chapter 3: Post-withdrawal treatment setting). 
• A motivational intervention and personalisation of the health effects of risky drinking,
especially if the drinker appears to be unsure or ambivalent about changing the drinking
behaviour (see Chapter 8: Psychosocial interventions).
• Referral for intervention for comorbid mental health problems that are detected if there are
no suitably skilled staff available in the agency to deal with such problems (see Chapter 11:
Interventions for specific client groups).
• Naltrexone or acamprosate should be considered for patients who are medically stable and
willing to comply with the medication. Pharmacotherapies should be used only as an
adjunct to a comprehensive treatment program (see Chapter 9: Relapse prevention).
• After the development of a client-centred relationship aimed to help the client to explore
methods of overcoming their dependence, the use of selected training in skills-based
approaches as necessary to deal with communication skills deficits, social skills deficits, lack
of assertiveness, relaxation or stress management problems, and relationship difficulties may
be helpful (see Chapter 8: Psychosocial interventions).
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· An introduction to AA may be arranged (see Chapter 10: Extended care).
· Relapse prevention intervention should be undertaken to minimise the risk of a return to problem
drinking (see Chapter 9: Relapse prevention).
· A reintegration or “re-entry” phase that assists the drinker to make a transition from institutional
care to self-care in the community should be included. 
· Scheduled aftercare or booster sessions should form an integral part of the intervention, and
should include professionally delivered relapse prevention procedures plus self-help if
appropriate. 
RECOMMENDATIONS STRENGTH OF RECOMMENDATION
It is recommended that intensive day patient or Strong
residential intervention proceed along similar lines 
to outpatient treatment. It should involve: 
•comprehensive assessment
•referral for serious comorbid disorders
•introduction of pharmacotherapies if appropriate 
•training in selected skills
•relapse prevention 
•referral to AA when the goal is abstinence
There should be a re-entry phase to the intervention 
wherein the client is assisted in returning to his or her 
usual environment while not relapsing to drinking.
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Appendices
Appendix 1: Safe drinking levels
FOR RISK OF HARM IN THE SHORT TERM
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Low risk 
(standard drinks)
Risky 
(standard drinks)
High risk
(standard drinks)
Up to 6 on any one
day, no more than 3
days per week
7 to 10 on any one
day
11 or more on any
one day
Up to 4 on any one
day, no more than 3
days a week
5 to 6 on any one day 7 or more on any one
day
Males 
On any one day
Females
On any one day
FOR RISK OF HARM IN THE LONG TERM 
Low risk
(standard drinks)
Up to 4 per day
Up to 28 per week
Risky
(standard drinks)
5 to 6 per day
29 to 42 per week
High risk 
(standard drinks)
7 or more per day
43 or more per week
Males
On an average day
Overall weekly level
Up to 2 per day
Up to 14 per week
3 to 4 per day
15 to 28 per week
5 or more per day
29 or more per week
Females
On an average day
Overall weekly level
Appendix 2: DSM-IV diagnostic criteria for substance abuse
A. A maladaptive pattern of substance use leading to clinically significant impairment or distress,
as manifested by one (or more) of the following, occurring within a 12-month period:
a. recurrent substance use resulting in failure to fulfil major role obligations at work, school,
or home.
b.  recurrent substance use in situations in which it is physically hazardous (e.g. driving while
intoxicated).
c.  recurrent substance-related legal problems.
d.  continued substance use despite having persistent or recurrent social or interpersonal
problems caused or exacerbated by the effects of the substance.
B. The symptoms have not met criteria for substance dependence.
198 Guidelines for the Treatment of Alcohol Problems
A
P
P
E
N
D
IC
E
S
Appendix 3: DSM-IV diagnostic criteria for substance dependence
A maladaptive pattern of substance use, leading to clinically significant impairment or distress, as
manifested by three or more of the following, occurring at any time in the same 12 month period:
1. Tolerance, as defined by either:
a.  a need for markedly increased amounts of the substance to achieve intoxication or the
desired effect.
b.  markedly diminished effect with continued use of the same amount of the substance.
2. Withdrawal, as manifested by either of the following:
a.  A characteristic withdrawal syndrome
b. The same or a closely related substance is used to relieve or avoid withdrawal symptoms
3. the substance is taken in larger amounts or for a longer period than intended.
4. there is a persistent desire or unsuccessful efforts to cut down or control substance use
5. a great deal of time in spent in activities necessary to obtain the substance, use the substance,
or recover from its effects.
6. important social, occupational or recreational activities are reduced or given up because of
substance use.
7. substance use is continued despite knowledge of having a persistent or recurrent physical or
psychological problem that is likely to have been caused or exacerbated by the substance.
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